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The Flaviviridae family consists of several medically important pathogens 
such as West Nile virus (WNV) and Dengue virus (DENV). Flavivirus capsid 
(C) protein is a key structural component of virus particles. However, the role 
of C protein in the pathogenesis of arthropod-borne flaviviruses is poorly 
understood. To examine whether flavivirus C protein can associate with 
cellular proteins, and contribute to viral pathogenesis, WNV/DENV C protein 
was screened against a human brain/liver cDNA yeast two-hybrid library. This 
study identified several interesting proteins associated with a wide variety of 
cellular functions. One of the exocyst components, human Sec3 protein 
(hSec3p) was discovered to be a novel interacting partner of WNV and DENV 
C protein. Mutagenesis studies showed that the SH2 domain-binding motif of 
hSec3p binds to the first 15 amino acids of C protein. Based on the functional 
roles of Sec3p in the secretory pathways and exocytosis process, it was 
hypothesized that flavivirus C protein might exploit hSec3p for virus 
trafficking and release. The knock-down of hSec3p should therefore prevent C 
protein-exocyst association and disrupt virus production. However, hSec3p 
knock-down potentiated virus replication/production in flavivirus-infected 
hSec3p knock-down cells while the reverse phenomenon was observed in 
hSec3p over-expressing cells. This contradicted the initial hypothesis and 
proposed hSec3p as a negative regulator of flavivirus infection. This is the 
first study that highlighted hSec3p as an anti-flaviviral host protein. This study 
reported for the first time that hSec3p modulated virus production by affecting 
viral RNA transcription and translation through the sequestration of elongation 




longer capable of binding to flaviviral RNA efficiently. This resulted in 
reduced binding of EF1 with flaviviral RNA genome or RNA-associated 
replicative complex and led to the decrement in viral RNA synthesis. By 
sequestering the translational enhancer, EF1, hSec3p also inhibited viral 
protein translation. This molecular discovery shed light on the protective role 
of hSec3p during flavivirus infection. This study also highlighted the 
antagonistic mechanism adopted by flavivirus C protein that activated the 
chymotrypsin-like proteolytic function of 20S proteasome to degrade hSec3p. 
This resulted in reduced hSec3p level that subsequently led to the decreased 
formation of EF1-hSec3p complex. This rendered free EF1 readily 
available to interact with 3’UTR of viral RNA to aid viral RNA transcription 
and translation. In this way, C protein nullified the anti-viral effects of hSec3p 
to support flavivirus life-cycle. Overall, this study illustrated the antagonistic 
relationship between flavivirus C protein and hSec3p and highlighted the new 
interface for pharmaceutical intervention. 
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1.0. LITERATURE REVIEW 
1.1. FLAVIVIRIDAE 
The family Flaviviridae comprises more than 70 closely related RNA viruses 
under three genera, namely flavivirus, pestivirus and hepacivirus. Members of the 
different genera are distantly related but share a similar gene order and conserved 
non-structural protein motifs. The genus flavivirus consists of most medically 
important groups of emerging arthropod-borne viruses that includes West Nile 
(WNV), dengue (DENV), yellow fever (YFV), Japanese encephalitis (JEV) and 
tick-borne encephalitis (TBEV) viruses (Gaunt et al., 2001; Heinz & Allison, 
2000; Kuno et al., 1998). The genus pestivirus includes classical swine fever virus 
(CSFV) and bovine viral diarrhea virus (BVDV). Hepatitis C virus (HCV) is the 
member of the genus, Hepacivirus (Taxonomy, 2000).  
 
1.2. FLAVIVIRUS 
The name, flavivirus was derived from YFV, a representative virus of the 
Flaviviridae family (In Latin, flavus means yellow). Flaviviruses are a group of 
small enveloped RNA viruses that cause serious diseases in humans and animals. 
Most of them are arthropod-borne viruses and are transmitted to vertebrate hosts 
by either mosquitoes or ticks (Gubler et al., 2007). These flaviviruses cause a 
range of distinct clinical diseases in humans. Based on the associated clinical 
manifestations, flaviviruses can be clustered into two main groups. The first group 
includes viruses that have the capacity to cause vascular leak and haemorrhage 




encephalitis (WNV, JEV and TBEV). However, relatively few infected 
individuals develop these severe clinical manifestations and many are 
asymptomatic or have an undifferentiated febrile illness. In this literature review, 
the focus is on WNV and DENV since these two representative viruses were 
chosen for studies in the following chapters although studies involving TBEV, 
YFV, JEV, HCV and other RNA viruses were also compared.  
 
1.3. TRANSMISSION 
West Nile virus is transmitted by Culex mosquitoes primarily between birds, the 
amplifying hosts of the virus. They also function as bridge vectors for 
transmission to humans, equines and other mammals (Turell et al., 2005). 
Humans are considered dead-end hosts because they usually develop viremia at 
an insignificant level to facilitate further transmission of the virus. West Nile 
virus transmission was also reported during organ transplantation (DeSalvo et al., 
2004; Jain et al., 2007; Murtagh et al., 2005; Wadei et al., 2004), blood 
transfusion (Dokland et al., 2004; Macedo de Oliveira et al., 2004; Montgomery 
et al., 2006) pregnancy (Dokland et al., 2004; Jamieson et al., 2006; O'Leary et 
al., 2006; Skupski et al., 2006) and lactation (Brinton, 2002). Occupational WNV 
infections in laboratory workers have also been documented (Brinton, 2002; 
Hamilton & Taylor, 1954). 
 
Dengue virus is transmitted by Aedes mosquitoes. Although the virus is 




the principal vector. Dengue viruses are maintained in an Aedes aegypti - human - 
Aedes aegypti cycle with periodic epidemics. Infected humans are the main 
carriers and amplification host of DENV. Female mosquitoes acquire DENV by 
biting infected humans in the viraemic phase and become infective after an 
extrinsic incubation period of 7-14 days. Since female mosquitoes are nervous 
feeders, the slightest movement will disrupt the feeding process. Few moments 
later, they will continue to feed on the same person or different person. This 
behavioral pattern allows the infected mosquito to feed on several people during a 
single blood meal, which in turn transmit DENV to many people in a short 
duration (Gubler, 1998). Dengue virus transmission was also reported during 
organ transplantation (Machado et al., 2009; Teo et al., 2009), blood transfusion 
(Teo et al., 2009) and pregnancy (Basurko et al., 2009).  
 
1.4. CLINICAL MANIFESTATIONS 
While the majority of WNV infections are asymptomatic, it can cause debilitating 
disease in humans and animals, with symptoms ranging from febrile illness to 
fatal encephalitis. About 20% of infected patients display a range of symptoms 
including fever, headache, malaise, back pain, myalgias, eye pain, pharyngitis, 
nausea, vomiting, diarrhea and abdominal pain. Out of that 20%, maculopapular 
rash appears in approximately half, a subset of which would acquire a form of 
neuroinvasive disease (Petersen & Roehrig, 2001; Watson et al., 2004). More 
serious manifestations of WNV are categorized as encephalitis, meningitis and 




Muscle weakness and flaccid paralysis is particularly suggestive of WNV 
infection (Petersen & Marfin, 2002). Asymmetric acute flaccid paralysis 
syndrome may also occur independent of encephalitis and has been noted to be a 
sign of impending respiratory failure (Sejvar et al., 2005).  
 
West Nile encephalitis is commonly reported in patients above the age of 55 and 
is higher among organ transplant recipients (Kumar et al., 2004; O'Leary et al., 
2002). West Nile poliomyelitis, West Nile choreoretinitis, hepatitis, pancreatitis, 
cardiac dysrhythmia and myocarditis have also been documented [reviewed in 
(Hayes & Gubler, 2006)]. Around 381 cases of WNV infection in United States 
with 12 fatalities were reported to CDC between January to November 2010 
(http://www.cdc.gov/ncidod/dvbid/westnile/surv&controlCaseCount10_detailed. 
htm). There was no reported human case of WNV infection in Singapore. 
 
Dengue virus causes a wide range of diseases in humans, ranging from acute 
febrile illness dengue fever to life-threatening dengue hemorrhagic fever/dengue 
shock syndrome (DHF/DSS). Febrile dengue fever is self-limited though 
debilitating illness characterized by fever, frontal headache, retro-orbital pain, 
myalgia, arthralgia, nausea, vomiting, weakness and rash. Constipation, diarrhea 
and respiratory symptoms are occasionally reported. Lymphadenopathy is 
common. Rash is variable but occurs in up to 50% of patients as either early or 
late eruptions. In some cases, an intense erythematous pattern with islands of 




Dengue hemorrhagic fever is marked by increased vascular permeability, 
thrombocytopenia and hemorrhagic manifestations. Common hemorrhagic 
manifestations include skin hemorrhages such as petechiae, purpuric lesions and 
ecchymoses. Epistaxis, bleeding gums, gastro-intestinal hemorrhage and 
hematuria occur less frequently. Dengue shock syndrome occurs when fluid 
leakage into the interstitial spaces results in shock, which without appropriate 
treatment may lead to death [reviewed from (Gubler, 1998; Halstead, 2007; 
Leong et al., 2007)]. It has been estimated that more than 2.5 billion people in 
over 100 countries are at risk of DENV infection. As many as 100 million people 
are infected yearly with 500,000 cases of DHF and 22,000 deaths mainly among 
children (http://www.cdc.gov/dengue/epidemiology/index.html and 
http://www.who.int/csr/disease/dengue/impact/en/). Dengue virus infection poses 
a major health problem in Singapore. Despite the active vector sutveillence 
programme in Singapore, about 1200 dengue cases have been reported in 2011 
(Jan to 1
st
 week of May). The number of dengue cases would significantly 
increase in the period of June to October which is the actual peak period of 
dengue infection.  
 
1.5. STRUCTURE OF FLAVIVIRUS  
The mature flavivirus is smooth and spherical with a diameter of approximately 
50 nm. The mature virus is symmetrically icosahedral with no spiky surface 
extensions (Mukhopadhyay et al., 2003). Each virion is composed of a single 
positive-strand genomic RNA. The RNA genome is housed within a poorly-
ordered cage-like nucleocapsid core composed of multiple copies of capsid (C) 




by a 4 nm thick lipid bilayer derived from the endoplasmic reticulum (ER) 
membrane of the host cell, within which 180 copies of two viral glycoproteins, 
membrane (M) and envelope (E) are anchored (Kuhn et al., 2002; Mukhopadhyay 
et al., 2003; Mukhopadhyay et al., 2005; Perera & Kuhn, 2008).  
 
The M and E proteins have different conformations in immature and mature 
virions, thereby conferring unique structural features to both forms of particles. In 
immature virion, E protein exists as a heterodimer with prM protein. These 
heterodimers form 60 trimeric spikes that extend away from virus surface and 
gives the virus a „spiky‟ morphology (Fig. 1.1). In mature virion, E proteins are 
found as 90 homodimers that lie flat against viral surface forming a „smooth‟ 
protein shell (Fig. 1.2). The structural transitions from immature (spiky) to mature 
(smooth) morphology occur in Trans-Golgi Network (TGN) and are driven 
predominantly by pH-driven conformational changes in E protein (Modis et al., 
2003; 2004; 2005; Zhang et al., 2004). In both mature and immature particles 
(Fig. 1.3), there is a gap of about 3 nm between the lipid bilayer and nucleocapsid 
core. Unlike alphaviruses, there are little or no connections between the viral 
outer coat and inner core (Kuhn et al., 2002; Mukhopadhyay et al., 2003; Zhang 
et al., 2003a; Zhang et al., 2003b).  
 
1.6. FLAVIVIRUS RNA GENOME ORGANIZATION AND VIRAL 
PROTEINS 
The flavivirus genome consists of a single-stranded RNA molecule of positive 
polarity. Since the genomic RNA is positive-stranded, it is infectious (Ada & 
























Fig. 1.3: Cross section of virus particle showing the ectodomain of prM 
protein in bluish white, lipid bilayer in green and nucleocapsid in orange 






single open reading frame (ORF) flanked by 5‟- and 3‟-untranslated regions 
(UTRs) (Fig. 1.4). The UTRs possess secondary structures that are essential for 
initiation of positive strand RNA synthesis, negative strand RNA synthesis and 
initiation of translation (Davis et al., 2007b; Paranjape & Harris, 2010; Tilgner et 
al., 2005; Tilgner & Shi, 2004; Villordo & Gamarnik, 2009; Wei et al., 2009; Yu 
et al., 2008b; Zhang et al., 2008a). In mosquito-borne flaviviruses, the 5‟UTR has 
a type I cap, but 3‟ UTR lacks the 3' terminal polyadenine tract (poly-A-tail), 
instead terminates with conserved dinucleotide CU
OH
 (Brinton et al., 1986; 
Westaway, 1987). 
 
The ORF encodes a polyprotein precursor of approximately 3400 amino acids, 
which are co-translationally and post-translationally processed by host cell 
signalases and viral proteases to form three structural and seven non-structural 
(NS) proteins (Fig. 1.4). The structural proteins capsid (C), pre-
membrane/membrane (prM/M) and envelope (E) constitute the virus particle 
while the NS proteins are involved in viral RNA replication, virus assembly and 
modulation of host cell responses (Beasley, 2005; Brinton, 2002; Chambers & 
Rice, 1987; Lindenbach & Rice, 2003; Rice, 1990). Table 1.1 summarizes the 


















Fig. 1.4: Schematic representation of flavivirus genome organization and 
polyprotein processing. The 11kb positive-sense, single-stranded RNA genome 
contains a 5‟ CAP, but no 3‟ poly-A tail. It is translated as one long polyprotein 
that is cleaved by viral and host proteases to form three structural proteins and 
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C 14 Yes No - Basic building blocks of nucleocapsid protein 
(Kiermayr et al., 2004; Kunkel et al., 2001; Patkar et 
al., 2007) 
 
- Conserved internal hydrophobic domain aids the 
oligomerization of C protein and assists the 
anchoring of C protein to cellular ER membrane 
(Bhuvanakantham & Ng, 2005; Markoff et al., 1997; 
Wang et al., 2004) 
 
prM 26 No No - Important for maturation of the virus with cleavage 
of prM to M (Chambers et al., 1990a; Stadler et al., 
1997) 
 
- Co-expression of prM is essential for proper 
folding of E protein (Holbrook et al., 2001; Konishi 
& Mason, 1993; Lorenz et al., 2002) 
 
- prM protects E protein from premature acid-
induced fusion in the acidic compartments of 
secretory pathway (Allison et al., 1995; Guirakhoo 
et al., 1992; Heinz & Allison, 2000; 2003; Heinz et 
al., 1994; Li et al., 2008; Yu et al., 2008a) 
 
- prM interacts with host proteins such as V-ATPase 
and claudin-1 to facilitate efficient virus entry and 
egression (Duan et al., 2008; Gao et al., 2010) 
 
E 50-60 No No  - Mediates virus binding to host cell receptors  
(Chambers et al., 1990a; Modis et al., 2004; Rey et 
al., 1995) 
 
- Mediates membrane fusion (Allison et al., 2001; 
Allison et al., 1995; Bressanelli et al., 2004; Heinz 
& Allison, 2000; 2003; Rey et al., 1995) 
 
- antigenic properties  (Chambers et al., 1990a; 
Modis et al., 2004; Rey et al., 1995) 
 
NS1 45 Yes Yes - Part of viral replication complex (Lindenbach & 
Rice, 1999; Mackenzie et al., 1996) 
 
- Attenuates complement activation (Chung et al., 
2006) 
 
- Elicits auto-antibodies against platelet and 
extracellular matrix proteins (Chang et al., 2002; 
Falconar, 1997)  
 
- Causes endothelial cell damage through antibody-
dependent complement-mediated cytolysis 
(Falconar, 1997; Lin et al., 2005a; Lin et al., 2003; 





NS2A 22 No Yes - Part of viral replication complex (Mackenzie et al., 
1998) 
 
- Modulates host interferon response (Liu et al., 
2004b; Liu et al., 2006b)  
 
- Affects the assembly of virus particles (Liu et al., 
2003) 
 
NS2B 14 No No - Functions as a co-factor for the serine protease 
activity of NS3 (Chambers et al., 1993; Chang et al., 
1999) 
 
- Mediates membrane permeability during flavivirus 
infection (Chang et al., 1999) 
 
NS3 70 Yes Yes - possesses serine protease, RNA helicase, RNA 
triphosphatase (RTPase) and RNA-stimulated 
nucleoside triphosphatase (NTPase) activities 
 
- The protease domain cleaves viral polyprotein at 
several sites (Amberg & Rice, 1999; Falgout et al., 
1991; Preugschat et al., 1990) 
 
- The helicase domain unwinds the RNA secondary 
structure in the 3‟UTR of viral RNA genome as well 
as the double-stranded replicative form of viral RNA 
(Benarroch et al., 2004; Chen et al., 1997a; Matusan 
et al., 2001) 
 
- The RTPase helps to synthesize and modify the cap 
structure at the 5‟ end of nascent viral genome 
(Wengler, 1993) 
 
- The NTPase activity of NS3 is essential to power 
RNA unwinding for helicase activity (Li et al., 1999) 
 
NS4A 16 No Yes - Induces membrane rearrangements, a unique 
feature observed with most RNA viruses (Miller et 
al., 2007; Roosendaal et al., 2006) 
 
- Modulates the host interferon response (Munoz-
Jordan et al., 2003) 
 
NS4B 27 Yes Yes - Inhibits host-induced interferon signaling (Munoz-
Jordan et al., 2005) 
 
- Modulates viral replication by interacting with NS3 
(Umareddy et al., 2006) 
 
NS5 105 Yes Yes - The RNA-dependent RNA polymerase activity is 
essential for virus replication (Khromykh et al., 
1998; Khromykh et al., 1999) 
 
- Its S-adenosyl methyl transferase activity helps to 
methylate the type I cap at the 5‟ end of viral 





1.7. FLAVIVIRUS LIFE CYCLE 
Flavivirions attach to target cells through binding of E protein to the receptor(s) 
on host cell surfaces. Several receptors and co-receptors have been identified for 
flaviviruses such as integrin V3, Fc, Rab5, heat shock cognate protein 70, C-
type lectin DC-SIGN, glycosaminoglycan and heparin sulphate (Chen et al., 
1997b; Chu & Ng, 2004c; Krishnan et al., 2007; Lee & Lobigs, 2000; Liu et al., 
2004a; Martina et al., 2008; Miller et al., 2008; Navarro-Sanchez et al., 2003; 
Ren et al., 2007). After binding to the cell receptors, virions enter the cells by 
receptor-mediated endocytosis (Acosta et al., 2008; 2009; Ang et al., 2010; Chu 
& Ng, 2004b; Peng et al., 2009). The acidic environment of endosomes triggers 
major conformational changes on E protein, which results in re-organisation of E 
homodimers into E homotrimers. This structural re-arrangement exposes the 
fusion peptide which helps in the insertion of the virus into the host endosomal 
membrane (Allison et al., 2001; Allison et al., 1995; Bressanelli et al., 2004; 
Heinz & Allison, 2000; 2003; Rey et al., 1995). After fusion has occurred, the 
nucleocapsid is released into the cytoplasm. The nucleocapsid further dissociates 
into RNA and C protein and this process is believed to be spontaneous (Heinz & 
Allison, 2000; Koschinski et al., 2003).  
 
Flaviviral RNA genome is translated by host cell machinery into a single 
polyprotein that is co-translationally and post-translationally processed by viral 
and host proteases to generate structural and non-structural proteins (Fig. 1.5). 




prM/E, E/NS1 and NS4A/NS4B junctions. As a result, C, prM, E and NS1 
proteins are released from the polyprotein. The prM and E proteins remain 
anchored on the luminal side of the membrane, while C protein remain anchored 
on the cytoplasmic side of ER membrane by a conserved hydrophobic signal 
sequence at its carboxy-termini. Within TGN, furin cleaves prM into M protein, 
releasing the “pr” region, which is subsequently secreted into the extracellular 
medium. The NS2B/NS3 protease cleaves the polyprotein at all protein-protein 
junctions on the cytosolic side of ER membrane, releasing all non-structural 
proteins. On the cytoplasmic side of ER membrane, the NS2B/NS3 protease also 
cleaves the anchored C protein before the carboxy-termini hydrophobic sequence. 
As a result, the signal sequence for translocation of prM into ER lumen is released 
and mature C is produced (Chambers et al., 1990a; Chambers et al., 1990b; 
Chambers & Rice, 1987; Markoff, 1989; Perera & Kuhn, 2008; Stocks & Lobigs, 
1995; 1998).  
 
After translation of input genomic RNA, NS5 through its RNA-dependent RNA 
polymerase activity together with other viral non-structural proteins and some 
host proteins, copies complementary minus strand RNA from genomic RNA. 
Flaviviral RNA synthesis occurs in an asymmetric and semi-conservative manner. 
A single, nascent minus RNA strand is synthesised from plus strand RNA genome 
and forms double-stranded RNA replicative form (RF). The RF is then used as a 
template for the synthesis of new RNA strands through a replicative intermediate 










Fig. 1.5: Schematic representation of flavivirus life cycle [adapted from 
(Mukhopadhyay et al., 2005; Perera & Kuhn, 2008)]. The virion binds to a cell 
surface receptor and enters the cell by endocytosis. The low pH within the 
endosome induces membrane fusion and release of nucleocapsid into cytosol 
where viral RNA (vRNA) is released. The translation of the polyprotein occurs at 
ER lumen. Host-encoded proteases and virus-encoded proteases cleave the 
polyprotein to form structural and non-structural proteins (shown in the Inset). 
Genome replication occurs on intracellular membranes. The structural proteins 
and the vRNAs then buds into the ER lumen to associate with prM-E 
heterodimers and forms immature virus particles. The immature virus particles are 
transported through TGN and cleaved by furin to produce mature, infectious 












single minus strand. The synthesis of plus strand RNA is 10 times more efficient 
than that of minus strand (Brinton, 2002; Chu & Westaway, 1985; Cleaves et al., 
1981; Mackenzie et al., 1998). Flavivirus replication occurs in the cytoplasm on 
virus-induced host cell membranes, which are believed to be derived from 
ER/Golgi membrane [vesicle pockets (VP)]. 
 
Uchil and colleagues (2003) suggested that VPs protect the RF from host defences 
through a tough double-membrane and protective protein cover. Other virus-
induced membranous structures called convoluted membranes (CM) and 
paracrystalline arrays (PC) are also reported to form near VPs. These virus-
induced membranous structures are concentrated in the perinuclear region of host 
cells, providing a scaffold structure to anchor viral replicative complexes for 
efficient processing and synthesis (Mackenzie, 2005; Mackenzie et al., 1996; 
Mackenzie et al., 1998; Mackenzie & Westaway, 2001). 
 
Virion assembly occurs in the lumen of rough ER (Mackenzie & Westaway, 
2001). The newly synthesized C protein undergoes oligomerisation 
(Bhuvanakantham & Ng, 2005; Kiermayr et al., 2004; Ma et al., 2004; Wang et 
al., 2004) and interacts with flaviviral RNA (Khromykh & Westaway, 1996) to 
form nucleocapsid and buds into the ER lumen. The nucleocapsid is then 
packaged into an ER-derived lipid bilayer containing heterodimers of prM and E 
proteins (Lobigs & Lee, 2004; Lorenz et al., 2003; Mackenzie & Westaway, 
2001). This results in the formation of non-infectious, immature virus particles 
which cannot induce host-cell fusion. Together with immature virus particles, 




immature and subviral particles are then transported through TGN, where host 
protease furin cleaves prM protein that is present on the immature virus particles 
to M protein (Chambers et al., 1990a; Stadler et al., 1997). This produces mature, 
infectious virus particles or subviral particles where M proteins remain inserted in 
the envelope of virus particle (Murray et al., 1993; Yu et al., 2008a).  
 
Recently, Yu and colleagues (2008a) showed that the „pr‟ portion of prM is also 
retained on virion to prevent membrane fusion. They also suggested that the „pr‟ 
portion retainment could be a mechanism of flavivirus processing and 
stabilization in cell secretory pathway. Virions are then transported to the plasma 
membrane in vesicles and are released from the host cell by exocytosis. The 
involvement of host proteins in assisting the exocytosis of flaviviruses is largely 
unknown. The exocyst complex plays an important role in the secretory pathway 
and vesicular trafficking (Hsu et al., 1999; TerBush et al., 1996) by targeting 
vesicles to the plasma membrane as well as regulating the later phases of 
exocytosis process (Zhang et al., 2008b). The exocyst is an octameric protein 
complex. The subunits are named as EXOC1, EXOC2, EXOC3, EXOC4, 
EXOC5, EXOC6, EXOC7 and EXOC8. These subunits were also known as Sec3, 
Sec5, Sec6, Sec8, Sec10, Sec15, Exo70 and Exo84. 
 
In yeast, Sec3 protein (Sec3p) serves as a spatial landmark for polarized secretion 
through its ability to bind phospholipids and small GTPases (Baek et al., 2010; 
Finger et al., 1998a; Finger & Novick, 1997; Guo et al., 2001; Hsu et al., 2004; 
Zhang et al., 2001). In yeast, Sec3p was shown to localize with Exo70 at the 




independent of actin assembly although localization of other exocyst components 
relies on actin cables that serve as tracks for motor-driven vesicle transport to the 
daughter cell (Boyd et al., 2004; Finger et al., 1998b; Finger & Novick, 1998; 
Zhang et al., 2005b).  
 
Recently, the structure for the amino-terminal region of yeast Sec3p in complex 
with Rho1 or by itself was unveiled (Baek et al., 2010; Yamashita et al., 2010). 
These studies defined a new subclass of pleckstrin homology domains in the 
exocyst complex and provided the structural insights into how an exocyst subunit 
might interact with both protein and phospholipid factors on the target membrane.  
 
In contrast to yeast Sec3p, very little is currently known about its mammalian 
orthologue, human Sec3 protein (hSec3p). Matern and colleague (2001) showed 
that human Sec3p (hSec3p) interacts with Sec5p and Sec8p, providing further 
evidence that the identified protein is part of the Sec6/8 exocyst complex Human 
Sec3p was the last subunit of the mammalian exocyst complex to have been 
identified (Matern et al., 2001). Unlike yeast Sec3p, hSec3p lacks the Rho binding 
domain and hence it is unlikely to directly bind GTPases of the Rho family. 
However, it was shown that hSec3p facilitated the delivery of matrix 
metalloproteinases to tumor cell invadopodia through an interaction with the 
polarity protein IQGAP1 that is regulated by RhoA and Cdc42 GTPases (Matern 
et al., 2001; Sakurai-Yageta et al., 2008). Human Sec3p has also been implicated 
in the maintenance of desmosomes (Andersen & Yeaman, 2010). A GFP fusion of 
human Sec3 failed to assemble into exocyst holocomplexes and remained 






as a spatial landmark for secretion in mammalian cells (Matern et al., 
2001). Moreover, the localization and function of endogenous hSec3p have not 
been investigated. Because this subunit is important for ensuring correct polarized 
localization of exocyst complexes in budding yeast, this represents an important 
gap in our knowledge of the mammalian exocyst complex. Examining the 
involvement of exocyst components, especially hSec3p, in flavivirus life cycle 
could shed light on host proteins associated with exocytosis of flaviviruses.  
 
1.8. THE CAPSID PROTEIN 
In this literature review, the structural and functional properties of C protein were 
analyzed in detail since C protein was chosen for studies in the subsequent 
chapters. The C protein is the first structural protein found in the ORF. The viral 
polyprotein is cleaved by host signalase and forms anchored C protein that remain 
anchored on the cytoplasmic side of ER membrane by a conserved hydrophobic 
signal sequence at its carboxy-termini. The carboxy-termini hydrophobic 
sequence of anchored C protein is cleaved by NS2B/NS3 protease and forms 
mature C protein (Chambers et al., 1990a; Markoff, 1989). The C protein is the 
basic building blocks of nucleocapsid which encapsidates viral RNA (Khromykh 
& Westaway, 1996; Kiermayr et al., 2004; Kunkel et al., 2001; Patkar et al., 
2007). 
 
1.8.1. Alignment of the amino acid sequences of flavivirus capsid protein 
As an initial step to examine the genetic relationship of flavivirus C proteins, 
alignment of the amino acid sequences of various flavivirus C protein was 
performed with CLUSTALW2 alignment software (Fig. 1.6). Among all the 




sequence identity between most genus members (Table 1.2). Various strains of 
WNV C proteins (NY, S and KUN) share ~90% sequence identity while C 
proteins of different serotypes of DENV share ~60-80% sequence identity. The C 
protein of WNV shares about 60-65% sequence identity with that of JEV C 
protein. It is not surprising since WNV belongs to Japanese encephalitis 
serocomplex of flavivirus genus as defined on the basis of cross-neutralization 
tests using polyclonal sera (Calisher et al., 1989; De Madrid & Porterfield, 1974; 
Poidinger et al., 1996). The C protein of WNV shares about 25-35% sequence 
identity with that of DENV. Among the viruses analyzed by multiple sequence 
alignment, WNV and DENV C protein share the least sequence identity with that 
of YFV and TBEV. It is not unforeseen since several studies demonstrated that 
TBEV and YFV are phylogenetically distinct from that of Japanese encephalitis 
serocomplex and dengue viruses (Gaunt et al., 2001; Kuno et al., 1998). 
 
Phylogenetic trees were also constructed from the aligned amino acid data with a 
neighbour-joining distance method using CLUSTALW2 and PHYLIP programs 
(Fig. 1.7). The topology of the tree indicated that all four serotypes of DENV 
form a cluster with close genetic relationship among the serotypes. As reported 
earlier, the C protein of KUN is closely associated with WNV(NY) although they 
form a cluster together with WNV(S) (Li et al., 2006).  
 
Although the amino acid sequences of flavivirus C proteins are poorly conserved, 
they are structurally and functionally similar. The C protein of flavivirus was 
shown to be an alpha-helical protein and it functions primarily to package the 
viral genome (Chambers et al., 1990a; Dokland et al., 2004; Jones et al., 2003; 







Fig. 1.6: Multiple amino acid sequence alignment of flavivirus C proteins 
derived using CLUSTALW software (http://www.ebi.ac.uk/Tools/ 
clustalw2/index.html). The accession numbers of the viruses are as follows: 
WNV(NY)-AF260967 (West Nile, New York); KUN-D00246 (Kunjin) WNV(S)-
AY688948 (West Nile Sarafend); JEV-U14163 (Japanese encephalitis); DENV1-
FN429887 (Dengue type 1); DENV2-FN429895 (Dengue type 2); DENV3-
DQ863638 (Dengue type 3); DENV4-M14931 (Dengue type 4); YFV-AF094612 
(Yellow fever); TBE-L40361 (Tick borne encephalitis). Red colour: small, 
hydrophobic or aromatic amino acids. Blue colour: acidic amino acids. Pink 
colour: basic amino acids. Green colour: amino acids with hydroxyl, amine or 













Fig. 1.7: Phylogram generated using CLUSTALW2 and PHYLIP programs. 
 
 










1.8.2. Structure of capsid protein  
Cryo-electron microscopy (EM) reconstructions of WNV and DENV showed that 
E protein on the surface is well-ordered. However, EM reconstructions did not 
show any structure of the inner core. This could be due to the core being 
disordered or having different symmetry from the envelope (Kuhn et al., 2002; 
Mukhopadhyay et al., 2003; Zhang et al., 2003b). Characterization of secondary 
structures in C proteins of DENV and YFV by nuclear magnetic resonance 
spectroscopy (NMR) revealed that flavivirus C protein is a symmetric dimer in 
solution. Further analysis of these C proteins with far-UV circular dichroism 
spectroscopic analyses indicated that flavivirus C protein is an alpha-helical 
protein (Jones et al., 2003; Ma et al., 2004). The crystal structure of KUNV C 
protein further confirmed that flavivirus C protein forms dimer and these dimers 
are organized into tetramers (Dokland et al., 2004). 
 
The secondary structure of DENV C protein is composed of four alpha helices 
(Fig. 1.8) namely helix I (1) to helix IV (4). Helix I (1) included the amino 
acids from 26 to 31 of DENV C protein. This is followed by a 14-residue loop, 
helix II (amino acids 45 to 55 of DENV C protein) and a short loop region 
(amino acids 56 to 62 of DENV C protein). Following this region are helix III 
(amino acids 63 to 69 of DENV C protein) and a fourth short loop region 
(amino acids 70 to 73 of DENV C protein). The conserved internal hydrophobic 





Fig. 1.8: Multiple sequence alignment of flavivirus C protein adapted from 
Ma and colleagues (2004). The four alpha-helices are shown at the top. The 
conserved hydrophobic regions are shaded grey. Residues with similarity greater 



















helix in flavivirus C protein is helix IV (4) that occurs at the C terminus of the 
protein (amino acids 74 to 96 in case of DENV C protein). The N terminus of C 
protein (amino acids 1 to 21 of DENV C protein) appeared to be the least 
structured region of the protein and could be removed without disrupting the 
structural integrity of the protein (Jones et al., 2003; Ma et al., 2004).  
 
1.8.3. Nucleocapsid formation 
Nucleocapsid assembly in general involves the interactions between C-C proteins 
and C protein-viral RNA. The viral genome is generally protected by multiple 
copies of C protein and the surrounding lipid envelope. The multiple copies of C 
proteins, encoded by a relatively short nucleic acid sequence, can encapsidate a 
relatively large volume of nucleic acid. This strategy reduces the burden of 
encoding a large protein, but generates a new problem of assembling multimers, 
in a biologically realistic time frame (Zlotnick, 2005). Moreover, studies 
suggested that C-C self-association and the eventual formation of a nucleocapsid 
is a spontaneous process in the presence of nucleic acid (Kiermayr et al., 2004; 
Kunkel et al., 2001). It is assumed that all the information required for assembly 
is built into the tertiary structure of C protein.  
 
1.8.3.1. Dimerization of flavivirus capsid protein 
The understanding of C protein interactions with itself would provide important 
data on how the nucleocapsid is organized in flavivirus during assembly. Several 




(Bhuvanakantham & Ng, 2005; Kiermayr et al., 2004; Wang et al., 2004). Self-
association of flavivirus C protein was mediated by the first three helices of C 
protein (Ma et al., 2004). Tryptophan at the amino acid residue 69 in the central 
hydrophobic region was shown to be a critical determinant in stabilizing the 
oligomerization of C protein (Bhuvanakantham & Ng, 2005). Studies suggested 
that dimeric form of C protein is the basic building block of flavivirus 
nucleocapsid (Kiermayr et al., 2004; Kunkel et al., 2001; Patkar et al., 2007). 
These observations were supported by structural analysis of KUNV and DENV C 
protein (Jones et al., 2003; Kuhn et al., 2002; Ma et al., 2004).  
 
1.8.3.2. Flavivirus capsid protein - RNA interaction  
The RNA binding properties of flavivirus C protein was first demonstrated with 
KUNV. The positively-charged clusters in amino- and carboxy-termini of C 
protein were involved in the recruitment of viral RNA to form nucleocapsid 
(Khromykh & Westaway, 1996). This was supported by the model proposed 
based on structural studies (Dokland et al., 2004; Ma et al., 2004). A 
conformational switch in the disordered N-terminal region caused the order-
disorder transition in helix I (1). As a result, the amino- and carboxy-termini of 
C protein were brought together. This is significant since the RNA-binding region 
on C protein was found on both amino- and carboxy-termini (Khromykh & 
Westaway, 1996). This property can be extended to other flavivirus C proteins 




C protein needs to be dephosphorylated for efficient RNA binding (Cheong & Ng, 
2010).  
 
However, the RNA encapsidation signal was not clearly defined although 5' UTR 
and 3' UTR of KUNV RNA was demonstrated to bind KUNV C protein 
(Khromykh & Westaway, 1996). Analysis of 5' UTR and 3' UTR of flavivirus 
genome revealed complex secondary structures such as stem loops and bulges. 
These structures undergo cyclization whereby the conserved regions on 5'UTR 
and 3'UTR are paired (Khromykh et al., 2001).  
 
1.8.4. Nuclear phase of flavivirus capsid protein  
The C proteins of arthropod-borne flaviviruses such as WNV, DENV, KUNV and 
JEV were localized in the cytoplasm and nuclei (Bulich & Aaskov, 1992; Chang 
et al., 2001; Makino et al., 1989; Mori et al., 2005; Oh & Song, 2006; Tadano et 
al., 1989; Westaway et al., 1997). However, the exact functions of flavivirus C 
protein in nucleus are unclear since positive-stranded RNA viruses are thought to 
utilize cellular components in the cytoplasm for replication. Nuclear localization 
of C protein for positive-stranded RNA viruses is not unusual though. The C 
protein of coronavirus, another positive-stranded RNA virus, was also shown to 
localize in the nucleus (Chen et al., 2002; Hiscox et al., 2001; Timani et al., 2005; 
Wurm et al., 2001). Nuclear localization of flavivirus C protein was shown to be 
essential for efficient virus replication (Bhuvanakantham et al., 2009; Mori et al., 




1.8.5. Interactions between virus capsid protein and host proteins 
Several studies showed that C proteins of RNA viruses functioned as important 
mediators of virus-host interactions besides serving as building blocks of virions 
(Beatch & Hobman, 2000; Hunt et al., 2007; Iinuma et al., 1971; Luo et al., 
2004a; Luo et al., 2004b; Moriishi et al., 2003; Oh et al., 2006; Ohkawa et al., 
2004; Plyusnina & Plyusnin, 2005; Tsukiyama-Kohara et al., 2004; Tyagi et al., 
2005; Yang et al., 2008). This is not surprising since it will be beneficial for the 
viruses to encode multifunctional proteins. Since C protein of several RNA 
viruses were localized in both cytoplasm and nucleus, C proteins were exposed to 
a wide variety of host cell proteins in the cytoplasm and nucleus during the 
replication cycle.  
 
Although C protein is the first viral protein to be synthesized in infected cells, 
they need not to be incorporated into virions immediately after synthesis. This 
suggested that there would be a large pool of C protein present within infected 
cells that could serve other nonstructural functions (Iinuma et al., 1971; Plyusnina 
& Plyusnin, 2005). For the sake of brevity, this literature review will be limited to 
C protein of arthropod-borne flaviviruses although C proteins of HCV and 
coronavirus are referred to on occasions.  
 
1.8.5.1. Interactions between flavivirus capsid protein and importins 
Nuclear translocation is generally mediated by a family of transporters or 




signal (NLS) motif bind to importin-α/ to mediate nuclear translocation of the 
protein (Goldfarb et al., 2004). The mechanism of nuclear translocation 
necessitates the binding of importin- to the NLS motif. Importin-, then acts as 
an adaptor for the binding of importin-. Subsequently, importin- docks the 
entire complex of NLS-bearing protein and importin-/ at the nuclear pore 
complex for nuclear translocation (Gorlich et al., 1996). The C protein of HCV 
interacted with importins to facilitate its nuclear entry (Suzuki et al., 2005). The C 
proteins of arthropod-borne flaviviruses were also reported to utilize importins for 
their nuclear translocation (Bhuvanakantham et al., 2009). Protein kinase C-
mediated phosphorylation of arthropod-borne flaviviruses C protein was shown to 
be essential to mediate efficient nuclear localization (Bhuvanakantham et al., 
2010).  
 
1.8.5.2. Interactions between flavivirus capsid protein and nucleolar proteins 
Several studies showed that JEV C protein interacted with nucleolar protein B23 
and heterogenous nuclear ribonucleoprotein (Mori et al., 2005; Tsuda et al., 
2006). It was also shown that nuclear phase of flavivirus C protein was important 
for efficient viral replication and disruption of nuclear localization was shown to 
be detrimental for viral replication (Bhuvanakantham et al., 2009; Mori et al., 
2005). However, the exact mechanism by which C protein in the nucleus exerts 
this effect remains to be unveiled. It is likely that being positively charged, C 
protein might interact with rRNA after entering the nucleolus, thereby regulating 




al., 2003; Hernandez-Verdun & Roussel, 2003; Hernandez-Verdun et al., 2002; 
Leung et al., 2003; Rubbi & Milner, 2003). This could alter the host cell 
environment to be more favourable to virus replication/production.  
 
1.8.5.3. Interactions between flavivirus capsid protein and cell cycle-
associated proteins 
Several studies suggested that flavivirus infection caused cell cycle arrest at 
various phases for efficient infection and virus production (Helt & Harris, 2005; 
Oh et al., 2006; Phoolcharoen & Smith, 2004; Su et al., 2001). Oh and colleagues 
(2006) reported that WNV C protein was able to mediate cell cycle arrest at G2 
phase. It is not surprising since the C protein of coronavirus, another positive-
stranded RNA virus, was also shown to involve in cell cycle arrest during 
infection through its interaction with cyclin/cyclin-dependent kinase complex (Li 
et al., 2007; Surjit et al., 2006). If cell cycle arrest is a virus-induced phenomenon 
to favour the virus, host should counteract to prevent virus infection. It was shown 
that C protein-induced cell cycle arrest was prevented when Jab1 protein was 
over-expressed (Oh & Song, 2006).  
 
  
1.8.5.4. Interactions between flavivirus capsid protein and apoptosis-related 
proteins 
Apoptosis is a well renowned phenomenon during flavivirus infection (Avirutnan 




Despres et al., 1996; Diniz et al., 2006; Espina et al., 2003; Jan et al., 2000; Liao 
et al., 1997; Marianneau et al., 1998; Mongkolsapaya et al., 2003; Myint et al., 
2006; Parquet et al., 2001; Prikhod'ko et al., 2002; Samuel et al., 2007; Shrestha 
et al., 2003; Su et al., 2001; Thongtan et al., 2004). Flaviviral proteins C, prM and 
NS2B-NS3 were shown to induce apoptosis during flavivirus infection (Catteau et 
al., 2003a; Catteau et al., 2003b; Prikhod'ko et al., 2002; Ramanathan et al., 2006; 
Shafee & AbuBakar, 2003; Yang et al., 2002). The C protein of WNV has been 
implicated in virus-mediated apoptosis via the induction of mitochondrial 
dysfunction and the activation of caspases-9 and -3. It was also capable of 
inducing apoptosis-mediated inflammation in mouse brain (Yang et al., 2002).  
 
Yang and colleagues (2008) showed that WNV C protein interacted with HDM2 
protein and sequestered it into the nucleolus. HDM2 protein participated in 
negative feedback loop of p53 to inhibit abnormal p53 accumulation under 
normal conditions (Haupt et al., 1997). Through direct interaction with HDM2, C 
protein interfered with HDM2-p53 complex formation. This in turn negatively 
affected p53 stabilization/Bax activation and led to apoptosis (Yang et al., 2008). 
Dengue virus C protein interacted with death domain-associated protein and 
induced Fas-mediated apoptosis (Limjindaporn et al., 2007; Netsawang et al., 
2010). It was also shown that nuclear localization of flavivirus C protein is 
important to induce apoptosis (Netsawang et al., 2010; Oh & Song, 2006; Yang et 





Certain host proteins have been shown to protect the cells from C-induced 
cytotoxic effects. Heat shock protein 70 inhibited the nuclear localization of C 
protein by directly interacting with WNV C protein and protect the host cells 
against the cytotoxic effects of C protein (Oh & Song, 2006). Another host 
protein, Jab1 also protected the host cells from C-induced cytotoxic effects by 
accelerating the nuclear export of C protein and by degrading C protein (Oh et al., 
2006).  
 
1.9. PROTEASOME DEGRADATION PATHWAY 
Several studies have shown the involvement of proteasome degradation pathway 
during virus infection (Ashour et al., 2009; Iwatani et al., 2009; Jung et al., 2007; 
Ko et al.; Loureiro & Ploegh, 2006; Mangeat et al., 2009; Marin et al., 2003; Oh 
et al., 2006; Sato et al., 2009). The majority of virus and host proteins were 
degraded by 26S proteasome (Rock et al., 1994). The 26S proteasome is a 
2.5MDa multisubunit complex that catalyzes ATP-dependent proteolysis of 
cellular or viral proteins. It is found both in nucleus and cytosol of all eukaryotic 
cells and is comprised of a single 20S core particle and 19S regulatory particles 
(Adams, 2002; Baumeister et al., 1998; Pickart & Cohen, 2004; Voges et al., 
1999).  
 
The 20S particle is a hollow cylinder composed of four stacked heptameric rings. 
They are composed of α and β subunits. The α subunits are structural in nature, 




subunits each and serve as docking domains for the regulatory particles. The 
alpha subunits form a gate to block the unregulated access of substrates to the 
interior cavity. The inner two rings contain seven β subunits each and contain 3 
different proteolytic sites which differ in their specificity (Groll et al., 1997; 
Nandi et al., 2006). Three major proteolytic activities namely chymotrypsin-like, 
trypsin-like and caspase-like are contained within 20S core.  
 
The chymotrypsin-like site cleaves peptide bonds after hydrophobic residues, 
trypsin-like site cuts after basic residues, while caspase-like site cuts 
preferentially after aspartates (Heinemeyer et al., 1997). All these active sites 
cleave peptide bonds via a nucleophilic attack on the hydroxyl group of the N-
terminal threonine of the catalytic β-subunit (Goldberg, 2000; Heinemeyer et al., 
1997; Lowe et al., 1995; Stock et al., 1995). The active subunits are generated 
from larger precursors that contain a propeptide at their N-terminus, which block 
the active sites until removed autocatalytically during assembly of 20S particle 
(Schmidt et al., 1997; Schmidtke et al., 1997). These chymotrypsin-like, trypsin-
like and caspase-like activities are responsible for much of the protein degradation 
required to maintain cellular homeostasis including degradation of critical cell-
cycle proteins, tumor suppressors, transcription factors, inhibitory proteins, 
damaged cellular proteins and viral proteins (Adams, 2002; Glickman & 
Ciechanover, 2002; Glickman & Maytal, 2002; Heinemeyer et al., 1997; Ko et 





Proteins destined to be degraded by the proteasome are first selectively targeted 
by the addition of a series of covalently attached ubiquitin molecules (Rajkumar 
et al., 2005). The 19S regulatory particles are then able to bind and remove the 
ubiquitin chain. This helps to mediate unfolding and allow the protein to enter 
into the narrow core of 20S particle, where it is degraded to yield peptides ranging 
from 3-25 amino acids in length (Nussbaum et al., 1998).  
 
1.10. VACCINE DEVELOPMENT STRATEGY 
Although there are licensed vaccines for JEV and YFV, these viruses still claim 
thousands of life across their vast endemic areas  (Gould & Solomon, 2008; 
Gubler et al., 2007; Oya & Kurane, 2007). There are no approved vaccines 
available for WNV and DENV. The development of new vaccines or anti-
flaviviral drugs is thus of vital importance at this moment.  
 
The capsid gene could be targeted for the development of single-cycle infectious 
flavivirus mutants. The utility of this approach was first demonstrated by Kofler 
and colleagues (2004a; 2002; 2004b; 2003). Although large deletions in the 
internal hydrophobic domain of TBEV C protein impaired the formation of 
infectious virus particles, it was still capable of secreting significant amounts of 
sub-viral particles. Impact of removal of entire hydrophobic domain could also be 
limited by mutating the remaining amino acids to increase the overall 
hydrophobicity (Kiermayr et al., 2004; Kofler et al., 2004a; Kofler et al., 2002; 




these deletions in C gene failed to produce any infectious progeny or disease but 
significant levels of protective immune responses were elicited in adult mice 
(Aberle et al., 2005; Kofler et al., 2004a; Kofler et al., 2004b). 
 
 Similarly, attenuated DENV carrying deletion of internal stretch of hydrophobic 
residues were capable of inducing high levels of antibody (Zhu et al., 2007). 
RepliVAX containing C gene-deleted genome of YFV or WNV were shown to be 
attenuated in mice (Widman et al., 2008). All these observations demonstrated the 
potential benefits of this deletion strategy to generate attenuated vaccines against 
flavivirus.  
 
DNA vaccines encoding C protein of WNV elicited significant immune responses 
(Forgues et al., 2001; Lazo et al., 2007). The C protein of DENV showed a 
protective response against infection which was independent of antibody 
responses. This could eliminate the potential risk of antibody-dependant 
enhancement associated with the current vaccines under trial (Lazo et al., 2007). 
The use of chimeric E protein-C protein was also shown to be effective in mice by 
stimulating both arms of the acquired immune system (Gil et al., 2009; Valdes et 
al., 2009). Capsid-targeted inactivation of flavivirus was another important anti-
viral strategy (Qin & Qin, 2006). Despite the continuous research efforts on 






1.11. NEED FOR ANTI-VIRALS 
Although the development of vaccines offer promises, it is essential to work 
towards the generation of anti-virals as an alternative approach since arthropod-
borne flaviviruses present a growing threat to public health worldwide. Although 
these viruses account for few hundred million human infections annually, there 
are no effective therapeutic options currently available. Current treatment 
measures are largely supportive and involve the use of anti-viral drugs such as 
ribavirin. Early recognition and prompt supportive treatment can help us to lower 
the risk of developing severe disease. The most effective protective measures at 
this moment include vector control program and personal protective measures.  
 
In order to design an appropriate anti-viral drug, it is essential to understand virus 
morphogenesis and the molecular basis of pathogenesis. The interaction between 
the virus and host plays an important role during viral replication, virulence and 
pathogenicity. However, very little has been done in the context of flavivirus-host 
protein interactions. As far as the C protein of arthropod-borne flavivirus is 
concerned, the dissected host interacting proteins to date were closely associated 
with the process of apoptosis (Limjindaporn et al., 2007; Netsawang et al., 2010; 
Oh & Song, 2006; Yang et al., 2008). Targeting these host proteins might help to 






Virus infection and the host cell responses involve a complex interaction between 
cellular and viral networks. Many viruses attempt to subvert host cell processes to 
increase the efficiency of virus infection and likewise the cell employs a number 
of responses to generate an anti-viral state. The interactions between arthropod-
borne flavivirus C protein and host proteins are complex and poorly studied. 
Understanding how cellular proteins interact with viral RNA or viral proteins, as 
well as the roles of such interactions during virus infection will provide insights 
for designing novel anti-viral agents. This study aims to characterize the role of 
flavivirus C protein in contributing to viral pathogenesis.  
 
The specific objectives of this study are as follows: 
1) Identify novel host proteins that interact with flavivirus C protein. 
2) Examine the effect of identified host proteins on flavivirus life cycle. 
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2.0. MATERIALS AND METHODS 
2.1. CELL CULTURE TECHNIQUES 
All solutions and media for cell culture were made with sterile ultrapure water 
(Milipore, USA). All cell culture and media preparation work was performed 
under aseptic conditions in a Class II Type A2 Bio-safety Cabinet (ESCO Pte Ltd, 
Singapore). The cells used in this study were grown in 25/75 cm
2
 tissue culture 
flasks (Iwaki Glass, Japan) and 24-/96-well tissue culture plates (Greiner Bio-
One, USA). Cells were either cultured in a humidified 37C incubator with 5% 
carbon dioxide (CO2) or a dry incubator (Thermo Electron Corporation, USA). 
Only the mosquito cell line C6/36 was grown in the 28C dry incubator.  
 
2.1.1. Cell lines 
The cell lines used in this study are listed in Table 2.1. The types of media, 
passage numbers used for experiments in this project and the origin of cell lines 
are also included.  All cell lines used are adherent cell types.  
 
2.1.2. Media and reagents for cell culture 
All cell culture media were supplemented with foetal bovine serum [(FBS), (PAA 
Laboratories GmbH, Austria)] and their formulations can be found in Appendix 
1A to 1D for various cell lines. The heat-inactivated FBS (Appendix 1E) was used 
for C6/36 and HEK293 cells. The media pH was adjusted to approximately 7.3 
with solutions of 1 M hydrochloric acid and 1 M sodium hydroxide (Appendix 1F 
and 1G). 
 




Table 2.1: Cell lines used and related information  









Kidney cells FT 
(293FT) 
DMEM 10-21 Invitrogen, USA 
Mosquito cells 
derived from Aedes 
albopictus (C6/36) 
L-15 50-70 





Kidney Cells  21, 
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2.1.3. Cultivation and propagation of cell lines 
Flasks of cells were sub-cultured from confluent 75 cm
2
 flask monolayer at a ratio 
of 1:5. The growth medium (Appendix 1A to 1D) was discarded and the 
monolayer was rinsed with 5 ml of phosphate buffered saline (PBS - Appendix 
1H). This was followed by incubation with 2 ml of trypsin (Appendix 1I). The 
flask was then incubated at 37°C before the cells were dislodged by gentle 
tapping. The growth media was added to the cell suspension to neutralize the 
activity of trypsin (Appendix 1I) and the suspended cells were then aliquoted into 
new 75 cm
2 
culture flasks. The cells were incubated at 28°C for C6/36 cells or 
37°C for all other cell types.   
 
2.1.4. Cell counting using haemocytometer 
A haemocytometer was used for the quantification of cell number in a tissue 
culture flask or plate. The cell monolayer was first rinsed with PBS (Appendix 
1H) following the removal of the growth medium. The cells were then dislodged 
using trypsin (Appendix 1I). A sample of the cells (neat or undiluted) was mixed 
at 1:1 ratio with trypan blue (Sigma, USA) to allow differentiation of living and 
dead cells. The mixture of cells with trypan blue was aliquoted to the counting 
chamber of the haemocytometer by capillary action. The cells were counted in the 
four quadrants and averaged out to determine the number of cells in one quadrant. 
To ensure accuracy, the cells from a sample were counted thrice and averaged 
out.  
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2.1.5. Cultivation of cells in tissue culture plates 
A confluent cell monolayer of BHK, HEK293 or 293FT cells in a 75 cm
2 
tissue 
culture flask was used to seed four 6-well, 24-well or 96-well plates (Greiner Bio-
One, USA). The cell monolayer was treated as previously described (Section 
2.1.3) to produce single cell suspension. The cell suspension was then made up to 
a final volume of 100 ml using appropriate cell culture growth medium. Aliquots 
of 2 ml, 1 ml or 200 l of cell suspension were then transferred into each of the 6 
wells, 24 wells or 96 wells, respectively. Poly-L-lysine coating (Appendix 1J) was 
used prior to seeding of HEK293 cells. The plates were then incubated at 37°C in 
a humidified incubator with 5% CO2 (Thermo Electron Corporation, USA). The 
monolayers were confluent in 48 h and ready for use. 
 
2.1.6. Cultivation of cells on coverslips 
Individual glass cover slips were aseptically placed in 24-well tissue culture plate. 
A confluent monolayer of cells from a 75 cm
2 
tissue culture flask was used to seed 
the wells of 24-well plate (Section 2.1.5). Poly-L-lysine coating (Appendix 1J) 
was used prior to seeding of HEK293 cells. The plates were incubated at 37°C 
with 5% CO2 until they were about 80-90% confluent.  
 
2.2. INFECTION OF CELLS  
2.2.1. Viruses 
The viruses used in this study were WNV (strains Sarafend [WNV(S)], Wengler 
[WNV(W)] and Kunjin (KUNV)] and DENV serotype 2 (New Guinea C). These 
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viruses were the kind gifts from Emeritus Professor Edwin Westaway, Australia. 
The stock viruses were propagated in C6/36 cells for this study.  
 
2.2.2. Infection of cell monolayer for virus propagation 
Virus pools were prepared by infecting confluent monolayer of cells in 75 cm
2 
tissue culture flask. The cell culture supernatant was discarded and the monolayer 
was rinsed with 5 ml of PBS (Appendix 1H). About 1 ml of virus suspension was 
made up to 1.5 ml with virus diluent (Appendix 2A) and used to infect cells in 75 
cm
2
 at multiplicity of infection (MOI) of 1 or 10. The flask was incubated at 37°C 
for 1 h and rocked every 15 min to ensure even infection. After 1 h, unabsorbed 
virus was washed off with 5 ml of maintenance medium (Appendix 2B and 2C) 
and 10 ml of the same medium was then added after the wash. The infected cells 
were incubated at 37°C in a humidified incubator with 5% CO2 (Thermo Electron 
Corporation, USA) until the appropriate harvesting time. Mock-infected controls 
used in this study were prepared as mentioned above except that a similar amount 
of virus diluent (Appendix 2A) was used instead of virus.  
 
2.2.3. Preparation of virus pool 
Infection was carried out as described in Section 2.2.2. The virus was harvested 
when cytopathic effects were pronounced at appropriate timings post infection 
(p.i.) [18 h - WNV(S); 24 h - WNV(W) and KUNV; 48 h - DENV). To obtain 
extracellular virus, infected cell culture supernatant was removed from the flask 
and spun at 1000 x g for 10 min (Sigma, USA) to remove cellular debris. 
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Intracellluar virus was obtained by harvesting the monolayer of infected cells. The 
cells were detached from the flask using trypsin (Appendix 1I). The trypsin 
activity was neutralized with an equal amount of maintenance medium after the 
cells have detached. The resulting cell suspension was pelleted at 800 x g for 10 
min (Sigma. USA) and followed by 3 cycles of freeze-thaw action. The cell debris 
were removed by spinning (Sigma, USA) at 3000 x g for 15 min. Approximately 
500 l of infected supernatant (extracellular virus) or clarified cell lysate 
(intracellular virus) was aliquoted into 1 ml sterile cryovials (Nalge Nunc 
International, Denmark) and immediately snap frozen in -80°C liquid ethanol. 
The frozen virus stocks were stored at -80°C until further use. 
 
2.2.4. Plaque assay 
BHK cells were seeded onto 24-well plates as described in Section 2.1.5. Ten-fold 
serial dilutions of the virus sample were prepared in virus diluents (Appendix 2A) 
up to 10
-8
. Aliquots of 100 l from each dilution were transferred in triplicates 
onto confluent cell monolayers in the wells. The plates were incubated at 37°C 
with 5% CO2 and rocked every 15 min to ensure even distribution of virus 
inoculum. The virus inoculum was then removed following one hour incubation 
and cell monolayers were washed once with PBS (Appendix 1H). One ml of 
overlay medium (Appendix 2D) was pipetted into each well. The trays were 
incubated at 37°C for 2 days before the overlay medium was removed for 
staining. The plaques were visualized by staining the monolayer with 0.5% crystal 
violet in a 25% formaldehyde solution (Appendix 2E) for at least 2 h at room 
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temperature (RT) on orbital shaker (Labnet Intl. Inc., USA). The crystal violet 
solution was removed for proper hazardous chemical disposal and the plate was 
washed under a running tap to remove residual dye. Plaques were counted and the 
following equation was used to calculate the number of plaque forming units 
(PFU) per ml of supernatant: (Average number of plaques from triplicates) x 
(dilution factor) x 10.  
 
2.2.5. Virus growth kinetics 
Appropriate numbers of HEK293, hSec3p293OE and hSec3p293KD cells 
(5X10
5
) were infected with WNV/DENV (MOI: 1) or transfected (5-20 g) with 
WNV/DENV RNA in vitro transcribed from Xbal-linearized full length WNV (Li 
et al., 2005) or DENV (kind gift from Dr. Andrew Davidson) infectious clones as 
described by Li and group (2006). The full-length infectious clone of WNV was 
generated by Li and colleagues (2005) and DENV infectious clone was a 
generous gift from Dr. Andrew Davidson, Bristol University, United Kingdom. In 
another experiment, HEK293 cells were first transfected with V5-hSec3pSH2 
plasmid followed by infection with WNV/DENV or transfection with RNA in 
vitro transcribed from full length WNV/DENV infectious clone. The cell culture 
supernatant was collected at the indicated time points for plaque assay. 
 
2.3. MOLECULAR TECHNIQUES 
2.3.1. Extraction of viral RNA 
Viral RNA extraction was carried out using QIAmp Viral RNA extraction kit 
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(Qiagen, USA) following the manufacturer‟s protocol. Briefly, about 200 μl of 
virus supernatant was added to AVL buffer and then transferred to the QIAquick 
spin column. Following centrifugation (Sigma, USA) and subsequent washes, 
viral RNA was eluted with elution buffer. Quantity and purification of extracted 
nucleic acids was determined using Nanodrop spectrophotometer (Thermo 
Scientific, USA). The extracted viral RNA was stored at -80°C until further use. 
 
2.3.2. Complementary DNA (cDNA) synthesis 
First strand cDNA was synthesized from viral RNA samples isolated as described 
in Section 2.3.1. About 500-750 ng of viral RNA was mixed with 1 l of 10 mM 
C protein specific primer or random hexamer and 1 l of 1 mM deoxynucleotide 
mix [(dNTP) (Promega, USA)]. The mixture was then heated to 65C for 5 min 
and placed on ice for 1 min. Subsequently, 4 l of 5x first strand synthesis buffer 
(Invitrogen, USA), 2 l of 0.1 M dithiothreitol (Invitrogen, USA), 1 l of RNAsin 
(Promega, USA) and 1 l of Superscript® III Reverse Transcriptase (Invitrogen, 
USA) was added to the mixture. The mixture was then heated to 42C for 30 min 
and 72C for 15 min. The resulting cDNA was stored at -20C until further use.  
 
2.3.3. Polymerase Chain Reaction (PCR) 
Polymerase chain reaction was used to amplify specific gene sequences using the 
appropriate primers. The reaction consisted of a 5 l of 10x reaction buffer 
(Fermentas, USA), 1 l of 10 mM dNTP (Promega, USA), 1 l each of 10 mM of 
forward and reverse gene specific primer, 1 l of Taq polymerase (Fermentas, 
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USA) and an appropriate amount of template. The reaction was topped up to 50 l 
with ultrapure water (Milipore, USA). The primers used in this study were shown 
in Appendix 3A. All primers were synthesized by Proligo Singapore Pte Ltd. The 
primers are partially purified through desalting procedures performed by the 
manufacturers. The mixture was amplified in a PCR thermocycler (Bio-Rad, 
USA). The PCR mixture was first subjected to initial denaturation step in a 
thermocycler at 95C for 4 min. this was followed by 28 cycles of denaturation at 
95C for 2 min, annealing at 55C for 30 sec and extension at 72C for 1 min to 
10 min. Final extension at 72C was carried out for 3 min.  
 
2.3.4. DNA purification from PCR reaction and agarose gel electrophoresis 
The PCR amplified DNA was purified using QIAquick PCR purification kit 
(Qiagen, USA) following manufacturer‟s instructions to remove the buffer and 
enzymes in the solution. Briefly, the PCR product was mixed with the binding 
buffer and added to the QIAquick spin column. Following centrifugation (Sigma, 
USA) and subsequent washes, the PCR amplicons were eluted with elution buffer.  
The resulting amplicons were analyzed using agarose gel electrophoresis 
[Appendix 3B(i-iii)]. An appropriate amount of DNA sample was mixed with 10x 
gel loading buffer [Appendix 3B(iv)] before loading into the well. Approximately 
5 l of 1000 bp or 100 bp DNA markers (Promega, USA) was added in another 
well to indicate the relative size of the DNA sample. The sample was 
electrophorized at 120 V for 40 min. The DNA bands were then visualized using 
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UV transilluminator (Vilber Lourmat, UK) and the gel images were captured 
using ChemiGenius2 software (Syngene, UK). 
 
2.3.5. Restriction endonuclease (RE) digestion 
The purified PCR products were digested with 1 l of respective restriction 
enzymes (Appendix 3A, RE sequences were underlined in primer sequence) 
supplemented with 5 l of 10x reaction buffer (Promega, USA). The mixture was 
incubated at 37C for 4 h. Similarly, 1 g of various vectors (Appendix 3A) was 
digested with appropriate restriction enzymes.  
 
2.3.6. Ligation and transformation for plasmid amplification  
The RE-digested PCR product and the vector were mixed at the molar ratio of 1:5 
together with 1 l of T4 DNA ligase and 1 l of 10x ligation buffer (Promega, 
USA). The mixture was incubated at 4C overnight. Two microlitres of ligation 
mixture was added into 100 l of thawed DH5 competent cells (Invitrogen, 
USA) and incubated on ice for 20 min. This was followed by heat shock at 42C 
for 2 min and incubation at 30C for 1.5 h. After the recovery of cells, the culture 
was spun (Sigma, USA) at 4000 x g for 1 min and the supernatant was discarded. 
The cells were resuspended in 100 l of LB broth [Appendix 3C(i)] and plated 
onto agar plate [Appendix 3C(ii)] containing 100 g/ml of ampicillin or 50 g/ml 
of kanamycin (Sigma, USA). The plate was then incubated at 30C overnight. All 
bacterial plates were stored at 4C for future use. 
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2.3.7. Colony PCR 
Several colonies from Section 2.3.6 were picked for PCR colony screening. This 
method screened for the presence of inserts in transformed bacteria. The bacterial 
colonies were picked using pipette tips and tapped gently onto a new agar plate 
containing either ampicillin or kanamycin [Appendix 3C(ii)] before dislodging 
the remaining cells into a PCR reaction as described in Section 2.3.3 by pipetting 
up and down. The resulting DNA product was analyzed with gel electrophoresis 
(Section 2.3.4). Positive colonies were picked from the new agar plates for 
plasmid extraction (Section 2.3.8).  
 
2.3.8. Plasmid extraction 
At least five colonies were selected and inoculated for plasmid extraction. 
Colonies were picked and inoculated into 2 ml of LB broth containing ampicillin 
or kanamycin [Appendix 3C(iii)]. The inoculated cultures were allowed to shake 
for 18 h at 30C (Sartorius, Germany). This seed culture was diluted and used for 
plasmid extraction using QIAprep Miniprep or Maxiprep Kits (Qiagen, USA). 
The resulting plasmids were sequenced (Section 2.3.9) to ensure the correct 
reading frame.   
 
2.3.9. Sequencing 
Approximately 500 ng of plasmid DNA was added to 4 l of Big-Dye Terminator 
v3.1 (Applied Biosystems, USA) and 1 l of the appropriate primer as listed in 
Appendix 3D. The mixture was topped up to 10 l with deionised water and 
Materials and Methods 
48 
 
placed in a thermocycler (Bio-Rad, USA). The reaction protocol was as follows: 
95C for 4 min, 30 cycles of 95C for 30 sec, 55C for 30 sec, 72C for 1 min and 
a final extension for 5 min at 72C. The product was then purified via ethanol 
precipitation. Ethanol precipitation was performed by adding 3 M sodium acetate 
(Promega, USA) and 95% ethanol (Sigma, USA). The resulting mixture was 
transferred to a 1.5 ml eppendorf tube and incubated on ice for 20 min. The 
precipitated DNA was then pelleted down at 16000 x g for 30 min at 4C (Sigma, 
USA). The supernatant was removed carefully and 500 l of 70% ethanol 
[(Appendix 3E(ii)] was added. The precipitate was pelleted down again with 
similar conditions and the ethanol was discarded. The DNA pellet in the tube was 
sent to the Microbiology Department sequencing laboratory for electrophoresis 
(ABI 310 sequencer, Perkin Elmer, USA). Sequences were analyzed using Basic 
Local Alignment Search Tool (www.ncbi.nlm.nih.gov/blast). 
 
2.3.10. Site-directed mutagenesis 
Site-directed mutagenesis was performed using QuickChange Lightning kit 
(Stratagene, USA). The primer design and reaction assembly were performed 
according to the manufacturer‟s recommendation. The primer sequences and the 
templates used in the mutagenesis study were shown in Appendix 3F. Briefly, the 
template plasmid was mixed with the appropriate primers, dNTPs and pfu 
polymerase and PCR reaction was carried out. The parental plasmid was then 
digested with Dpn I enzyme. The resulting mutated plasmids were transformed 
into XL10 Gold competent cells (Stratagene, USA).  
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2.3.11. Mutagenesis of the infectious clones of WNV and DENV 
Mutations were first introduced on the 1.3 kb carrier plasmid of WNV and DENV 
as described in Section 2.3.10. The 1.3 kb carrier plasmid contains 5‟UTR, C, 
prM and partial envelope sequences of flavivirus in pBR322 vector. After 
confirming the presence of introduced mutations by sequencing (Section 2.3.9), 
the remaining purified plasmids were subjected to RE digestion with 1 l of BsiW 
I and Mlu I (New England Biolabs, USA) each at 37C for 2 h. The reaction was 
subjected to agarose gel electrophoresis and the 1.3 kb fragment carrying the 
mutations was excised from the gel and purified using Gel extraction and 
purification kits (Qiagen, USA). The full-length infectious clones of WNV/DENV 
were also RE-digested and subjected to electrophoresis in the same manner and 
the 11 kb fragment was purified from the gel. Approximately 7.5 l of the 1.3 kb 
fragment and 0.5 l of 11 kb DNA fragments were ligated using 1 l T4 DNA 
ligase and transformed into DH5 cells. Positive clones were then sequenced and 
propagated.  
 
2.3.12. In vitro synthesis of infectious RNA 
About 5 g of full-length/mutant infectious clones of WNV and DENV were 
linearized with Xba I (Promega, USA). The linearized DNA was purified by 
phenol-chloroform extraction and ethanol precipitation and reconstituted in 15 l 
of RNase-free water [(Appendix 3E(i)]. The linearized DNA was used for in vitro 
synthesis of infectious RNA using T7 Ribomax
TM
 large scale RNA production 
system and cap analogue according to the manufacturer‟s protocol (Promega, 
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USA). Briefly, the linearized DNA was mixed with T7 reaction components and 
incubated at 37
o
C for 4 h. The resulting RNA was purified using 
phenol:chloroform:isoamyl alcohol (25:24:1, v/v, Invitrogen) and precipitated 
with isopropanol on ice. The precipitated RNA was then pelleted at 16000 x g for 
30 min (Sigma, USA) and washed with 70% ethanol in RNase-free water 
[Appendix 3E(ii)]. The RNA was resuspended in RNase-free water [Appendix 





) were transfected (single or co-transfection) with various 
recombinant plasmids or in vitro transcribed RNAs from the infectious clones of 
WNV/DENV using Lipofectamine2000 (Invitrogen, USA). The amount of 
plasmid DNA, Lipofectamine2000 and Opti-Mem media (Invitrogen, USA) used 
for 6-well plate, 24-well plate and 96-well plate are listed in Table 2.2.  
 
The appropriate amount of DNA and Lipofectamine2000 (Invitrogen, USA) were 
diluted separately with an appropriate amount of Opti-Mem media (Invitrogen, 
USA) and incubated at RT for 5 min. Both the diluted DNA and 
Lipofectamine2000 solutions were mixed and incubated at RT for 30 min. After 
incubation, the DNA-liposome complexes were added to the cell monlayers in the 
culture vessel. The cells were incubated at 37C for 5 h. The supernatant was 
removed after 5 h and fresh culture medium containing 2% FBS was added to the 
cells.  
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Table 2.2: The amount of DNA and Lipofectamine2000 required to transfect 








Lipofectamine2000 (l) Opti-Mem  (l) 
6 well (for 1 well) 5 10 500 
24 well (for 1 well) 1 2 100 
96 well (for 1 well) 0.2 0.5 50 
 
2.3.14. Electroporation 
HEK293 cells were rinsed once with PBS (Appendix 1H) and dislodged with 
trypsin (Appendix 1I). Trypsinization step was neutralized by the addition of 
DMEM medium (Appendix 2C) and cells were then transferred to 50 ml conical 
centrifuge tube (BD Bioscience, USA). The cells were spun at 250 x g (Sigma, 
USA) for 10 min at 4
o
C. The supernatant was removed and the cells were 
resuspended with 10 ml of DEPC-treated PBS (Appendix 3G). The cell 
suspension was spun (Sigma, USA) again as mentioned above and the supernatant 
was decanted. The cell pellet was resuspended in 600 μl of DEPC-treated PBS 
and added to a 1.5 ml microcentrifuge tube (Axygen, USA) containing RNA. The 
mixture was transferred to a pre-chilled curvette (BTX, USA) and electroporated 
thrice at 0.85 kV and 25 μF. Following this, the cells were allowed to stand at RT 
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2.3.15. Real-time PCR 
Real-time PCR (RT-PCR) was performed using using Taqman probes and ABI 
prism 7000 (Applied biosystems, USA). HEK293, hSec3p293KD and 
hSec3p293OE cells were infected with WNV/DENV. At indicated timings, cells 
were washed with PBS (Appendix 1H), incubated with
 
an alkaline/high-salt 
solution (1 M NaCl, 50 mM Na bicarbonate, pH 9.5) and washed three
 
times in 
PBS to remove surface-bound viruses. Total RNA was extracted and analysed by 
RT-PCR with GAPDH mRNA as the endogenous control. It was shown earlier 
(Ng et al., 2001) that unlike many of the flaviviruses, WNV (Sarafend) has a 
relatively short latent period of 4 to 6 h p.i compared to those of other flaviviruses 
(16 to 24 h p.i.). West Nile virus RNA yields were quantitated at 5 h p.i. to avoid 
measuring viral RNA from multiple infection rounds. Similarly, at 24 h p.i., prior 
to significant
 
levels of DENV secretion and spread to neighboring cells (Helt & 
Harris, 2005), total RNA was harvested. Plus- and minus-strand viral RNA from 
hSec3p293KD/OE cells was determined relative to that from HEK293 cells as 
described by Davis and colleagues (2007a). The primers used were shown in 
Appendix 3H.  
 
2.4. EXPRESSION AND PURIFICATION OF PROTEINS 
2.4.1. Expression and purification of proteins in bacteria 
Expression and purification of C protein in bacterial system was kindly performed 
by Mr. Adrian Cheong (Ph.D student, Department of Microbiology). The 
WNV/DENV C protein was cloned downstream of a histidine tag using pET28a 
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vector (Novagen, USA). The plasmid encoding the histidine-tagged C (His-C) 
protein was transformed into the BL21-CodonPlus competent E. coli bacteria 
cells (Stratagene, USA). The cells were grown in LB broth at 30C until the 
optical density of culture reached 0.6. The expression of His-C was then induced 
with 1 mM isopropyl β-D-1-thiogalactopyranoside (Sigma, USA) and purified 
with immobilized metal ion affinity chromatography (Sartorius, USA).  
 
2.4.2. Expression and purification of C protein in mammalian cells 
HEK293 cells transfected with Myc-tagged C protein were harvested at 24 h post-
transfection and lysed at RT for 30 min using M-Per mammalian lysis buffer 
(Thermo Scientific, USA) supplemented with protease and phosphatase inhibitors 
(Roche, Germany). Cell debris were removed from the supernatant by spinning 
the cell lysate at 16000 x g (Sigma, USA) for 10 min. Myc-C protein was 
immuno-purified with 20 l of sepharose beads conjugated to anti-Myc antibodies 
(Sigma, USA). The beads were washed thrice in PBS (Appendix 1H) and 
incubated with cell lysate overnight at 4C. The beads were spun down at 800 x g 
(Sigma, USA) for 1 min and washed thrice with PBS. Myc-tagged C protein was 
eluted from beads by competitive elution using Myc peptide (50 g/ml) and re-
suspended in Tris-HCl buffer, pH 7.4 supplemented with protease and 
phosphatase inhibitors. The immuno-purified protein was stored at -20C until 
further use.  
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2.4.3. Expression and purification of proteins in rabbit reticulocyte lysates 
TNT quick-coupled transcription/translation system was used to in vitro 
transcribe and translate 1 g of plasmid DNA or RNA following manufacturer‟s 
instructions (Promega, USA). The plasmid DNA or RNA was added to the rabbit 
reticulocyte mixture and incubated at 30
o
C for 1.5 h. The resulting products were 
subjected to immunopurification (Section 2.4.2). This system was used to in vitro 
translate V5-hSec3pf1, V5-galactosidase, HAC, HAC5‟∆15, Myc-C, Myc-
C5‟∆15, pEF1 plasmids and viral RNA or V5-galactosidase RNA or IRF2 RNA 
or Importin- RNA or CAML RNA. The resulting proteins V5-hSec3pf1, HAC, 
HAC5‟∆15, Myc-C, Myc-C5‟∆15, Importin- and EF1 were purified using anti-
hSec3p, anti-HA, anti-Myc, anti-importin- or anti-EF1 conjugated sepharose 
beads as mentioned in Section 2.4.2.  
 
2.5. ANALYSIS OF PROTEIN SAMPLES 
2.5.1. Sodium-dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
Laemmli  discontinuous gel system (Laemmli, 1970) was used for protein 
separation. To cast 12% separation gel, 4.5 ml of the resolving gel mixture 
(Appendix 4A) was pipetted into the gel casting apparatus (Bio-Rad, USA) and 
iso-propanol was layered on top of the mixture. The gel was allowed to 
polymerize before the isopropanol was decanted. A layer of 5% stacking gel 
(Appendix 4B) was layered on top of the polymerized resolving gel. Finally, 
combs were inserted into the stacking gel and the gel was allowed to polymerize. 
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After polymerization, the comb was removed and the wells were flushed with 
running buffer (Appendix 4C) before loading the protein samples.  
 
Protein samples were prepared by adding 4x sample loading buffer (Appendix 
4D) and boiled at 100C for 1 min. Each well is loaded with protein samples of up 
to 20 l. Pre-stained or unstained molecular weight markers (Promega, USA) 
were added to one well in each gel. The upper-tank of the gel electrophoresis was 
filled to the brim with upper-tank running buffer [Appendix 4C(i)] and the lower 
tank was filled with lower-tank running buffer [Appendix 4C(ii)]. Electrophoresis 
was carried out using a constant voltage of 100 V for approximately 1.5 h at 4C. 
After electrophoresis, the proteins were transferred to a polyvinylidene fluoride 
(PVDF) membrane (Bio-Rad, USA).   
 
2.5.2. Western blotting 
Transfer of proteins onto a blotting paper was accomplished through a dry transfer 
method. The dry method involved the use of iBlot transfer apparatus (Invitrogen, 
USA). The gel was placed onto bottom blotting stack and then overlayed with top 
blotting stack (Invitrogen, USA). The assembly was then placed in the iBlot 
machine for 7 min. The membrane, which the proteins were transferred to, was 
removed from the assembly and soaked in Tris-buffered solution containing 
Tween-20 (TBST, Appendix 4F) with 5% skimmed milk (Appendix 4G) for 1 h at 
RT. The blot was then washed thrice with TBST for 5 min each. Primary 
antibodies were prepared in TBST with 5% skimmed milk (Anlene, Australia) 
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and added to the membrane. The membrane was incubated overnight at 4
o
C. The 
primary antibody was removed and washed thrice with TBST for 5 min each. The 
membrane was then incubated for 1 h at RT with goat anti-rabbit or anti-mouse 
IgG conjugated with horseradish-peroxidase (Pierce Biotechnology, USA) 
followed by washing thrice with TBST for 5 min each. Membranes incubated 
with HRP-conjugated secondary antibodies (Pierce Biotechnology, USA) were 
developed using SuperSignal Pico system (Pierce Biotechnology, USA). 
Luminescence was detected with a CL-XPosure film (Thermo Scientific, USA) 
and the film was processed in an X-ray film developer (Konica Minolta, Japan) 
after exposure.   
 
2.5.3. Cell-based fluorescence assay 
HEK293 cells were seeded onto poly-D-lysine (Sigma, USA) coated 96-well 
plates (Section 2.1.5) and transfected with various plasmids (Section 2.3.13) or 
infected with WNV/DENV at MOI of 1. At various timings post-transfection or 
infection, culture supernatant was removed and the cells were washed with 1 ml 
of PBS (Appendix 1H). Cells were fixed with 4% paraformeldyhyde (Appendix 
4J) for 15 min and permeabilized with 0.2% Triton-X (Appendix 4K) for 5 min at 
RT. Cells were then blocked with 1% BSA in PBS for 1 h. This was followed by 
the addition of mouse monoclonal anti-hSec3p (Abnova, USA) and rabbit 
polyclonal anti-actin (Sigma, USA) antibodies and incubated at 37
o
C for 2 h.  
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Following three washes with PBS, the samples were treated with anti-mouse or 
anti-rabbit Alexa488 or Alexa594 secondary antibodies (Invitrogen, USA) at 
37C for 1 h and washed thrice in PBS before analyzing samples in a microtitre 
plate
 
reader. The flow chart describing the major steps involved in this assay is 
shown in Fig. 2.1. Similar assays were developed to detect hSec6p, viral E 
proteins and HA/Myc-tagged C proteins using anti-hSec6p (Abnova, USA), anti-
flaviviral E (4G2, Chemicon, USA), anti-HA and anti-Myc (Clontech, USA) 
antibodies.  
 
2.5.4. Quantitation of proteins in a sample - Bradford assay 
The BSA standards ranging from 10 g/ml to 1000 g/ml was prepared and 
added to the assay reagent (Bio-Rad, USA). Similarly, the protein sample to be 
measured was also added to the assay reagent and incubated for 3 min. Each 
concentration of the BSA protein standards and sample were then placed in 
spectrometer to measure absorbance at 595 nm.  
 
2.5.5. Densitometry 
The intensity of the bands on the immunoblot was quantified using GeneTools 
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2.6. YEAST TWO-HYBRID ASSAY (Y2H) 
Yeast two-hybrid experiments were performed using MATCHMAKER GAL4 
Two-Hybrid System 3 kit (Clontech, USA). Yeast mating assays to detect 
potential human protein interacting partners were performed using Matchmaker 
Pre-transformed Human brain or liver cDNA library (Clontech, USA). 
 
2.6.1. Preparation of yeast competent cells 
An overnight starter culture was prepared by inoculating several (2-3 mm) 
colonies from a freshly streaked plate of Saccharomyces cerevisiae, strain 
AH109, into 1 ml of YPDA broth (Appendix 5A). This inoculum was then 
transferred into an Erlenmayer flask containing 50 ml of YPDA and incubated at 
30°C for 16-18 h with shaking at 250 rpm (Sartorius, Germany). This starter 
culture was then used to inoculate a new flask containing 300 ml of fresh YPDA 
broth to give an initial OD600 reading of 0.2-0.3. The culture was then incubated at 
30°C for 3 h with shaking at 230-270 rpm until the OD600 reading reached 0.5 ± 
0.1. Yeast cells from the entire culture were collected by centrifugation (Sigma, 
USA) at 1000 x g for 5 min at RT. After decanting the supernatant, yeast cells 
were resuspended in 25-50 ml of sterile water and centrifuged (Sigma, USA) 
again at 1000 x g for 5 min at RT. The resulting cell pellet was resuspended in 
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2.6.2. Transformation of bait-expressing vectors into yeast host strain AH109 
Bait vectors containing WNV and DENV C protein or the prey vectors containing 
partial/full-length hSec3p were singly- or co-transformed into yeast strain AH109 
via polyethylene glycol/lithium acetate (PEG/LiAc)-mediated transformation of 
yeast using YEASTMAKER™ Yeast Transformation System 2 (Clontech, USA). 
Small-scale yeast transformations were performed as follows: To perform single 
plasmid transformation, 0.1 μg of plasmid DNA, 0.1 mg of herring testes carrier 
DNA (Appendix 5C) and 0.1 ml of yeast competent cells were added to a 1.5 ml 
microfuge tube and mixed by high speed vortexing (Sigma, USA). For 
simultaneous co-transformation, both bait and prey plasmids should be added. An 
aliquot of 0.6 ml of sterile PEG/LiAc solution (Appendix 5D) was added to the 
tube and the contents were vortexed again (Sigma, USA). The tube was incubated 
at 30°C for 30 min with shaking at 200 rpm (Sartorius, Germany).  
 
After incubation, 70 μl of sterile DMSO (Sigma, USA) was added to the tube and 
the contents were mixed by gentle inversion. Heat shock was then performed by 
incubating the tube contents in a 42°C water bath for 15 min. The tube was then 
removed from the water bath and chilled on ice for 2 min. The contents were then 
centrifuged at 14000 rpm for 5 sec (Sigma, USA) to collect the cells and 0.5 ml of 
sterile water was used to resuspend the cells. One hundred μl of the suspension 
was then plated out on SD-Trp plates (Appendix 5E) and the plates were 
incubated colony-side down at 30°C for 2-3 days. Ten-fold serial dilutions of the 
suspension (1:10, 1:100 and 1:1000) were also performed to ensure that at least 
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one dilution set produces a plate of evenly spaced out colonies. About 100 μl of 
each dilution was plated onto at least two SD-Trp and SD-Leu (Appendix 5E) 
plates and the rest were plated onto DDO, TDO and QDO plates (Appendix 5E).  
 
2.6.3. Autoactivation assay 
To ensure that the bait itself does not self-activate the Y2H reporter genes, 
autoactivation assays were performed on AH109 transformed with single bait 
constructs (WNV or DENV C) as  follows: Equal amounts of inocula were taken 
from a single large (2-3 mm) colony of positive control (AH109 co-transformed 
with pGBKT7-murine p53 and the pGADT7-SV40 large T-antigen), negative 
control (AH109 transformed with pGBKT7 or pGBKT7-LaminC) and each of the 
bait-expressing constructs (AH109 transformed with bait plasmid). Each 
inoculum was then streaked on a SD-His plate (Appendix 5E) in a gridded 
fashion. Plates were incubated colony side down at 30°C for 3 days.  
 
2.6.4. Verification of bait expression in pGBKT7 vector 
Expression of the bait fusion protein was verified by Western blotting. A single 
colony of AH109 transformed with bait plasmid was inoculated in SD-Trp broth 
and incubated overnight at 30°C with shaking at 200 rpm (Sartorius, Germany). 
The cells were collected by centrifugation at 14000 x g for 1 min (Sigma, USA). 
The cell pellet was washed once with sterile water and collected again by 
centrifugation (Sigma, USA). Cells were resuspended in 100 μl of sample loading 
buffer and heated at 95°C for 5 min. The samples were then centrifuged (Sigma, 
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USA) at 14000 x g for 5 min at 4°C to pellet cell debris. Twenty-five μl of sample 
was then loaded per lane and resolved on a 12% SDS-PAGE gel and the protein 
bands detected by Western blotting (Section 2.5.2). 
 
2.6.5. Yeast mating assay 
Yeast mating assay was performed as per the manufacturer's protocol as follows: 
One large (2-3 mm) fresh colony of AH109 transformed with bait was inoculated 
into 50 ml of SD-Trp broth to maintain selection pressure for the bait 
transformations. The culture was incubated at 30°C for 16-24 h with shaking at 
250-270 rpm (Sartorius, Germany). When the OD600 of the culture reached above 
0.8, the cells were collected from the entire content of the culture by 
centrifugation at 1000 x g for 5 min (Sigma, USA). Culture supernatant was 
decanted and the residual liquid (approximately 5 ml) was used to resuspend the 
cell pellet by vortexing.  
 
Prior to use, one frozen vial of the pre-transformed yeast (strain Y187) library 
culture was thawed and mixed by gentle vortexing. The 5 ml inoculum obtained 
from harvesting the overnight culture was then combined with 1 ml library culture 
in a 2 L Erlenmeyer flask containing 45 ml of 2 x YPDA/Kan medium (Appendix 
5F). Two 1 ml aliquots of 2 x YPDA/Kan medium were used to rinse the cells 
from the library tube. The total volume of the culture was topped up to 50 ml with 
2 x YPDA/Kan medium and incubated at 30°C overnight for 24 h with gentle 
swirling at 30-50 rpm. 
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After 24 h of mating, the mating mixture was transferred to a sterile centrifuge 
tube and the cells were spun down by centrifuging at 1000 x g for 10 min (Sigma, 
USA). The mating flask was rinsed twice with 50 ml 2 x YPDA/Kan medium. 
These two rinses were used to resuspend the first pellet and the cell suspension 
was centrifuged (Sigma, USA) again at 1000 x g for 10 min. The cell pellet was 
resuspended in 10 ml of 0.5 x YPDA/Kan medium (Appendix 5G) and plated on 
to SD-Trp, SD-Leu, SD-Trp,Leu (DDO), SD-Trp,Leu,His (TDO) and SD-
Trp,Leu,His,Ade (QDO) plates and incubated at 30°C for 3-7 days. All white or 
light pink colonies growing on TDO or QDO plates with diameters >2 mm were 
replica plated onto QDO medium containing X-α-Gal (Appendix 5H) and 
incubated at 30°C for 3-6 days.  
 
2.6.6. Plasmid isolation from yeast 
For each yeast co-transformant identified from the yeast mating assay, a single 
large well-isolated yeast colony grown on QDO plates was used to inoculate 0.5 
ml of QDO broth. The cells were thoroughly resuspended by vigorous vortexing. 
The culture was then incubated at 30°C overnight with shaking at 230-250 rpm 
(Sartorius, Germany). Cells were harvested by centrifugation (Sigma, USA) at 
14000 rpm for 5 min. The supernatant was completely removed by pipetting and 
the pellet was resuspended in 50 μl of potassium phosphate. Ten μl of lyticase 
solution (Clontech, USA) was added to each tube, mixed by pipetting and the 
entire contents were incubated at 37°C for 60 min. Ten μl of 20% SDS was added 
and subjected to one freeze/thaw cycle (-20°C). The samples were kept at -20°C 
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until required for use. The bait and prey plasmids from the yeast library were 
extracted from yeast cotransformants using YEASTMAKER™ Yeast Plasmid 
Isolation Kit (Clontech, USA) following manufacturer's protocol. Briefly, the 
yeast cells were incubated with lyticase and SDS. The resulting mixture was 
loaded onto the spin column and centrifuged (Sigma, USA) and the bait and prey 
plasmids were eluted using elution buffer.    
 
2.6.7. Isolation of prey expressing plasmids 
The samples obtained from Section 2.6.6 contained a mixture of bait and prey 
plasmids. To separate the prey plasmids from the yeast plasmid solution, 10 μl of 
yeast plasmid solution (Section 2.6.6) were used to transform chemically 
competent DH5 E. coli cells as described in Section 2.3.6. Selection for prey 
plasmids were performed by plating the cells on LB-ampicillin [Appendix 3C(ii)] 
since the library pACT2 plasmid contains ampicillin selection marker. Plasmids 
were then isolated (Section 2.3.8) and sequenced (Section 2.3.9). The blastn and 
blastp algorithms were used to analyse the sequence data and to confirm the 
identity of the library interacting partners. 
 
2.7. PROTEIN-PROTEIN INTERACTION ASSAYS 
2.7.1. Co-immunoprecipitation (Co-IP) 
HEK293 cells (5X10
5
) were infected with WNV or DENV (MOI: 1) or co-
transfected with 4 g of GFP/V5/HA/Myc-tagged C (full length, truncated or 
mutated) and V5-tagged hSec3p (full length or truncated) plasmids using 
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Lipofectamine2000 (Invitrogen, USA) or electroporated (Bio-Rad, USA) with 20 
g of in vitro transcribed RNAs from pWNS plasmid as described in Sections 
2.3.13 and 2.3.14. At 14 or 24 h (WNV/DENV) post-infection (p.i.) or 24 h post-
transfection, cells were washed with PBS (Appendix 1H) and lysed using lysis 
buffer (Miltenyi Biotec, Germany) containing protease inhibitors cocktail (Roche, 
USA).  
 
For NS3 protein interaction assay, cell lysates were pre-treated in the presence 
and absence of RNaseA/DNase (Promega, USA) at 30
o
C for 1 h. Cell lysate was 
pre-mixed with either anti-WNV C (2 g, gift from E. G. Westaway) or anti-
DENV C (2 g, gift from Dr. Prida Malasit, Mahidol University, Thailand) or 
anti-GFP (2 g, Sigma, USA) or anti-V5 (2 g, Invitrogen, USA) or anti-HA/anti-
Myc (2 g, Clontech, USA) or anti-EF1 (2 g, Santa Cruz Biotechnology, USA) 
or anti-importin- (2 g, Sigma, USA) antibody-conjugated magnetic microbeads 
for 30 min on ice and purified using μMACs column (Miltenyi Biotec, Germany).  
The column was rinsed thrice with wash buffer (Miltenyi Biotec, Germany) and 
eluted with pre-heated elution buffer (Miltenyi Biotec, Germany). For Western 
blotting (Section 2.5.2), samples from co-immunoprecipitation assays or co-
transfected cell lysates were electrophoresed in 12% SDS-PAGE gels and 
transferred on to PVDF membrane. The membrane was then incubated with 
rabbit-polyclonal anti-WNVC (1:200, gift from E.G. Westaway, Australia) or 
mouse-monoclonal/rabbit-polyclonal anti-V5 (1:1000) or rabbit-polyclonal anti-
HA (1:1000) or mouse-monoclonal/rabbit-polyclonal anti-hSec3p (1:300) or 
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rabbit-polyclonal anti-NS3 (1:300; commercially generated by Sigma, USA) or 
mouse-monoclonal anti-PTB (1:500; Invitrogen, USA) or mouse-
monoclonal/rabbit-polyclonal anti-Myc (1;1000; Sigma, USA) or mouse-
monoclonal anti-Sec6 (1:400; Abnova, USA) or mouse-monoclonal anti-actin 
(1:2000; Millipore, USA) or mouse-polyclonal anti-IRF2 (1:300; Santa Cruz 
Biotechnology, USA) or mouse-monoclonal/rabbit-polyclonal anti-importin- 
(1:400; Sigma, USA) or mouse-monoclonal anti-CAML (1:400; Abnova, USA) or 
mouse-monoclonal anti-GFP (1:500; Invitrogen, USA) or mouse-polyclonal anti-
phosphoserine (1:500; Millipore, USA) antibodies followed by goat anti-rabbit or 
anti-mouse IgG conjugated with horseradish-peroxidase (1:10000; Pierce 
Biotechnology, USA) and the immunoreactive bands were developed using 
SuperSignal Pico system (Pierce Biotechnology, USA). 
 
2.7.2. Mammalian two-hybrid (M2H) assay 
The cDNA encoding sequences of full-length/mutated/truncated C proteins were 
amplified and joined to pSV40-GAL4 50 element and SV40 pA 3‟ element to 
create bait proteins of interest. Similarly, the cDNA encoding sequences of hSec3 
protein was amplified and joined to pSV40-VP16 5‟ element and SV40 pA 3‟ 
element. The controls used in M2H assay were listed in Appendix 6A. Co-
transfection was performed using DNA linear constructs generated from above 
along with pGAL/lacZ plasmid using Lipofectamine2000 (Invitrogen, USA). At 
24 h post-transfection, -galactisodase assay was performed as mentioned earlier 
(Bhuvanakantham & Ng, 2005) and the specific activity of samples were 
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calculated using the following formula: nmoles of ortho-nitrophenyl--D-
galactopyranoside hydrolyzed/incubation time/mg protein.  
 
2.8. KNOCK-DOWN AND OVER-EXPRESSION OF HUMAN Sec3 
PROTEIN 
2.8.1. Prediction of human Sec3 gene sequence for short hairpin-RNA 
(shRNA)-targeted gene knock-down 
In order to predict unique sites for hSec3 gene knock-down by lentivirus system, 
the mRNA sequence of hSec3p (Genebank accession number NM_018261) was 
input into an RNAi designer algorithm, BLOCK-iT RNAi Designer (Invitrogen, 
USA). It is critical that the shRNA obtained targets only hSec3 mRNA so as to 
minimise any off-target effects. Putative sites predicted were further validated by 
aligning them against NCBI nucleotide database using Blast software 
(http://www.ncbi.nlm.nih.gov/BLAST). Designing of the oligonucleotides 
containing the required shRNA sequence was done as instructed by the 
manufacturer‟s protocol of BLOCK-iT Lentiviral RNAi kit (Invitrogen, USA). A 
scrambled sequence containing exactly the same number of nuclotides as that of 
predicted shRNA sequence was obtained by inputting the selected shRNA 
sequence into nucleotide scrambling algorithm, siRNA Wizard (InvivoGen, 
USA). On top of containing the same number of nucleotides as the predicted 
shRNA sequence, the obtained scrambled sequence had no known human 
homologues to prevent off-target effects. The primers used in lentivector-
mediated gene knock-down studies are shown in Appendix 7A. 
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2.8.2. Insertion of nucleotide containing shRNA sequence into entry vector 
Polyacrylamide gel electrophoresis-purified oligonucleotides containing the 
shRNA sequence and the scrambled sequence for cloning into pENTR™/U6 entry 
vector (Invitrogen, USA) were commercially obtained (1st Base, Singapore). The 
oligonucleotides and their respective complementary strands were annealed and 
diluted according to the manufacturer‟s protocol. Subsequently, the diluted 
double-stranded (ds) oligonucleotides encoding hSec3p and scrambled shRNA 
were ligated with pENTR™/U6 entry vector (Invitrogen, USA) to create a U6 
entry clone. After ligation of ds-oligonucleotides with pENTR™/U6 entry vector 
was complete, the circularised plasmid was introduced into TOP10 competent 
cells (Invitrogen, USA) for plasmid amplification (Section 2.3.6) and subsequent 
clone selection (Section 2.3.7). The DNA sequencing reaction was then 
performed to ensure correct reading frames (Section 2.3.9). The flow chart 
describing the major steps necessary to produce a pENTR™/U6 entry clone is 
shown in Fig. 2.2. 
 
2.8.3. Generation of shRNA expression clones for lentivirus production 
The shRNA expression clones containing the U6 RNAi cassette of interest were 
generated by performing a highly specific LR recombination reaction between the 
entry clone and the pLenti6/BLOCK-iT™-DEST vector using LR clonase 
(Invitrogen, USA). In order to amplify the resultant plasmid, it was introduced 
into Stbl3 competent cells (Invitrogen, USA) by transformation (Section 2.3.6). 
Appropriate clones were then selected using colony PCR (Section 2.3.7). It was 
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not necessary to confirm the sequence of shRNA-producing sequence as the 
recombination reaction was highly specific and shRNA-producing sequence had 
been ascertained previously. The flow chart describing the major steps necessary 
to produce a pLenti6/BLOCK-iT expression plasmid is shown in Fig. 2.3. 
 
2.8.4. Generation of hSec3p over-expressing plasmid 
To generate hSec3p over-expressing construct, hSec3p gene was cloned into 
pLenti6/V5 Directional TOPO cloning vector (Invitrogen). This resulted in the 
generation of pLenti6/V5 expression plasmid. The primers used for cloning in 
lentivectors were shown in Appendix 7B.  
 
 














Fig. 2.2: The flow chart showing the major steps necessary to produce a 
pENTR™/U6 entry clone (adapted from www.invitrogen.com). 
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Fig. 2.3: The flow chart showing the generation of a pLenti6/BLOCK-iT 












LR recombination between 
pENTR/U6 entry plasmid 
and pLenti/BLOCK-iT-
DEST to generate 
pLenti6/BLOCK-iT 
expression plasmid 
Materials and Methods 
72 
 
2.8.5. Obtaining lentivirus for transduction of HEK293 cells 
The stocks of lentivirus for transduction of HEK293 cells were obtained by 
following manufacturer‟s protocol (Invitrogen, USA). Briefly, the shRNA 
expression clones or hSec3p over-expression clones were co-transfected with 
ViraPower packaging mix into 293FT cells (Invitrogen, USA) to produce knock-
down or over-expression lentiviral stocks. At 24 h post-transfection, the culture 
supernatant containing the transfection reagent and excess plasmid was removed 
and fresh complete DMEM (Appendix 1B) was added. At 48 h post-transfection, 
the culture supernatant containing the lentivirus was aspirated into 50 ml falcon 
tubes and centrifuged (Sigma, USA) at 1000 x g for 10 min at 4
o
C to remove 
cellular debris. One ml of this supernatant was then aliquoted into sterile cryo-
vials, sealed and snap-frozen in cold ethanol (-80
o
C). The flow chart describing 
the steps necessary to produce lentivirus stocks is shown in Fig. 2.4. 
 
2.8.6. Lentiviral transduction of HEK293 Cells 
HEK293 cells grown to about 70% confluency in a 6-well plate (Nunc, Denmark) 
were transduced using knock-down and over-expression lentivirus obtained from 
Section 2.8.5. The media was removed and the monolayer was washed once with 
PBS (Appendix 1H). The frozen vial of knock-down and over-expression 
lentivirus was quickly thawed at 37
o
C and added to HEK293 cell monolayer and 
then incubated at 37
o
C with 5% CO2 (Thermo Electron Corporation, USA). The 
next day, fresh media containing Blasticidin (Invitrogen, USA) was added to 
select for stably-transduced HEK293 cells. 


























Fig. 2.4: The flow chart describing the steps necessary to produce stably-
transduced HEK293 cells (adapted from www.invitrogen.com). 
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The transduced knock-down and over-expressing cells were named as 
hSec3p293KD and hSec3p293OE cells, respectively. These transduced cell lines 
were maintained at 37°C incubator with 5% CO2 (Thermo Electron Corporation, 
USA) in DMEM supplemented with various components (Appendix 7C). The 
flow chart describing the steps necessary to produce stably-transduced HEK293 
cells is shown in Fig. 2.4. 
 
2.8.7. Determination of optimal drug concentration for the selection of stable 
cell lines  
Varying concentrations of the selection drug, Blasticidin (Invitrogen, USA) were 
added to HEK293 cells. The cells were observed for 6 days and fresh media 
containing respective concentrations of drug was added every day. The 
fluorescent MultiTox-Fluor Multiplex Cytotoxicity Assay (Promega, USA) was 
used to determine the cytotoxic effects of varying concentrations of Blasticidin 
following manufacturer‟s instructions. The live cell and dead cell substrates were 
mixed with cytotoxicity reagent and added to HEK293 cells incubated with 
varying concentrations of Blasticidin. After 1 h of incubation at 37
o
C, 
fluorescence relating to cytotoxicity and viability were read as mentioned in the 
manufacturer‟s protocol using a fluorescent reader (Tecan, Austria). 
 
2.8.8. Assaying for over-expression and knock-down efficiency 
The cell lysate of successfully transduced HEK293 cells were harvested and 
separated using SDS-PAGE gel (Section 2.5.1). Subsequently, the level of hSec3p 
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in hSec3p293OE and hSec3p293KD cells was detected by Western blotting 
(Section 2.5.2) using anti-hSec3p antibody. 
 
2.8.9. Survey of the proliferation capacity of stable cell lines 
The fluorescent MultiTox-Fluor Multiplex Cytotoxicity Assay (Promega, USA) 
was used to determine the proliferation capacity of hSec3p293OE and 
hSec3p293KD stable cell lines. Approximately 1000 cells in 100 μl of media 
were seeded into each well of a 96-black well plate (Greiner Bio-One, USA) and 
incubated overnight at 37°C with 5% CO2. The next day, 100 μl of sterile assay 
reagent (Promega, USA) was added to each well. After 1 h of incubation at 37 
o
C, 
fluorescence relating to cytotoxicity and viability were read as mentioned in the 
manufacturer‟s protocol using a fluorescent reader (Tecan, Austria). 
 
2.9. PROTEIN-RNA INTERACTION ASSAYS 
2.9.1 Preparation of RNA 
2.9.1.1. RNA synthesis 
The full-length WNV/DENV RNA was synthesised using T7 Ribomax
TM
 large 
scale RNA production system and cap analogue as described in Section 2.3.12. To 
synthesize specific regions of viral RNA (WNV/DENV 3‟UTR RNA), DNA 
sequences encoding those regions were amplified by PCR (Section 2.3.3) from 
WNV/DENV infectious clone and used as templates for RNA synthesis as 
described in Section 2.3.12.  
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2.9.1.2 RNA labelling 
An appropriate amount of full-length/partial WNV/DENV RNA was labelled with 
Label
IT
 biotinylation kit (Mirus Bio, USA). Reaction assembly and purification of 
labelled RNA was performed according to manufacturer‟s protocol. Briefly, full-
length/partial WNV/DENV RNA was mixed with biotin labelling reagent and 
incubated at 37
o
C for 2 h. This was followed by ethanol purification (Section 
2.3.9). Labelling of RNA was then confirmed by dot blotting the biotinylated 
RNA on to PVDF membrane and detected with streptavidin conjugated to HRP 
(Pierce Biotechnology, USA) to ensure that the RNA was labelled.  
 
2.9.2. Viral RNA Immunoprecipitation 
HEK293, hSec3p293KD and hSec3p293OE (5X10
5
) cells were infected with 
WNV (MOI of 10) or DENV (MOI of 1) or transfected with 4 g of 
biotinylated/non-biotinylated WNV/DENV 3‟UTR RNA (contains partial NS5 
and 3‟UTR region). At appropriate timings post-infection (14 h p.i.-WNV; 24 h 
p.i.-DENV) or 18 h post-transfection, cells were cross-linked with 1% 
formaldehyde and lysed using lysis buffer (Miltenyi Biotec, USA). Co-
immunoprecipitation assay was then performed as described in Section 2.7.1 
using anti-EF1 or anti-hSec3p or anti-PTB antibodies. Western blotting (Section 
2.5.2) of Co-IP eluents was also performed using anti-hSec3p, anti-EF1 or anti-
PTB antibodies. RNA was then isolated from the immunoprecipitated samples 
using RNeasy kit (Qiagen, USA) and analysed by real-time RT-PCR using 
Taqman probe as described earlier (Li et al., 2006).  
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2.9.3. RNA Pull-down assay 
HEK293, hSec3p293KD and hSec3p293OE (5X10
5
) cells were infected with 
WNV (MOI of 10) or DENV (MOI of 1) or transfected with 4 g of 
biotinylated/non-biotinylated WNV/DENV 3‟UTR RNA. At appropriate timings 
post-infection (14 h p.i.-WNV; 24 h p.i.-DENV) or 18 h post-transfection, cells 
were cross-linked with 1% formaldehyde and lysed using lysis buffer (Miltenyi 
Biotec, USA). For the pull-down assay, cell lysates were incubated with 100 μl of 
streptavidin-conjugated DynaL

 magnetic beads (Invitrogen, USA) for 4 h at RT. 
The beads were pulled down using DynaL
 
magnetic rack (Invitrogen, USA) and 
the supernatant was removed. The beads were then washed thrice with wash 
buffer (Appendix 8A). The beads were resuspended in wash buffer and the 
samples were subjected to Western blot analysis (Section 2.5.2) using anti-
hSec3p, anti-EF1or anti-PTB antibodies. 
 
2.9.4. Competition assay for EF1-3’UTR complex formation 
Equal amounts of biotinylated WNV/DENV 3‟UTRs were mixed with 
recombinant EF1 (Abnova, USA) in the presence or absence of recombinant 
hSec3p (Abnova, USA) or Sec6p (Abnova, USA). Identical experiments were 
performed in the presence and absence of non-biotinylated 3‟UTRs or tRNAs 
(Invitrogen, USA). The mixture was incubated overnight at 4
o
C before 
performing pull down assay using streptavidin dynaLbeads as described in 
Section 2.9.3. The eluents were analyzed by Western blotting (Section 2.5.2) 
using anti-EF1 or anti-PTB antibodies. 
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2.10. ANALYSIS OF INTRACELLULAR AND EXTRACELLULAR 
VIRUS PROTEINS 
HEK293, hSec3p293KD and hSec3p293OE cells were infected with 
WNV/DENV. At indicated time points, cell lysates and culture supernatants were 
harvested and quantified by Bradford assay (Section 2.5.4). Twenty-five g of 
protein from each experimental group was separated by SDS-PAGE (Section 
2.5.1) followed by immunoblotting (Section 2.5.2) using anti-WNV E (1:500, 
H546, Microbix, USA) or anti-DENV E (1:1000, 3H5, Chemicon, USA) 
antibodies.  
 
2.11. OTHER ASSAYS THAT UTILIZED QUICK-COUPLED 
TRANSCRIPTION/TRANSLATION (TNT) SYSTEM 
2.11.1. hSec3p immunodepletion assay 
TNT quick-coupled transcription/translation system (Promega, USA) was used to 
in vitro transcribe and translate 1 g of V5-hSec3pf1 plasmid following 
manufacturer‟s instructions (Promega, USA). The presynthesized V5-hSec3pf1 in 
the rabbit reticulocyte lysate was incubated with anti-hSec3p-conjugated magnetic 
beads for 4 h at 4
o
C and the resulting mixture was loaded onto the Miltenyi 
column (Miltenyi Biotec, Germany). The column was washed with wash buffer 
(Miltenyi Biotec, Germany). The flow-through and the eluent from the 
immunodepleted samples were analyzed for the presence of hSec3p by Western 
blotting (Section 2.5.2) using anti-hSec3p antibody.  
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2.11.2. In vitro translation assay  
TNT quick-coupled transcription/translation system (Promega, USA) was used to 
in vitro transcribe and translate 1 g of V5-hSec3pf1 plasmids. Ten g of viral or 
IRF2 or Importin- or CAML RNA was generated as described in Section 2.3.12. 
The presynthesized V5-hSec3pf1 was added to reticulocyte mix containing 
WNV/DENV RNA in the presence or absence of 10 M MG132 (Calbiochem). 
The flow-through from the immunodepleted sample (Section 2.11.1) was mixed 
with 10 g WNV, DENV, IRF2, CAML or importin- RNA in the new 
reticulocyte reaction. The hSec3p, CAML, IRF2, importin- and E protein levels 
were analysed by Western blotting (Section 2.5.2). The EF1 competition assays 
were then performed using 2- or 5-fold
 
mole excess of EF1. 
 
2.11.3. Competition assay using C protein 
TNT quick-coupled transcription/translation system (Promega, USA) was used to 
in vitro transcribe and translate 1 g of V5-hSec3pf1, HAC, HAC5‟∆15, Myc-C 
or Myc-C5‟∆15 plasmids. The presynthesized V5-hSec3pf1, HAC, HAC5‟∆15, 
Myc-C and Myc-C5‟∆15 proteins were purified using anti-hSec3p, anti-HA or 
anti-Myc-conjugated magnetic beads as mentioned in Sections 2.4.2 and 2.4.3. 
Purified hSec3p or EF1 were fractionated on SDS-PAGE gels (Section 2.5.1) 
and transferred on to PVDF membranes (Section 2.5.2). Blots were blocked
 
in 




by incubation at 4°C 
overnight in binding buffer containing 20 nM of purified EF1 or hSec3p. Blots 
were then
 
washed at RT (five times for 15 min; 100 ml/wash)
 
in binding buffer 
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without BSA (Appendix 8C). The hSec3p-bound EF1 or EF1-bound hSec3p 
was detected
 
by incubation with anti-EF1 or anti-hSec3p antibody in phosphate-
buffered saline with 5% skimmed milk (Appendix 4G). Primary antibody was 
removed by
 
washing (four times for 10 min) in TBST (Appendix 4F) and 
antibody-antigen complexes were detected
 
as described in Section 2.5.2. 
Competition assays were performed as described above except a 5- or 10-fold
 
mole excess of either HAC/HAC5‟∆15 or Myc-C/Myc-C5‟∆15 proteins was 
added to the
 
binding reaction mixtures.  
 
2.11.4. In vitro translation assay to study hSec3p degradation 
The full-length or truncated WNV/DENV C plasmids such as MyCC (WNV), 
DMycC (DENV), MycC5‟∆15 (WNV) or DMycC5‟∆15 (DENV) were added to 
the rabbit reticulocyte mix in the TNT quick-coupled transcription/translation 
system (Promega, USA) together with hSec3p RNA. The in vitro translation assay 
was performed at 30
o
C for 1.5 h following manufacturer‟s instructions (Promega, 
USA). The amount of hSec3p was then analysed by Western blotting using anti-
hSec3p antibody (Abnova, USA).  
 
2.12. METHODS RELATED TO PROTEASOME DEGRADATION 
PATHWAY  
2.12.1. Drug inhibition studies 
Actinomycin D blocks new RNA synthesis and hence allows the analysis of the 
fate of the preexisting cellular mRNAs. Host cell transcription was blocked by 
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incubating HEK293 cells with 2 g/ml of Actinomycin D (Sigma, USA) for 1 h. 
This was followed by infection with WNV/DENV. Actinomycin D was included 
throughout the infection period. MG132 is the reversible cell-permeable 
proteasome inhibitor. HEK293 cells were treated with 10 μM MG132 
(Calbiochem, USA) for 1 h. This was followed by infection with WNV/DENV or 
transfection with plasmids encoding recombinant WNV/DENV C proteins. 
MG132 was included throughout the infection or transfection period. Epoxomicin 
is an irreversible cell-permeable proteasome inhibitor. HEK293 cells were treated 
with 100 nM epoxomicin (Sigma, USA) for 1.5 h. This was followed by infection 
with WNV/DENV or transfection with plasmids encoding recombinant 
WNV/DENV C proteins. HEK293 cells were incubated with various 
concentrations of inhibitors such as lactacystin (inhibitor of chymotrypsin-like 
activity) and YU-102 (inhibitor of caspase-like activity) at 37
o
C for 2 h and 
observed for cytotoxic effects using the fluorescent MultiTox-Fluor Multiplex 
Cytotoxicity Assay (Promega, USA).   
 
2.12.2. Titration of various proteolytic activities of 26S proteasome in 
HEK293 cells 
HEK293 cells were serially diluted in a 96-well plate as 100 l/well samples. 
Proteasome-Glo cell-based assay kits for for chymotrypsin-like, trypsin-like and 
caspase-like activities were used following manufacturer‟s instructions (Promega, 
USA). Equal volumes of luminescent Proteasome-Glo reagents containing 
substrates for chymotrypsin-like, trypsin-like, or caspase-like activity were added 
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to the 96-well plate. Luminescence was then determined 10-15 min after addition 
using a luminometer. The Proteasome-Glo reagents were prepared as follows: The 
Proteasome-Glo cell-based buffers were thawed and equilibrated to room 
temperature together with the lyophilized luciferin detection reagents. The 
luciferin detection reagents were then reconstituted by adding the appropriate 
volume of Proteasome-Glo cell-based buffer. The Proteasome-Glo reagents were 
then prepared by adding the Proteasome-Glo substrates to the reconstituted 
luciferin detection reagent. For Proteasome-Glo trypsin-like assay, specific 
inhibitors provided in the kit were added.  
 
2.12.3. Measurement of proteolytic activities of 26S proteasome 
HEK293 cells were seeded on to 96-well plate and transfected with various full-
length/truncated/mutated WNV/DENV C plasmids or RNAs in vitro transcribed 
from infectious clones of WNV/DENV. At 12 or 24 h post-transfection, 
Proteasome-Glo cell-based assay kits for for chymotrypsin-like, trypsin-like and 
caspase-like activities were used to measure the chymotrypsin-like, trypsin-like 
and caspase-like activities of 26S proteasome as mentioned in Section 2.12.2.  
 
2.13. FLUORESCENCE MICROSCOPY  
2.13.1. Preparation of cells 
HEK293, hSec3p293OE and hSec3p293KD cells were seeded onto poly-D-lysine 
(Sigma, USA)-coated coverslips. These cells were either transfected with various 
plasmids or infected with WNV/DENV. At various timings post-transfection or 
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infection, culture supernatant was removed and the cells were washed with 1 ml 
of PBS (Appendix 1H).  Cells were fixed with 4% paraformeldyhyde for 15 min 
and permeabilized with 0.2% Triton-X for 5 min at RT. After fixation, cells were 
washed thrice with PBS.  
 
2.13.2. Immuno-staining of cells 
For hSec3p localization studies, the cells were incubated with anti-hSec3p 
(Abnova, USA), anti-C (kind gift from E.G. Westaway and Professor Prida 
Malasit), anti-EF1 (Santa Cruz Biotechnology, USA), anti-NS3 (commercially 
produced by Sigma, USA) or anti-dsRNA (English & Scientific Consulting, 
Hungary) antibodies at 37C for 1 h and washed thrice in PBS (Appendix 1H) for 
5 min each. The samples were then treated with anti-mouse or anti-rabbit 
Alexa488 or Alexa594 secondary antibodies (Invitrogen, USA) at 37C for 1 h 
and washed thrice in PBS for 5 min each. Cell nuclei were stained with DAPI 
(Invitrogen, USA). Finally, the cover slips were mounted onto glass slide 
(Marienfeld, Germany) with Prolong Gold anti-fade mounting reagent 
(Invitrogen, USA). Image analysis was performed with Nikon A1Rsi confocal 
microscope and NIS Elements imaging software (Nikon Imaging Centre, 
Singapore).  
 
2.14. BIOINFORMATICS SOFTWARE USED IN THIS PROJECT 
Various bioinformatics softwares were used in this project for sequence analyses 
and domain prediction. The major softwares used were listed in Appendix 9.  
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2.15. STATISTICAL ANALYSIS 
Means, standard deviations, P values, and 95% confidence intervals were carried 


















































3.0. IDENTIFICATION OF NOVEL HOST PROTEINS INTERACTING 
WITH FLAVIVIRUS CAPSID PROTEIN AND DOMAIN MAPPING 
3.1. INTRODUCTION 
Flavivirus capsid (C) protein is a key structural component of virus particles. 
However, the role of C protein in the pathogenesis of arthropod-borne flaviviruses 
is poorly understood. Hence, this study sought to identify the potential host 
proteins interacting with flavivirus C protein using yeast two-hybrid (Y2H) 
library screening. In this chapter, flavivirus C gene was cloned in yeast vectors 
encoding GAL4 DNA-binding domain (BD) and expressed in yeast cells as fusion 
protein. Yeast mating was then performed to isolate the potential cellular proteins 
that could associate with C protein and have roles in flavivirus replication 
process. This could aid in the design of novel anti-flaviviral peptides that could 
disrupt the association between flavivirus C protein and the host proteins.   
 
3.2. YEAST TWO-HYBRID LIBRARY SCREENING 
3.2.1. Construction of yeast two-hybrid (Y2H) bait plasmids encoding West 
Nile and dengue virus capsid proteins 
To perform Y2H library screening, it was essential to construct Y2H bait 
plasmids encoding WNV/DENV C protein with the GAL4 DNA-binding domain 
to facilitate yeast mating since the prey cDNA inserts used in Y2H library was 
cloned into yeast vectors encoding GAL4 DNA-activation domain (AD). To 















Fig. 3.1: PCR amplification of WNV and DENV C genes. WNV and DENV C 
genes were amplified by PCR from viral cDNA. Lane 1: 1 KB DNA ladder 
(Promega); Lane 2: WNV C (arrowhead); Lane 3: DENV C (arrowhead). Arrows 

























































WNV and DENV C genes were amplified (Fig. 3.1, primers used were shown in 
Appendix 3A) from first strand cDNA obtained via reverse transcription of 
extracted WNV and DENV genomic RNA (Sections 2.3.1 to 2.3.3). The resulting 
DNA fragments were digested with EcoRI and BamHI (Section 2.3.5) and ligated 
with T4 ligase into yeast expression vector, pGBKT7 (Section 2.3.6). The 
pGBKT7 vector had previously been digested with EcoRI and BamHI (Section 
2.3.5). The ligation mixture was transformed into E. coli DH5 cells, which were 
subsequently grown under kanamycin selection (Section 2.3.6). Colony PCR 
(Section 2.3.7) was performed to identify the putative positive clones (Fig. 3.2). 
Plasmid DNA was extracted from the putative positive clones and verification of 
vector-insert junctions as well as the sequence integrity of the inserts were 
analysed by DNA sequencing (Section 2.3.9). The bait-expressing plasmids were 





































Fig. 3.2: Colony PCR amplification of BDC and D-BDC constructs. WNV and 
DENV C genes were amplified by PCR from the colonies to identify the putative 
positive clones. Lane 1: 1 KB DNA ladder; Lanes 2-6: BDC (arrowhead); Lane 7: 
1 KB DNA ladder; Lane 8-12: D-BDC (arrowhead); Lane 13: 1 KB DNA ladder. 





















































3.2.2. Expression of West Nile and dengue virus capsid fusion proteins 
It is important to transform the bait-expressing plasmids (BDC and D-BDC) into 
the yeast strain, AH109 before mating with Y182 yeast cells containing prey 
proteins. Hence, the bait-expressing plasmids (BDC and D-BDC) were 
transformed individually into AH109 cells (Section 2.6.2). This resulted in the 
generation of AH109[BDC] and AH109[D-BDC] cells. To test for the expression 
of fusion protein in AH109[BDC] and AH109[D-BDC] cells, yeast cell lysates 
were prepared and subjected to Western blotting (Section 2.5.2) using anti-GAL4 
DNA binding domain antibody. Both BDC and D-BDC fusion proteins were 

























Fig. 3.3: Expression of BDC and D-BDC fusion proteins. AH109 cells were 
transformed with BDC and D-BDC and pGBKT7 (BD) vector. Cell lysates were 
subjected to Western blotting. Lane 1:  Untransformed AH109; Lane 2: AH109 
transformed with BDC; Lane 3: AH109 transformed with D-BDC. Lane 4: 
AH109 transformed with BD vector. Arrows at the left indicate positions of 15 to 
55 kD sizes from pre-stained protein ladder. Arrowheads at the right indicate 
positions of 19 kD and 33 kD sizes corresponding to the sizes of Gal4 BD domain 































































3.2.3. Auto-activation assay 
The activation of the reporter genes in Y2H system makes use of a transcription 
event. Hence, the general problem encountered is the activation of transcription 
by bait proteins non-specifically or in the absence of the interacting partners. It is 
thus crucial to check if the bait protein of interest is capable of initiating 
transcription non-specifically. If that is the case, it would seriously affect the 
successful use of that bait protein in Y2H mating assay.  
 
Auto-activation assay (Section 2.6.3) was thus performed to test for the aberrant 
activation of reporter genes by BDC and D-BDC in the absence of interacting 
partners. It is important to ascertain that expression of WNV and DENV C 
proteins alone in AH109 cells do not lead to the activation of the HIS3 reporter 
gene. The bait proteins were singly transformed into AH109 or co-transformed 





 and plated onto SD-His plates. Auto-activating transformants would activate 
HIS3 gene and grow on SD-His plates. As indicated in Table 3.1, no intrinsic or 



























- - - - - - - 
D-BDC 
- - - - - - - 
BDC + 
AD vector 
- - - - - - - 
D-BDC + 
AD vector 
- - - - - - - 
p53/T 
+++ +++ +++ +++ +++ +++ +++ 
AH109 
- - - - - - - 
 
All serially diluted transformants were plated onto SD-His plates in triplicate. 
+++, strong growth; -, no growth. AH109 cells co-transformed with pGBKT7-
murine p53 and the pGADT7-SV40 large T-antigen (p53/T) served as the positive 




















3.2.4. Yeast mating  
To examine whether flavivirus C protein can associate with cellular proteins, 
WNV/DENV C protein was screened against human brain/liver cDNA yeast two-
hybrid library (Section 2.6.5). From 6 x 10
7
 cDNA library clones screened, 
several transformants containing putative WNV/DENV C protein-interacting 
partners were identified based on the activation of HIS3 and ADE2 reporter genes. 
This was visualized by the growth of the transformants on high stringency QDO 
selection plates. The authenticity of the interacting partners was further confirmed 
by plating these transformants on QDO+X--Gal plates. True positives obtained 
from Y2H screening should be able to activate -galactosidase (-gal) reporter 
gene. Such transformants would appear greenish-blue whereas false positives will 
remain colourless. Several transformants were able to activate -gal reporter. 
 
3.2.5. Identity of the interacting partners 
It is essential to delineate the identity of the interacting partners from the positive 
transformants (obtained in Section 3.2.4) in order to determine their potential 
relevance to flavivirus pathogenesis. To achieve this, plasmid DNA was extracted 
from the putative positive clones (Sections 2.6.6 and 2.6.7) and sequenced 
(Section 2.3.9) using Matchmaker
TM 
AD insert screening amplimer. The resulting 
nucleotide sequences were then compared against GenBank non-redundant 
database using BLASTN and BLASTP algorithms 
(www.ncbi.nlm.nih.gov/BLAST) with program default parameters. GenBank 
entries with the highest hit against the library insert sequences were then 
identified. Host proteins that showed two or more hits in Y2H library screening 
were listed in Table 3.2 together with their functions. Table 3.3 summarizes the 




Table 3.2: List of identified WNV/DENV C protein-interacting partners with 













Secretory pathway and 
vesicular trafficking (Hsu et 











Involved in Ca signaling 
pathway and prevents 
apoptosis (Boya et al., 2004; 
Edgar et al., 2010; Feng et 
al., 2002) 
Testis-specific 







Interacts with EF1a and 
enhances protein translation 








Repairs isomerized proteins 
and protects from Bax-
induced apoptosis (Huebscher 
et al., 1999; Shimizu et al., 
2005) 
Activating 





Unfolded protein response, 
apoptosis (Manga et al., 
2010; Medigeshi et al., 2007; 
Tanimura et al., 2009) 






Acidifies various intracellular 
organelles and influences low 
pH dependant-entry and 
efficient virus egression 
(Duan et al., 2008; Nishi & 
Forgac, 2002) 








(Pasupuleti et al., 2010; Paul 
et al., 2010) 







Maintains Ca homeostasis, 
thereby preventing the 
initiation of apoptosis (Liu et 
al., 2006a; Oh & Song, 2006; 






Table 3.3: List of identified WNV/DENV C protein-interacting partners with 












Assists in protein folding, 
protein degradation and  cell 
signaling (Imai et al., 2003; 
Jakob et al., 1995; Picard, 






Trafficking of flavivirus 








Nuclear protein functions as 
the inhibitor of the 
serine/threonine phosphatase, 
PP2A (Hunt et al., 2007) 





RING-finger type ubiquitin 
ligase helps in the formation of 
ubiquitylated inclusions in 
neurodegenerative diseases 








exocytic process and mediates 
anti-diuretic hormone activity 























The host proteins, human Sec3 protein (hSec3p) and calcium-modulating 
cyclophilin binding ligand (CAML) interacted with both WNV and DENV C 
protein. The known functions of CAML were closely associated with apoptosis 
(Boya et al., 2004; Edgar et al., 2010; Feng et al., 2002). All the previously 
identified host interacting proteins of arthropod-borne flavivirus C protein were 
implicated in the apoptotic function (Lee et al., 2006; Limjindaporn et al., 2007; 
Netsawang et al., 2010; Oh & Song, 2006; Yang et al., 2008).  The hSec3p which 
is novel and not reported previously was chosen for downstream studies based on 
its functional relevance (Table 3.2).  
 
From 6 x 10
7
 clones screened in the Y2H library, six independent positive clones 
encoding the carboxy-terminal 72 aa of hSec3p were found to be the binding 
partner of WNV C protein. Similarly, four clones represented hSec3p as the 
interacting partner for DENV C protein. The Sec3 protein is one of the eight 
subunits of the exocyst complex (Lipschutz & Mostov, 2002). In yeast, the 
exocyst complex plays an important role in the secretory pathway and vesicular 
trafficking (Hsu et al., 1999; TerBush et al., 1996) by targeting vesicles to the 
plasma membrane as well as regulating the later phases of exocytosis process 
(Zhang et al., 2008b). However, the functional role of human Sec3p remains to be 
defined. Based on the known functions of Sec3p in yeast, it was hypothesized that 
flavivirus C protein might exploit hSec3p for virus trafficking and release. If the 
interaction between C protein and hSec3p was disrupted, it could interrupt 







3.3. VERIFICATION OF CAPSID PROTEIN-hSec3p INTERACTION 
IDENTIFIED FROM YEAST MATING ASSAY 
3.3.1. Yeast two-hybrid (Y2H) assay  
The hSec3p isolated from Y2H library screening encoded only the partial hSec3p. 
Full-length hSec3p was thus cloned in pGADT7 (AD) vector to generate 
hSec3pf1 plasmid and the resulting plasmid was sequenced (Sections 2.3.4 to 
2.3.6). The hSec3p cDNA used in this study showed the exact match with 
homosapiens Sec3p with accession number NP_060731.2).  
 
To re-affirm the interaction between flavivirus C protein and partial or full-length 
hSec3p in yeast system, WNV/DENV C protein interacting partners (CIP, i.e. 
partial hSec3p) or full-length hSec3pf1 were co-transformed into Saccharomyces 
cerevisiae AH109 strain with pGBKT7 (BD) plasmids expressing C proteins 
(BDC/D-BDC) (Section 2.6.2).  
 
Co-transformants that grew on QDO plates were tested for -galactosidase 
production. Strong -galactosidase signals were obtained for the interaction pairs 
such as WNV/DENV CIP-BDC/D-BDC and hSec3pf1-BDC/D-BDC pairs (Table 
3.4). To eliminate autoactivation (Section 2.6.3), all the BD fusion plasmids were 
co-transformed with empty AD vector. Likewise, specificity of interaction was 
tested by co-transforming WNV/DENV CIPs or hSec3pf1 with BD vector 
containing human lamin-C or empty BD vector. Non-specific interaction or auto-
activation was not detected with the isolated library plasmids or with the full-
length hSec3pf1 (Table 3.4). This confirmed that the interaction between 





Table 3.4: Interaction of WNV/DENV C protein and hSec3p in yeast two-






Lamin-C BD vector p53 
WNVCIP3/69/ 
77/79/157/342 
+++ (+++) - (-) - (-) 
 
DENVCIP5/8/88/257 +++ (+++) - (-) - (-) 
hSec3pf1 +++ (+++) - (-) - (-) 
AD vector - (-) - (-) - (-) 
SV40 T  +++ (+++) 
 
WNVCIP or DENVCIP represents WNV/DENV C protein interacting partners. 
WNVCIP3/69/77/79/157/342 or DENVCIP5/8/88/257 represent the clone 
numbers (numbers given during Y2H library screening process) showing hSec3p 
as the interacting partner of C protein. The results obtained from -galactosidase 
assay are shown in bold. The relative strength of interaction is determined based 
on the intensity of the blue phenotype obtained from the positive control after 48 
h. Interaction of p53 with SV40 large T-antigen serves as positive control. +++, 
deep blue colonies (strong interaction); -, white colonies (no interaction). All the 
constructs were concurrently assayed for non-specific reporter gene activation by 
transforming singly or with control BD-Lamin C or BD vector and plated on to 
SD-His plates. The results obtained from HIS3 autotrophy are shown in 
parenthesis. Growth is recorded after 2 days when the positive control shows clear 
growth. (+++), clear growth (strong interaction); (-), no growth (no interaction). 











To ensure that the interaction between C protein and hSec3p was not limited by 
the requirement of nuclear translocation in Y2H system, the hSec3p-C protein 
interaction was tested in mammalian model (Section 2.7.1). HEK293 cells were 
infected with WNV/DENV. At 14 h (WNV) and 24 h (DENV) p.i., proteins in 
cell lysates were precipitated using anti-hSec3p antibody followed by 
immunoblotting using anti-WNV/DENV C antibody. Lanes 1 and 4 [Fig. 3.4(i)] 
were loaded with HEK293 cell lysates. Lanes 2 and 5 [Fig. 3.4(i)] were loaded 
with the mock-infected samples. Lanes 3 and 6 [Fig. 3.4(i)] were loaded with 
WNV/DENV-infected cell lysates, respectively. The appearance of bands (14 kD) 
in Lanes 3 and 6 [Fig. 3.4(i)] confirmed the binding between hSec3p and C 
proteins in HEK293 cells. To ensure the successful precipitation of hSec3p, the 
precipitated immune complexes were also probed with anti-hSec3p antibody [Fig. 
3.4(ii)]. The expression of hSec3p, WNV/DENV C protein and actin loading 
controls were shown in Fig. 3.4(iii-v). The antibody isotype controls did not pull 
down the protein of interest [Fig. 3.4(vi)]. No interaction between hSec3p and 
flavivirus E protein was detected [Fig. 3.5(i)]. These results demonstrated that 
























Fig. 3.4: Interaction between WNV/DENV C protein and hSec3p. HEK293 
cells were infected with WNV/DENV. (i) Cell lysates were immunoprecipitated 
with anti-hSec3p mouse antibody and immunoblotted with anti-C rabbit antibody. 
The presence of bands (14 kD) in Lanes 3 and 6 confirm C protein-hSec3p 
binding in WNV- and DENV-infected HEK293 cells, respectively. (ii-v) The 
precipitation efficiency, expression of hSec3p/C protein in cell lysates and actin 
loading control are detected using anti-hSec3p or anti-WNV/DENV C or anti-
actin antibodies. (vi) Antibody isotype control. (IP: Immunoprecipitated sample; 






IP: Mouse isotype control 
WB: Anti-WNV/DENV C Ab 
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Fig. 3.5: Interaction between WNV/DENV E protein and hSec3p. (i) HEK293 
cells were infected with WNV/DENV. (i) Cell lysates were immunoprecipitated 
with anti-hSec3p antibody and immunoblotted with anti-E antibody. The absence 
of bands on the immunoblot confirms that there is no interaction between E 
protein-hSec3p in WNV-/DENV-infected HEK293 cells. (ii) The expression of E 
protein (50 kD) is detected in WNV-/DENV-infected cells using anti-
WNV/DENV E antibody (Lanes 3 & 6). (IP: Immunoprecipitated sample; WB: 
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3.3.3. Confocal analysis 
As further evidence of interaction, WNV/DENV-infected cells were examined for 
co-localization of the proteins by an immunofluorescence confocal microscopy 
(Section 2.13). Confocal analysis showed that hSec3p and flavivirus C protein co-
localized at the cytoplasmic and perinuclear region (Fig. 3.6). These data 
supported the physical interaction of WNV/DENV C protein and hSec3p 























Fig. 3.6: Cellular localization of C protein and hSec3p in WNV-/DENV-
infected cells. HEK293 cells were infected with WNV/DENV. The cells were 
then processed for confocal microscopy using anti-WNV/DENV C or anti-hSec3p 
antibody together with Alexa488 (green) or Alexa594 (red) secondary antibodies, 
respectively. Co-localization of hSec3p and C proteins is observed in cytoplasmic 
and perinuclear regions as depicted in the merged images (arrows). Cell nuclei are 






















                     




3.4. MAPPING THE ASSOCIATION DOMAIN OF FLAVIVIRUS CAPSID 
PROTEIN AND HUMAN Sec3 PROTEIN 
3.4.1. Delineation of flavivirus capsid protein and human Sec3 protein 
binding domains 
In yeast, Sec3p played a crucial role in the secretory pathways and the facilitation 
of polarized growth (Finger et al., 1998a; Finger & Novick, 1997; Wiederkehr et 
al., 2003). It was thus hypothesized that flavivirus C protein might exploit hSec3p 
for virus trafficking and release. Mapping the interacting domains of C protein 
and hSec3p could aid in the design of novel site-specific peptides that would 
disrupt the important association between flavivirus C protein and hSec3p.   
 
3.4.2. Delineation of human Sec3 protein-binding domain of flavivirus capsid 
protein 
To define hSec3p binding domain of WNV/DENV C protein, several constructs 
expressing truncated C proteins were generated (Fig. 3.7). West Nile virus full-
length/truncated C proteins were expressed as HA-tagged fusion proteins. The 
DENV full-length/truncated C proteins were expressed as Myc-tagged fusion 
proteins as expression of HA-tagged DENV C protein was extremely low.  
 
HEK293 cells were co-transfected with full-length hSec3p (V5-hSec3pf1) and a 
series of truncated C plasmids. Transfected lysates were precipitated with anti-
mouse V5 antibody and immunoblotted with anti-rabbit HA antibody. As shown 















Fig. 3.7: Schematic diagram of 5’ and 3’ truncated WNV and DENV C 
mutants. These truncated C plasmids were used for Y2H and Co-IP assays. 
Truncations were performed by deleting 15 amino acids successively from the N-
terminal end of C protein (5‟Δ15, 5‟Δ30 and 5‟Δ45). The cytotoxic motif at the 
last 18 amino acids (3‟Δ18) and the NLS domain together with the cytotoxic 
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transfection with V5-hSec3pf1 and HAC5‟15, HAC5‟30 or HAC5‟45 
(Lanes 3, 4 & 5) did not show any interaction. In contrast, lysates from co-
transfection with V5-hSec3pf1 and HAC, HAC3‟18 or HAC3‟39 [Lanes 2, 6 
& 7 in Fig. 3.8(i)] showed interactions. To confirm the successful precipitation of 
hSec3p, the precipitated complexes were also probed with anti-V5 antibody [Fig. 
3.8(ii)]. The amount of V5-tagged hSec3p and WNV C protein in whole cell 
lysates was shown in Fig. 3.8(iii & iv). Actin loading controls were shown in Fig. 
3.8(v). Identical hSec3p-binding domain was obtained from DENV C protein 
[Fig. 3.8(vii-xi)]. The antibody isotype controls did not pull down the protein of 
interest [Fig. 3.8(vi and xii)]. The reciprocal Co-IP performed showed the same 
results (Fig. 3.9). This confirmed that the first 15 aa of WNV/DENV C protein 
were important for hSec3p binding. Similar results were obtained from Y2H assay 
(Table 3.5).  
 
3.4.3. Delineation of flavivirus capsid protein-binding region of human Sec3 
protein 
The C protein-binding region of hSec3p was also defined using Y2H (Section 
2.6.2) and Co-IP (Section 2.7.1) assays. Several constructs expressing truncated 
hSec3p were generated (Fig. 3.10). Plasmids encoding full-length or truncated 
hSec3p were co-transfected with HAC (Fig. 3.11) or Myc-C (Fig. 3.12) in 
HEK293 cells (Section 2.3.13). As depicted in Figs. 3.11(i) and 3.12(i), lysates 
from mock-transfection (Lane 1) or from HAC/Myc-C/V5-hSec3pf5 co-



















Fig. 3.8: Delineation of hSec3p-associating domain of C protein. (i-vi) 
Delineation of hSec3p-associating domain of WNV C protein. (i) HEK293 cells 
were co-transfected with V5-hSec3pf1 and full-length/truncated C plasmids. Cell 
lysates were immunoprecipitated using anti-V5 mouse antibody and 
immunoblotted with anti-HA rabbit antibody. The absence of bands in Lanes 3, 4 
and 5 indicate that the first 15 aa of WNV C protein are required for hSec3p 
binding. (ii-vi) Immunoprecipitation control, expression controls, actin loading 
control and antibody isotype control. (vii-xii) Delineation of hSec3p-associating 
domain of DENV C protein. (vii) HEK293 cells were co-transfected with V5-
hSec3pf1 and full-length/truncated C plasmids. Cell lysates were 
immunoprecipitated using anti-V5 mouse antibody and immunoblotted using anti- 
Myc rabbit antibody. The absence of band in Lane 3 indicates that the first 15 aa 
of DENV C protein are required for association with hSec3p. (viii-xii) 
Immunoprecipitation control, expression controls, actin loading control and 
antibody isotype control. (IP: Immunoprecipitated sample; WB: Western blot; 
WCL: Whole cell lysate). 
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Fig. 3.9: Reciprocal Co-IP to delineate hSec3p-associating domain of C protein. 
HEK293 cells were co-transfected with V5-hSec3pf1 and full-length/truncated C 
plasmids. Cell lysates were immunoprecipitated using (i) anti-HA rabbit or (iv) anti-Myc 
rabbit antibody and analyzed by immunoblotting using anti-V5 mouse antibody. (i) The 
absence of bands in Lanes 3, 4 & 5 and (iv) Lane 3 indicate that the first 15 aa of 
WNV/DENV C protein are required for association with hSec3p. (ii & v) 
Immunoprecipitation using anti-HA/Myc antibody and immunoblotting with anti-
HA/Myc antibody to ensure successful immunoprecipitation in all experimental groups. 
(iii & vi) Reciprocal immunoprecipitation using rabbit antibody isotype control and 
immunoblotting with anti-V5 antibody. (IP: Immunoprecipitated sample; WB: Western 
blot; WCL: Whole cell lysate). 
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Table 3.5: Mapping the hSec3p binding domain of WNV C protein in the 




The results obtained from -galactosidase assay are shown in bold. The relative 
strength of interaction is determined based on the intensity of the blue phenotype 
obtained from the positive control after 48 h. Interaction of p53 with SV40 large 
T-antigen serves as positive control. +++, deep blue colonies (strong interaction); 
-, white colonies (no interaction). All the constructs were concurrently assayed for 
non-specific reporter gene activation by transforming singly or with control BD-
Lamin C or BD vector and plated on to SD-His plates. The results obtained from 
HIS3 autotrophy are shown in parenthesis. Growth is recorded after 2 days when 
the positive control shows clear growth. (+++), clear growth (strong interaction); 
(++), moderate growth (moderate interaction); (-), no growth (no interaction). As 
depicted in the Table, non-specific activation is not observed for all the fusions. 











hSec3pf1 Lamin-C BD vector p53 
C +++ (+++) - (-) - (-) 
 
C5‟15 - (-) - (-) - (-) 
C5‟30 - (-) - (-) - (-) 
C5‟45 - (-) - (-) - (-) 
C3‟18 +++ (++) - (-) - (-) 
C3‟39 +++ (++) - (-) - (-) 
AD vector - (-) - (-) - (-) 




transfection with HAC/Myc-C and V5-hSec3pf1 or V5hSec3pf6 [Lanes 2 & 4 in 
transfection with HAC/Myc-C and V5-hSec3pf1 or V5hSec3pf6 [Lanes 2 & 4 in 
Figs. 3.11(i) and 3.12(i)] showed interactions, confirming that the last 15 aa of 
hSec3p was crucial for binding. Similar results were obtained from Y2H assay 
(Table 3.6). To facilitate specific domain identification, the protein sequence of 
hSec3p was subjected to ELM software analysis (Section 2.14). ELM analysis 
indicated that the last 15 aa of hSec3p contains putative PDZ and SH2 domains. 
Mutagenesis studies performed on the putative PDZ [(aa 867 and 869), Lane 5, 
Figs. 3.11(i) and 3.12(i)] and SH2 [(aa 871), Lane 6, Figs. 3.11(i) and 3.12(i)] 
binding motifs in the last 15 aa of hSec3p revealed that the aa 871 in the SH2 
domain of hSec3p was crucial for this interaction. The reciprocal Co-IP 
performed showed identical results (Fig. 3.13). This indicated that the SH2 
binding motif at the aa residue 871 of hSec3p was crucial for C protein binding.  
 
Overall, yeast two-hybrid library screening performed using WNV/DENV C 
protein as bait identified several host interacting partners of C protein. Among the 
new cellular proteins found to interact with WNV/DENV C protein, hSec3p was 
chosen for further studies due its functions known in yeast. Using a combination 
of molecular, biochemical and microscopic analyses, the domains mediating the 
interactions of C protein and hSec3p was delineated and shown that the first 15 
amino acids of WNV/DENV C protein is crucial to mediate the interaction 





















Fig. 3.10: Schematic diagram of 5’ and 3’ truncated hSec3p mutants. The 
truncated plasmids of hSec3p were generated at random and were used for Y2H 
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Table 3.6: Mapping the WNV and DENV C protein binding domain of 
hSec3p in the yeast two-hybrid system, assayed for -galactosidase activity 
and HIS3 autotrophy.  
 
 
The results obtained from -galactosidase assay are shown in bold. The relative 
strength of interaction is determined based on the intensity of the blue phenotype 
obtained from the positive control after 48 h. Interaction of p53 with SV40 large 
T-antigen serves as positive control. +++, deep blue colonies (strong interaction); 
-, white colonies (no interaction). All the constructs were concurrently assayed for 
non-specific reporter gene activation by transforming singly or with control BD-
Lamin C or BD vector and plated on to SD-His plates. The results obtained from 
HIS3 autotrophy are shown in parenthesis. Growth is recorded after 2 days when 
the positive control shows clear growth. (+++), clear growth (strong interaction); 
(++), moderate growth (moderate interaction); (-), no growth (no interaction). As 
depicted in the Table, non-specific activation is not observed for all the fusions. 















































Fig. 3.11: Delineation of WNV C protein-binding domain of hSec3p. (i) 
HEK293 cells were mock-transfected (Lane 1) or co-transfected with HAC and 
full-length (Lane 2) or truncated (Lanes 3 & 4) or mutated (Lanes 5 & 6) hSec3p 
plasmids. Cell lysates were immunoprecipitated using anti-HA antibody and 
immunoblotted with anti-V5 antibody. The absence of bands in Lanes 3 and 6 
show that SH2 binding motif in the last 15 aa of hSec3p is important for binding 
with WNV C protein. (ii-v) Immunoprecipitation control, expression controls and 
actin loading controls. (IP: Immunoprecipitated sample; WB: Western blot; WCL: 







 hSec3p 100 kD 
WNV 
WCL 
WB: Anti-V5 Ab 
(iii) 
Sec3pf6 




WB: Anti-actin Ab 
 
WCL 
WB: Anti-HA Ab (iv) C 
14 kD 
   1         2        3        4        5        6 
     1        2        3        4         5        6 
10 kD 
IP   : Anti-HA Ab 
WB: Anti-HA Ab 
        1         2        3         4       5        6 
     1       2       3       4          5        6 
IP   : Anti-HA Ab 
WB: Anti-V5 Ab  (i) 























































































C 14 kD  (ii) 
42 kD 



















Fig. 3.12: Delineation of DENV C protein-binding domain of hSec3p. (i) 
HEK293 cells were mock-transfected (Lane 1) or co-transfected with Myc-C and 
full-length (Lane 2) or truncated (Lanes 3 & 4) or mutated (Lanes 5 & 6) hSec3p 
plasmids. Cell lysates were immunoprecipitated using anti-Myc antibody and 
immunoblotted with anti-V5 antibody. The absence of bands in Lanes 3 and 6 
show that SH2 binding motif in the last 15 aa of hSec3p is important for binding 
with DENV C protein. (ii-v) Immunoprecipitation control, expression controls 
and actin loading controls. (IP: Immunoprecipitated sample; WB: Western blot; 
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Fig. 3.13: Reciprocal Co-IP to delineate C protein-binding domain of hSec3p. 
HEK293 cells were mock-transfected (Lane 1) or co-transfected with (i) HAC or 
(iii) Myc-C and full-length (Lane 2) or truncated (Lanes 3 & 4) or mutated (Lanes 
5 & 6) hSec3p plasmids. Cell lysates were immunoprecipitated using anti-V5 
antibody and immunoblotted with (i) anti-HA or (iii) anti-Myc antibody. The 
absence of bands in Lanes 3 and 6 show that SH2 binding motif in the last 15 aa 
of hSec3p is important for binding with C protein. (ii & iv) Reciprocal 
immunoprecipitation using mouse antibody isotype control and immunoblotting 
with (ii) anti-HA or (iv) anti-Myc antibody. (IP: Immunoprecipitated sample; 
WB: Western blot; WCL: Whole cell lysate). 
IP: Mouse isotype control 
WB: Anti-HA Ab 
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4.0. INFLUENCE OF HUMAN Sec3 PROTEIN ON FLAVIVIRUS LIFE 
CYCLE 
4.1. INTRODUCTION 
Having established the interaction between flavivirus C protein and hSec3p, the 
next question to address is if hSec3p influences flavivirus production. To 
investigate the effect of hSec3p on flavivirus life-cycle, it was essential to create a 
controlled environment whereby the level of hSec3p remained approximately 
constant. HEK293 cells were thus transduced using lentiviral system either over-
expressing hSec3p gene or causing a knock-down of hSec3p gene. To ensure 
consistent and reproducible experimental outcomes, HEK293 stable cell lines 
representing hSec3p over-expression or hSec3p knock-down were created 
(Section 2.8). The effect of hSec3p over-expression and knock-down on flavivirus 
production was examined. This was followed by investigation on the limiting 
step(s) which hSec3p targets in flavivirus life-cycle.  
 
4.2. OVER-EXPRESSION AND KNOCK-DOWN OF HUMAN Sec3 GENE 
USING LENTIVIRUS SYSTEM 
4.2.1. Determination of Blasticidin concentration to select stably-transduced 
HEK293 cells 
The vector, pLenti6/BLOCK-iT™-DEST, used to produce lentivirus for 
transduction of HEK293 cells contained a Blasticidin resistant gene. This 
permitted for the selection of stably-transduced HEK293 cells using Blasticidin. 
To allow rapid and efficient selection of cells stably-expressing the desired gene 






Fig. 4.1: Determination of Blasticidin concentration to select stably-
transduced HEK293 cells. Various concentrations of Blasticidin were added to 
the growth media of HEK293 cells. It is determined that a minimum of 25 μg/ml 
concentration of Blasticidin is essential to select for stably-transduced cells in the 









necessary to kill off large amounts of non-transduced HEK293 cells in the 
shortest time possible. Increasing concentrations of Blasticidin (0-50 μg/ml) was 
added to the growth media of HEK293 cells and observed for cytotoxic effects 
(Section 2.8.9). It was determined that Blasticidin at 25 μg/ml concentration was 
adequate to kill significant number of non-transduced cells in 4 days (Fig. 4.1).  
 
4.2.2. Establishment of stably-transduced HEK293 cells 
Although 25 μg/ml of Blasticidin was adequate to kill significant number of non-
transduced cells (Fig. 4.1), 30 μg/ml of Blasticidin was used to select stably-
transduced HEK293 cells to enhance the efficiency of selection. After two weeks 
of selection, the stably-transduced hSec3p293OE and hSec3p293KD cells were 
lysed to analyse the hSec3p level (Section 2.8.8) by Western blot [Fig. 4.2(i)]. A 
highly-expressed protein, β-actin, was used as a loading control [Fig. 4.2(ii)]. 
Band quantification of the immunoblot revealed that lentivirus-mediated gene 
knock-down decreased the endogenous hSec3p level by 75% in hSec3p293KD 
cells. Seventy-one percent increase in hSec3p expression was seen in 























Fig. 4.2: Western blot analysis showing the effect of hSec3p gene silencing 
and over-expression in HEK293 cells. (i) The lysates from HEK293, Expression 
control (control plasmid-transduced HEK293 cells), hSec3p293OE, Scrambled 
(scrambled sequence-transduced HEK293 cells) and hSec3p293KD cells were 
subjected to Western blotting using anti-hSec3p antibody. Increased hSec3p level 
is detected in hSec3p293OE cells (Lane 3) and decreased level is observed in 
hSec3p293KD cells (Lane 5). (ii) The actin loading controls are shown to confirm 
the equal loading. (iii) The hSec3p bands were quantified using GeneTools 
program (Syngene). An arbitrary density of 100% is attributed to the endogenous 
hSec3p level in HEK293 cell lysate. As revealed by the densitometric analysis, 
lentivirus-mediated gene knock-down decrease the endogenous hSec3p level by 
75% in hSec3p293KD cells while 71% increase in hSec3p expression is seen in 
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Fig. 4.3: Relative cytotoxicity and viability of transduced-HEK293 cells. The 
viability and cytotoxicity of HEK293, Expression control, hSec3p293OE, 
Scrambled and hSec3p293KD cells were tested. The stably-transduced cells are 





















4.2.3. Determination of transduction-related cytotoxicity 
To determine whether there was any transduction-associated cytotoxicity, 
cytotoxicity and viability test was performed on hSec3p293OE and 
hSec3p293KD cells (Section 2.8.9). The results indicated that the stably-  
transduced cells had a cytotoxicity and viability profile like that of the non-
transduced HEK293 cells. This indicated that there was no transduction-
associated cytotoxicity and the transduced cells were highly viable (Fig. 4.3).  
 
4.3. EFFECT OF OVER-EXPRESSION AND KNOCK-DOWN OF HUMAN 
Sec3 PROTEIN ON THE ABUNDANCE OF PROTEINS INVOLVED IN 
SECRETORY PATHWAY  
Human Sec3 protein is one of the exocyst components involved in secretory 
pathway. Over-expression and knock-down of hSec3p could therefore affect the 
abundance of other proteins involved in secretory pathway. It is thus essential to 
check if differential expression of hSec3p alters the abundance of several proteins 
involved in secretory pathway. The other components of exocyst complex, Exo70 
and human Sec6 protein were chosen to investigate if the abundance of these 
proteins (involved in secretory pathway) was altered when hSec3p was 
differentially expressed. Western blotting (Section 2.5.2) of whole cell lysates 
obtained from HEK293, hSec3p293KD and hSec3p293OE cells were performed 
using anti-Exo70 and anti-Sec6 antibodies (Fig. 4.4). The results demonstrated 
that the abundance of host proteins involved in secretory pathway was not 














Fig. 4.4: Western blotting of whole cell lysates derived from HEK293, 
hSec3p293OE and hSec3p293KD cells. Twenty-five micrograms of cell lysate 
from each experimental group was separated using SDS-PAGE gel and probed 
with (i) anti-Exo70 or (ii) anti-hSec6 antibodies. There are no observable 
differences in the levels of proteins involved in the secretory pathway in 
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4.4. EFFECT OF HUMAN Sec3 PROTEIN OVER-EXPRESSION AND 
KNOCK-DOWN ON FLAVIVIRUS PRODUCTION 
4.4.1. Influence of human Sec3 protein on flavivirus production 
After establishing hSec3p293OE and hSec3p293KD cells, the effect of hSec3p on 
virus production was examined. Based on the known functions of Sec3p in yeast, 
it was deduced that the knock-down of hSec3p should prevent C protein-exocyst 
association and disrupt virus production and subsequently virus egression. 
Similarly, over-expression of hSec3p should facilitate efficient C protein-exocyst 
association and enhance virus production and transport. This hypothesis was 
tested by infecting hSec3p293KD and hSec3p293OE cells with WNV or DENV. 
As shown in Fig. 4.5, an increase in virus titre from as early as 6 h p.i. in 
WNV(Sarafend) and 15 h p.i. in DENV was detected in hSec3p293KD cells 
compared to virus-infected HEK293 cells. The maximal increment in virus titre 
was seen at 18 h and 72 h p.i. for WNV(Sarafend) and DENV, respectively.  
Following these time points, the differences in virus titres between infected 
HEK293 and hSec3p293KD cells started to decline. No significant difference in 
the virus titres was observed in virus-infected control vector/scrambled HEK293 
cells. This confirmed that the increase or decrease in virus titres observed in 





























Fig. 4.5: Effect of hSec3p KD/OE on virus titres following virus infection. 
HEK293, scrambled/control vector + HEK293 and hSec3p293KD/OE cells were 
infected with (i) WNV(Sarafend) or (ii) DENV or (iii) WNV(Wengler). The 
supernatants were harvested at the indicated timings to determine virus titres. The 
results are representatives of 3 independent experiments ± standard deviation. A 
significant increment or decrement in virus titres is detected in 
WNV(Sarafend)/DENV/WNV(Wengler)-infected hSec3p293KD/OE cells 
compared to scrambled/control vector-transduced 293 cells. * indicates P<0.05 as 









































The reverse trend was observed in WNV-/DENV-infected hSec3p293OE cells 
(Fig. 4.5). Reduction in virus titre was observed at as early as 6 h p.i. in 
WNV(Sarafend) and 15 h p.i. in DENV in hSec3p293OE cells compared to virus-
infected HEK293 cells. The maximal decrement in virus titre was seen at 18 h and 
120 h p.i. for WNV(Sarafend) and DENV, respectively. Similar to hSec3p293KD 
cells, the differences in virus titres between infected HEK293 and hSec3p293OE 
cells were reduced at later timings.  
 
These observations contradicted the initial hypothesis. Instead, hSec3p was shown 
to be a negative regulator of flavivirus infection. It was also observed that changes 
in hSec3p expression had a more pronounced effect on DENV compared to 
WNV(Sarafend). Dengue virus has a relatively longer latent period [(12-24 h) 
(Helt & Harris, 2005) compared to WNV(Sarafend) which possess a very short 
latent period [(6 h) (Ng et al., 2001)]. The hSec3p might require longer period to 
execute its anti-viral effect. Since DENV possess longer latent period, hSec3p 
might have enough time to fully implement its anti-viral activity compared to 
WNV(Sarafend).  
 
To test this postulation, WNV(Wengler) was chosen since WNV(Wengler) has a 
similar length of replication cycle as that of DENV. WNV(Wengler) was used to 
infect hSec3p293KD and hSec3p293OE cells. Similar to WNV(Sarafend) and 
DENV, an increase in virus titre was observed in WNV(Wengler) infected-





hSec3p293OE cells [Fig. 4.5(iii)]. Furthermore, it was also observed that 
differential expression of hSec3p showed a more pronounced effect on 
WNV(Wengler) compared to WNV(Sarafend). This demonstrated that the 
duration of latent period would influence the anti-viral effect of hSec3p. 
 
4.4.2. Effect of capsid protein-binding defective human Sec3 protein mutant 
on flavivirus production 
The effect of C protein-binding defective hSec3p mutant, hSec3pSH2 on 
flavivirus production was then examined to check if hSec3p needed to physically 
bind to C protein to negatively influence flavivirus production. The V5-
hSec3pSH2 mutant was over-expressed in HEK293, hSecp293OE and 
hSec3p293KD cells and infected with WNV and DENV. The growth 
characteristics of both WNV and DENV were determined by plaque assay 
(Sections 2.2.4 and 2.2.5). When hSec3pSH2 mutant was over-expressed in 
HEK293, hSec3p293OE and hSec3p293KD cells, the virus titres were decreased 
in HEK293, hSec3p293OE and hSec3p293KD cells (Fig. 4.6). The inhibitory 
trend of hSec3pSH2 mutant was surprisingly similar to that observed with full-
length V5-hSec3pf1-transfected cells. This indicated that the physical binding 
between hSec3p and C protein was not essential to influence flavivirus 
production. The physical binding between hSec3p and C protein might be 
required to negate the anti-viral activity of hSec3p (Chapter 6). Moreover, there 
could be other unknown factor(s) mediating the effect of hSec3p on flavivirus 







Fig. 4.6: Growth kinetics of WNV/DENV in hSec3pSH2 mutant-over-
expressed 293, hSec3p293OE and hSec3p293KD cells. HEK293, hSec3p293OE 
and hSec3p293KD cells were transfected with V5-hSec3pSH2/V5-hSec3pf1and 
infected with WNV or DENV. The culture supernatants were harvested over time 
and virus titres were determined by plaque assay. The results are representatives 
of 3 independent experiments ± standard deviation. When hSec3pSH2 mutant is 
over-expressed, a significant decrement in virus titres is detected in WNV/DENV-
infected hSec3p293KD/OE cells compared to that of HEK293 cells. * indicates 










































































4.5. INFLUENCE OF HUMAN Sec3 PROTEIN ON VIRUS ENTRY 
Following the observation that hSec3p is a negative regulator of flavivirus 
production, the first question to address is whether hSec3p-induced fluctuations in 
virus titres were due to differences in the early events such as viral entry or 
genome uncoating.  
 
To answer this query, these processes were bypassed by electroporating HEK293, 
hSec3p293KD and hSec3p293OE cells using WNV/DENV RNA transcribed 
from full-length infectious clones (Section 2.3.14). At the indicated time points, 
the titres of infectious virus were then determined by plaque assay (Section 2.2.4). 
As shown in Fig. 4.7(i), virus titres were higher in WNV RNA-transfected 
hSec3p293KD cells and lower in WNV RNA-transfected hSec3p293OE cells. 
Similar trends were observed with DENV RNA transfection [Fig. 4.7(ii)]. No 
significant difference in the virus titres was observed in viral RNA-transfected 
control vector/scrambled HEK293 cells. This confirmed that the increase or 
decrease in virus titres observed in hSec3p293KD or hSec3p293OE cells were 
specifically due to modulation of hSec3p levels. This indicated that hSec3p-

























Fig. 4.7: Effect of hSec3p KD/OE on virus titres following viral RNA 
transfection. HEK293, scrambled/control vector + HEK293 and 
hSec3p293KD/OE cells were transfected with (i) WNV RNA or (ii) DENV RNA. 
The supernatants were harvested from RNA-transfected cells to determine virus 
titres. The results are representatives of three independent experiments ± standard 
deviation. A significant increment or decrement in virus titres is detected in 
WNV/DENV RNA-transfected hSec3p293KD/OE cells compared to 
scrambled/control vector-transduced 293 cells. * indicates P<0.05 as compared to 
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4.6. INFLUENCE OF HUMAN Sec3 PROTEIN ON PLUS (+) AND MINUS 
(-) STRAND RNA SYNTHESIS 
To determine if hSec3p-induced effects on virus titres were due to altered viral 
RNA synthesis, HEK293, hSec3p293KD and hSec3p293OE cells were infected 
with WNV/DENV. Plus (+) and minus (-) strand viral RNA from WNV/-DENV-
infected HEK293, hSec3p293OE and hSec3p293OE cells were then quantitated 
using real-time PCR (Section 2.3.15). To avoid measuring viral RNA from 
multiple infection rounds, WNV and DENV RNA levels were quantitated at 5 h 
and 24 h p.i., respectively.  
 
Interestingly, (+) RNA levels were 8 fold higher in WNV-infected hSec3p293KD 
cells and 5 fold lower in WNV-infected hSec3p293OE cells [Fig. 4.8(i)]. The 
levels of (-) RNA were 7.4 fold higher in WNV-infected hSec3p293KD cells and 
4.7 fold lower in WNV-infected hSec3p293OE cells [Fig. 4.9(i)]. Similar trends 
were observed in (+) and (-) RNA levels in DENV-infected hSec3p293KD and 
hSec3p293OE cells [Figs. 4.8 (ii) & 4.9(ii)]. No significant difference in (+) and 
(-) RNA levels was observed in virus-infected control vector/scrambled HEK293 
cells. This confirmed that the increase or decrease in (+) and (-) RNA levels 
observed in hSec3p293KD or hSec3p293OE cells were specifically due to 
modulation of hSec3p levels. These results suggested that differential expression 























Fig. 4.8: Influence of hSec3p on (+) RNA synthesis. HEK293, hSec3p293OE 
and hSec3p293KD cells were infected with (i) WNV or (ii) DENV and RNA was 
extracted and quantified by RT-PCR. The disparity in viral RNA level was 
expressed as fold difference normalized against the RNA present in WNV-
/DENV-infected HEK293 cells. A significant increase [(i) WNV: 8 fold; (ii) 
DENV: 275 fold] or decrease [(i) WNV: 5 fold; (ii) DENV: 117 fold] in viral (+) 
strand level is detected in virus-infected hSec3p293KD and hSec3p293OE cells, 
respectively compared to that of scrambled/control vector-transduced 293 cells. * 




































Fig. 4.9: Effect of hSec3p on (-) RNA synthesis. HEK293 and 
hSec3p293KD/OE cells were infected with (i) WNV or (ii) DENV and RNA was 
extracted and quantified by RT-PCR. The disparity in viral RNA level was 
expressed as fold difference normalized against the RNA present in WNV-
/DENV-infected HEK293 cells. A significant increase [(i) WNV: 7.4 fold; (ii) 
DENV: 258 fold] and decrease [(i) WNV: 4.7 fold;(ii) DENV: 98 fold] in viral (-) 
strand level is detected in hSec3p293KD and hSec3p293OE cells, respectively 
compared to that of scrambled/control vector-transduced 293 cells. * indicates 
















4.7. INFLUENCE OF HUMAN Sec3 PROTEIN ON VIRAL PROTEIN 
PRODUCTION 
The above results suggested that viral RNA synthesis was affected by hSec3p 
expression. To evaluate if hSec3p also influences viral protein production, the 
level of viral protein synthesized from WNV-/DENV-infected hSec3p293KD/OE 
cells was analyzed by Western blotting (Section 2.5.2) at various time points 
using anti-E antibody [Figs. 4.10 and 4.11(i)]. The E protein was used as a 
surrogate marker for viral protein production. Actin loading controls were 
included to ensure equal loading [Figs. 4.10 and 4.11(ii)].  
 
Densitometry (semi-quantitative) analysis of the above immunoblots using 
Syngene program [Figs. 4.10 and 4.11(iii)] revealed that viral E protein synthesis 
was increased in virus-infected hSec3p293KD cells (WNV: 150-217%; DENV: 
249-397%) and decreased in virus-infected hSec3p293OE cells (WNV: 17-38%; 
DENV: 25-36%) following normalization against the E protein level in HEK293 
cells (100%). This trend was similar to that observed with viral RNA synthesis 
(Section 4.6). This indicated that excess hSec3p has negative effect on viral 
protein production as well. In addition, it was also observed that differential 
expression of hSec3p had a greater effect on DENV protein levels compared to 
that of WNV. This could be due to the differences in the duration of latent period 














Fig. 4.10: Effect on WNV protein production. HEK293, hSec3p293KD and 
hSec3p293OE cells were infected with WNV. (i) At the indicated timings, cells 
were lysed and immunoblotted for E protein. The intracellular viral E proteins 
increase in hSec3p293KD cells (Lanes 1-3) and decrease in hSec3p293OE cells 
(Lanes 7-9) compared to HEK293 cells (Lanes 4-6). (ii) Actin loading control to 
ensure equal loading. (iii) The band intensities of E protein from various 
experimental groups were quantified using GeneTools program. An arbitrary 
density of 100% is attributed to the E protein level in WNV-infected HEK293 
cells. Results from three independent experiments are averaged for semi-
quantitative illustration. Significant changes in the amount of E proteins are 
observed in WNV-infected hSec3p293KD/OE cells (* indicates P<0.05) as 
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Fig. 4.11: Effect on DENV protein production. HEK293, hSec3p293KD and 
hSec3p293OE cells were infected with DENV. (i) At the indicated timings, cells 
were lysed and immunoblotted for E protein. The intracellular viral E proteins 
increase in hSec3p293KD cells (Lanes 1-3) and decrease in hSec3p293OE cells 
(Lanes 7-9) compared to HEK293 cells (Lanes 4-6). (ii) Actin loading control to 
ensure equal loading. (iii) The band intensities of E protein from various 
experimental groups were quantified using GeneTools program. An arbitrary 
density of 100% is attributed to the E protein level in DENV-infected HEK293 
cells. Results from three independent experiments are averaged for quantitative 
illustration. Significant changes in the amount of E proteins are observed in 
DENV-infected hSec3p293KD/OE cells (* indicates P<0.05) as compared to 
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4.8. EFFECT OF HUMAN Sec3 PROTEIN ON VIRUS SECRETION 
To examine if hSec3p influences virus secretion, HEK293, hSec3p293OE and 
hSec3p293KD cells were infected with WNV or DENV. At the indicated time 
points, viral RNAs were extracted from the culture supernatant using QIAamp 
viral RNA kit (Section 2.3.1) and quantified using real-time RT-PCR [(Section 
2.3.15) (Fig. 4.12)]. The viral RNA levels in WNV/DENV-infected HEK293 cell 
culture supernatants were assigned arbitrarily as one and compared to the viral 
RNA levels from that of virus-infected hSec3p293KD and hSec3p293OE cell 
culture supernatants. A significant increase (WNV: 8 fold; DENV: 250 fold) and 
decrease (WNV: 4 fold; DENV: 100 fold) in viral RNA level was detected in 
WNV-/DENV-infected hSec3p293KD and hSec3p293OE cell culture 
supernatants, respectively.  
 
Secreted E protein levels were also quantified by Western blotting (Section 2.5.2) 
and densitometry [(Section 2.5.5) (Fig. 4.13)]. The amounts of secreted E proteins 
in WNV/DENV-infected HEK293 cell culture supernatants were assigned as 
100% and compared to that from virus-infected hSec3p293KD and hSec3p293OE 
cell culture supernatants. The level of viral E proteins increased (WNV: 220%; 
DENV: 600%) in hSec3p293KD cells and decreased (WNV: 45%; DENV: 85%) 
in hSec3p293OE cell culture supernatants. The observed reduction in secreted 
viral RNA and protein levels in hSec3p293OE cell culture supernatants correlated 
with the decreased intracellular viral RNA and protein synthesis reported in 
Sections 4.6 and 4.7 using quantitative real-time PCR (Section 2.3.15) and semi-
quantitative Western blotting (Section 2.5.2). 
 
In this chapter, the effct of hSec3p on flavivirus life cycle was investigated using 
lentivirus-mediated knock-down and over-expression system. It was shown that 




















Fig. 4.12: Effect on secreted viral RNA level: HEK293 and hSec3p293KD/OE 
cells were infected with WNV or DENV and viral RNAs were extracted from the 
cell culture supernatants and quantified using real-time RT-PCR. A significant 
increase (WNV: 8 fold; DENV: 250 fold) and decrease (WNV: 4 fold; DENV: 
100 fold) in viral RNA level is detected in virus-infected hSec3p293KD and 

















































Fig. 4.13: Effect on secreted viral protein level: HEK293 and 
hSec3p293KD/OE cells were infected with WNV or DENV. At the indicated time 
points, cell culture supernatants were harvested and the level of secreted E protein 
was quantified by Western blotting and densitometry. The level of viral E proteins 
increase in WNV/DENV-infected hSec3p293KD cell culture supernatants and 
decrease in WNV/DENV-infected hSec3p293OE cell culture supernatants (* 
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5.0. MOLECULAR INSIGHTS INTO THE ANTI-VIRAL ROLE OF 
HUMAN Sec3 PROTEIN 
5.1. INTRODUCTION 
The previous two chapters elaborated that hSec3p influenced flavivirus 
production in a bimodal manner by targeting viral RNA transcription and viral 
protein production. This chapter sought to address the molecular mechanism 
underlying the bimodal anti-viral activity of hSec3p using a combination of 
biochemical, molecular and microscopic techniques. 
  
5.2. MECHANISM BEHIND HUMAN Sec3 PROTEIN-INDUCED 
REDUCTION IN VIRAL RNA SYNTHESIS 
5.2.1. Interaction between elongation factor 1 (EF1 and human Sec3 
protein 
Studies have shown that yeast Sec3p was a putative binding partner of EF1a 
key translational regulator (Gavin et al., 2006). Hence, it was investigated if 
Sec3p-EF1 interaction also occurs in human cells by examining the interaction 
between EF1 and hSec3p in uninfected, WNV-infected and DENV-infected 
HEK293, hSec3p293KD or hSec3p293OE cells (Section 2.7.1). The cell lysates 
were precipitated using anti-hSec3p antibody and immunoblotted with anti-EF1 
antibody. As shown in Fig. 5.1[A-C(i)], hSec3p-EF1 interaction was detected in 
HEK293, hSec3p293KD and hSec3p293OE cells albeit the level of hSec3p-EF1 
complexes was higher in hSec3p293OE cells (Lane 3) and lower in 






Fig. 5.1: Influence on the interaction between EF1 and hSec3p. EF1-
hSec3p interaction in (A) uninfected, (B) WNV-infected or (C) DENV-infected 
HEK293, hSec3p293KD and hSec3p293OE cells were determined by 
immunoprecipitation using anti-hSec3p antibody and immunoblotted with anti-
EF1 antibody. Although the interaction between EF1 and hSec3p is observed 
in all the experimental groups, more hSec3p-EF1 complexes are detected in 
hSec3p293OE cells (Lane 3) while much lower level is observed in 
hSec3p293KD cells (Lane 5). (ii-v) Immunoprecipitation control, expression 
controls and actin loading control. IP: Immunoprecipitated sample; WB: Western 
blot; WCL: Whole cell lysate. (D) Densitometry analysis of the bands on the 
above immunoblots from (A-C)  shows that significantly higher level of hSec3p-
EF1 complexes are detected in uninfected hSec3p293OE cells while lower 
levels are observed in uninfected  hSec3p293KD cells (** indicates P<0.05 as 
compared to uninfected HEK293 cells). Furthermore, the amount of EF1-
hSec3p complex formation is significantly lowered in the infected cells compared 
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Densitometry analysis (Section 2.5.5) was performed on the immunoblots 
obtained from the uninfected and WNV/DENV-infected lysates. In Fig. 5.1(D), 
the arbitrary value of 100% is given to the formation of EF1-hSec3p complex in 
uninfected HEK293 cells. The EF1-hSec3p complex formation in uninfected 
expression control, hSec3p293OE, scrambled and hSec3p293KD cells were then 
compared against the arbitrary value of 100% given to that of HEK293 cells. 
Similarly, the formation of EF1-hSec3p complex in WNV/DENV-infected 
expression control, hSec3p293OE, scrambled and hSec3p293KD cells were 
compared against the arbitrary value of 100% given to HEK293 cells.  
 
Densitometry analysis showed that there was an increase (~100%) and decrease 
(~80%) in the formation of EF1-hSec3p complex in uninfected hSec3p293OE 
and hSec3p293KD cells, respectively. Similar trend was observed with virus-
infected hSec3p293OE and hSec3p293KD cells. It was also noted that the amount 
of EF1-hSec3p complex formation was significantly lowered in virus-infected 
cells (WNV: 60-80%; DENV: 40-90%) compared to uninfected cells regardless of 
the expression levels of hSec3p. The binding of EF1 to hSec3p correlated with 
the amount of hSec3p in the lysate of both uninfected and infected cells [Fig. 
5.1A-C(iv)]. This indicated that WNV/DENV infection interfered with EF1-









5.2.2. Interaction between elongation factor 1 and hSec3p flavivirus C 
protein-binding defective mutant 
The study was extended to examine if hSec3p flavivirus C protein-binding 
defective mutant, hSec3pSH2 is still capable of interacting with EF1. HEK293 
cells were transfected with V5-tagged galactosidase, full-length hSec3p and 
hSec3pSH2 mutant and co-immunoprecipitation was performed using anti-V5 
antibody. The resulting eluents were subjected to SDS-PAGE analysis followed 
by immunoblotting with anti-EF1 antibody. As shown in Fig. 5.2(i), the 
interaction between hSec3p/hSec3pSH2 and EF1 was detected in V5-hSec3pf1 
(Lane 3) and V5-hsec3pSH2 mutant (Lane 4) transfected HEK293 cells. This 
indicated that hSec3pSH2 mutant can still recognize EF1 and form a complex 






























Fig. 5.2: Co-immunoprecipitation of EF1 and hSec3pSH2 mutant. (i) 
HEK293 cells were transfected with V5-hSec3pf1 (full-length) or V5-hSec3pSH2 
mutant. Cell lysates were immunoprecipitated using anti-V5 antibody followed by 
immunoblotted with anti-EF1 antibody. The results showed that hSec3pSH2 
mutant can bind to EF1(Lane 4). (ii & iii) The expression of 
hSec3pf1/hSec3pSH2/EF1 was detected using anti-hSec3p/anti-EF1 












5.2.3. Influence of human Sec3 protein on the interaction between EF1 and 
WNV/DENV RNA 
Studies have demonstrated that EF1 influenced viral replication by binding to 
3‟UTR of viral genome (Blackwell & Brinton, 1995; 1997; Davis et al., 2007a; 
Shi et al., 1996). Following the observation that more hSec3p-EF1 complexes 
were formed in hSec3p293OE cells, it was explored if this association affects 
EF1 binding to flavivirus RNA genome. HEK293, hSec3p293OE and 
hSec3p293KD cells were infected with WNV/DENV or transfected with 
biotinylated WNV/DENV RNA. At 14 h (WNV)/24 h (DENV) p.i. or 18 h post-
transfection, cells were cross-linked and lysed for immunoprecipitation (Section 
2.9.2) or pull down assay (Section 2.9.3) using anti-EF1 or anti-hSec3p 
antibody.  
 
RNA was extracted from the eluents and subjected to RT-PCR (Section 2.3.15) to 
detect the differences in the level of EF1-bound RNA in WNV-/DENV-infected 
or RNA-transfected HEK293 and hSecp293KD/OE cells. In addition, RT-PCR 
was used to detect if hSec3p directly binds to WNV/DENV RNA. Normalization 
was performed against mock-transfected samples and GAPDH in all data sets.  
 
As shown in Fig. 5.3(i & ii), EF1-bound viral RNA levels in WNV-
infected/RNA-transfected hSec3p293OE cells were lower by 40% compared to 
HEK293 cells. Conversely, EF1-bound viral RNA levels were higher by 40% in 





observed with DENV infection/DENV RNA transfection [Fig. 5.3(i & ii)]. No 
signal was detected in RT-PCR from the hSec3p-immunoprecipitated samples 
following WNV/DENV infection or RNA transfection [Fig. 5.3(iii & iv)]. This 






































Fig. 5.3: Measurement of EF1/hSec3p-bound flavivirus RNA. (i) 
WNV/DENV-infected or (ii) biotinylated WNV/DENV 3‟UTR RNA-transfected 
cells were immunoprecipitated using anti-EF1 antibody. The EF1-bound RNA 
was quantitated by RT-PCR. In WNV-infected/RNA-transfected cells, 40% 
reduction in EF1-bound viral RNA level is detected in hSec3p293OE cells and 
40% increment is detected in hSec3p293KD cells. Similarly, 50% reduction in 
EF1-bound viral RNA level is observed in DENV-infected/RNA-transfected 
hSec3p293OE cells and 250% increment is observed in DENV-infected/RNA-
transfected hSec3p293KD cells. * indicates P<0.05 as compared to virus-
infected/RNA-transfected HEK293 cells. (iii) WNV/DENV-infected or (iv) 
biotinylated WNV/DENV 3‟UTR RNA-transfected cells were 
immunoprecipitated using anti-hSec3p antibody. The hSec3p-bound RNA was 
quantitated by RT-PCR. No signal is detected in RT-PCR from the hSec3p-























To reaffirm that the differential binding of EF1 to viral RNA was hSec3p-
specific, the effects of hSec3p over-expression or knock-down were tested on the 
binding of another RNA-binding host protein [polypyrimidine-tract binding 
protein, PTB (Anwar et al., 2009, De Nova-Ocampo et al., 2002, Jiang et al., 
2009, Kim et al., 2006)] to viral genome. Polypyrimidine-tract binding protein 
was reported to affect DENV transcription and not translation (Anwar et al., 
2009, Jiang et al., 2009). In contrast to EF1, PTB binding to viral RNA was not 
affected significantly by the over-expression or knock-down of hSec3p (Fig. 5.4). 
This reaffirmed that the disruption of EF1α-viral RNA complex [Fig. 5.3 (i & ii)] 
was mediated specifically by hSec3p.  
 
The biotinylated/non-biotinylated RNA-transfected samples were also subjected 
to pull down assay (Section 2.9.3) using Streptavidin beads followed by 
immunoblotting using anti-hSec3p/anti-EF1 antibody. Interestingly, 
(biotinylated) RNA-bound EF1 levels were significantly reduced in viral RNA-
transfected hSec3p293OE cells [Fig. 5.5(i & v), Lane 3, WNV: 30%; DENV: 
60%) and increased in viral RNA-transfected hSec3p293KD cells [Fig. 5.5(i & v), 
Lane 5, WNV: 24%; DENV: 40%) compared to viral RNA-transfected HEK293 
cells [Fig. 5.5(i & v)], Lane 1, normalized as 100%). The results from RNA-
precipitation/pull down study were consistent with EF1/hSec3p antibody-
precipitation assay as described above (Fig. 5.3). In addition, identical experiment 
was carried out using Streptavidin beads and anti-PTB antibody. In agreement 
with the results obtained from Fig. 5.4, PTB-viral RNA complex formation was 























Fig. 5.4: Measurement of PTB-bound flavivirus RNA. (i) WNV/DENV-
infected or (ii) biotinylated WNV/DENV 3‟UTR RNA-transfected cells were 
immunoprecipitated using anti-PTB antibody. The PTB-bound RNA were 
quantitated by RT-PCR. No significant changes (P>0.05) are observed in the 
levels of PTB-bound viral RNA level in both virus-infected and viral RNA-


































Fig. 5.5: Measurement of RNA-bound EF1. (i) The biotinylated WNV and (v) DENV 
3‟UTR RNA-transfected samples were subjected to pull down assay using Streptavidin 
beads and immunoblotted using anti-EF1 antibody. The interaction between EF1 and 
3‟UTR [(i) and (v)] is detected in HEK293 (Lane 1), Expression control (Lane 2), 
hSec3p293OE (Lane 3), Scrambled (Lane 4) and hSec3p293KD (Lane 5) cells. Lower 
level of EF1-3‟UTR complexes are detected in hSec3p293OE cells (Lane 3) while 
higher level is observed in hSec3p293KD cells (Lane 5). (ii-iv and vi-viii) The 
experimental controls are shown. (IP: Pulled down sample; WB: Western blot; 
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Fig. 5.6. Measurement of RNA-bound PTB. (i) The biotinylated WNV and (iii) 
DENV 3‟UTR RNA-transfected samples were subjected to pull down assay using 
Streptavidin beads and immunoblotted using anti-PTB antibody. The interaction 
between PTB and 3‟UTR [(i) and (iii)] is not affected when hSec3p is expressed 
differentially. (ii-iv) The expression of PTB in cell lysate is shown. (IP: Pulled 













To further support the hypothesis that differential level of hSec3p affected the 
amount of EF1 binding to viral 3'UTR, competition assay (Section 2.9.4) was 
performed in which different doses of recombinant purified hSec3p was added to 
fixed amount of EF1 and 3‟UTR. As shown in Fig. 5.7(i & ii), the amount of 
EF1-3‟UTR complexes decreased with increasing concentration of hSec3p. It 
was also shown that this competition assay was specific as Sec6p (another exocyst 
component) did not alter the binding of EF1 to 3‟UTR [Fig. 5.7(iii & iv)].  
 
The specificity of EF1 binding to viral 3'UTR was also tested by mixing a fixed 
amount of EF1and biotinylated WNV/DENV 3‟UTR in the presence or absence 
of non-biotinylated viral 3‟UTRs or tRNAs (Section 2.9.4). Pull down assay was 
then performed using Streptavidin beads followed by immunoblotting using anti-
EF1 antibody. As shown in Fig. 5.8(i & ii), the amount of EF1-
(biotinylated)3‟UTR complexes decreased in the presence of increasing 
concentration of non-biotinylated viral 3‟UTRs. It was also shown that this 
competition assay is specific as tRNA did not alter the binding of EF1 to 
biotinylated 3‟UTR [Fig. 5.8(iii & iv)].  
 
Collectively, these observations demonstrated that EF1binds to viral 3‟UTR 
specifically and hSec3p interfered with EF1-3‟UTR complex formation in a 
dose-dependent manner. In short, WNV/DENV RNA and hSec3p are competing 
for binding to EF1. Reduced binding of EF1 to viral RNA might account for 
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Fig. 5.7: Competition assay. Biotinylated WNV/DENV 3‟UTRs, recombinant 
EF1 were incubated with recombinant (i & ii) hSec3p or (iii & iv) Sec6p and 
subjected to pull-down assay. This demonstrates that hSec3p interferes with 
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Fig. 5.8: Competition assay. Biotinylated WNV/DENV 3‟UTRs, recombinant 
EF1 were incubated with (i & ii) non-biotinylated 3‟UTRs or (iii & iv) tRNAs. 
Pull down eluents were analyzed by Western blotting. The results show that EF1 
binds specifically to viral 3‟UTRs. IP: Pulled down sample; WB: Western blot. 












5.2.4. Influence of human Sec3 protein on the interaction between elongation 
factor 1 and viral replicative machinery 
Davis and colleagues (2007a) reported that EF1 is capable of interacting with 
the viral replicative complex. It was thus tested if this interaction is affected in 
WNV-/DENV-infected hSec3p293KD/OE cells by immunoprecipitating the cell 
lysates using anti-EF1 antibody and probing for NS3 protein (surrogate marker 
for viral replicative complex) using anti-NS3 antibody (Section 2.7.1). As shown 
in Fig. 5.9(i & viii), the level of NS3 protein immunoprecipitated with anti-EF1 
antibody was reduced in WNV-/DENV-infected hSec3p293OE cells (Lane 3) and 
increased in hSec3p293KD cells (Lane 5) compared to wild-type (Lane 1) or 
expression control plasmid (Lane 2) or scrambled sequence (Lane 4) expressing 
HEK293 cells. Densitometry analysis (Section 2.5.5) performed on the two 
representative immunoblots revealed that the level of NS3 protein 
immunoprecipitated with anti-EF1 antibody is drastically reduced (70%) in 
WNV-/DENV-infected hSec3p293OE cells and significantly increased (25%) in 
hSec3p293KD cells. This suggested that the level of hSec3p could modulate the 
association of EF1 with viral replicative complex. 
 
Next, it was examined if the immunoprecipitation of NS3 protein by EF1α is 
mediated by an RNA bridge by performing Co-IP assay (Section 2.7.1) in the 
presence of RNase using anti-EF1 antibody. The membrane was then probed for 





Fig. 5.9: Effect of hSec3p on EF1-NS3 complex formation. RNase-untreated 
(i & viii) and treated (ii & ix) cell lysates from WNV-/DENV-infected HEK293 
and hSec3p293KD/OE cells were precipitated using anti-EF1 antibody and 
probed with anti-NS3 antibody. Significantly lower level of EF1-NS3 complex 
is detected in hSec3p293OE cells [(i & viii), Lane 3] and higher level of EF1-
NS3 complex is observed in hSec3p293KD cells [(i& viii), Lane 5] compared to 
HEK293 [(i & viii), Lane 1], expression control [(i & viii), Lane 2] and scrambled 
control [(i & viii), Lane 4] in RNase-untreated lysates. (ii & ix) The EF1-NS3 
interaction is not observed in RNase-treated samples. [(iii-vii) and (x-xiv)] 
Precipitation control, expression controls and actin loading control in each 
experimental group are shown. (IP: Immunoprecipitated sample; WB: Western 
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was not precipitated with anti-EF1 antibody following RNase treatment. The 
successful immunoprecipitation using anti-EF1 antibody was confirmed by 
probing with anti-EF1 antibody [Fig. 5.9(iii, iv, x & xi)]. Taken together, this 
showed that the interaction between NS3 protein and EF1 was mediated by an 
RNA bridge [Fig. 5.9(i, ii, viii & ix)] and the inability of EF1α to associate with 
RNA (Figs. 5.3 and 5.5) would have prevented the co-immunoprecipitation of 
EF1-NS3 complex in hSec3pOE cells [Fig. 5.9(i & viii)].  
 
To assess if hSec3p has an effect on the cellular distribution of EF1 and viral 
replicative machinery, co-localization studies (Section 2.13) were performed in 
WNV/DENV-infected HEK293, hSec3p293OE and hSec3p293KD cells. The 
surrogate markers NS3 (Fig. 5.10) and viral RNA (Fig. 5.11) were used to 
represent viral replicative machinery. As depicted in Figs. 5.10 and 5.11, NS3, 
dsRNA and EF1 co-localized predominantly in the perinuclear regions (arrows) 
regardless of the expression level of hSec3p. This suggested that hSec3p did not 












Fig. 5.10: Association of EF1 with NS3. Cellular localization of EF1 and 
NS3 in WNV/DENV-infected cells. (i) HEK293, (ii) hSec3p293KD and (iii) 
hSec3p293OE cells were infected with WNV/DENV. The cells were then 
processed for confocal microscopy using anti-NS3 and anti-EF1 antibodies 
together with Alexa488 (green) or Alexa594 (red) secondary antibodies, 
respectively. Co-localization of NS3 and EF1 proteins are predominantly 
observed in the perinuclear regions (white arrows) of WNV/DENV-infected 
HEK293 and hSec3p293KD/OE cells as depicted in the merged images. Cell 












































































































































































































































Fig. 5.11: Association of EF1 with viral dsRNA. Cellular localization of EF1 
and dsRNA in WNV/DENV-infected cells. (i) HEK293, (ii) hSec3p293KD and 
(iii) hSec3p293OE cells were infected with WNV/DENV. The cells were then 
processed for confocal microscopy using anti-dsRNA and anti-EF1 antibodies 
together with Alexa488 (green) or Alexa594 (red) secondary antibodies, 
respectively. Co-localization of dsRNA and EF1 proteins are predominantly 
observed in the perinuclear regions (white arrows) of WNV/DENV-infected 
HEK293 and hSec3p293KD/OE cells as depicted in the merged images. Cell 

























































































































































































































































5.3. MECHANISM BEHIND HUMAN Sec3 PROTEIN-INDUCED 
REDUCTION IN VIRAL PROTEIN SYNTHESIS 
5.3.1. Influence of human Sec3 protein on impaired viral RNA translation 
The excess hSec3p had negative effect on viral protein expression (Figs. 4.10 and 
4.11). The next question to address is if hSec3p has direct effect on viral protein 
translation. To answer this issue, in vitro translation assay (Sections 2.4.3 and 
2.11.2) was performed using pre-synthesized full-length V5-hSec3pf1 or V5-
galactosidase and WNV/DENV RNA in the absence of MG132, a proteasome 
inhibitor. The in vitro reaction showed that translation of E protein was reduced in 
the presence of hSec3p [Fig. 5.12(i & ii), Lane 2] and remained unaffected in the 
absence of hSec3p [Fig. 5.12(i & ii), Lanes 1 & 3]. This indicated that hSec3p had 
direct influence on viral RNA translation.  
 
Reduced viral protein levels could result from impaired viral RNA translation or 
accelerated protein degradation. The in vitro translation was thus performed in the 
presence of MG132. If the reduction in viral protein levels was attributed to 
protein degradation, addition of MG132 should prevent the reduction in viral 
protein levels. As shown in Fig. 5.12(i & ii), Lane 5], addition of MG132 did not 
restore the levels of viral protein, indicating that hSec3p directly impaired viral 













Fig. 5.12: In vitro translation assay. (i) WNV RNA or (ii) DENV RNA was 
translated by adding presynthesized V5-hSec3pf1 or V5-galactosidase in the 
absence/presence of MG132. The E proteins were analyzed by Western blotting 
and the band intensities were quantified. The presence of hSec3p results in 60% 
reduction in WNV/DENV E protein levels (Lane 2) even in the presence of 
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5.3.2. Immunodepletion of human Sec3 protein 
To determine if the inhibitory effects of hSec3p were attributed to translation in 
general or specific to viral translation, immunodepletion assay (Section 2.11.1) 
was performed where hSec3p was depleted. The in vitro translated hSec3p in the 
reticulocyte mix was immunodepleted using anti-hSec3p antibody and isotype 
control antibody. The resulting flow-throughs (Fig. 5.13, Lanes 1 & 3) and the 
eluents (Fig. 5.13, Lanes 2 & 4) were tested for the presence of hSec3p using 
Western blotting (Section 2.5.2).  
 
Significant amount of hSec3p was immunodepleted in the flow-through fraction 
of anti-hSec3p antibody-treated samples (Fig. 5.13, Lane 1) and the majority of 
hSec3p was eluted in the eluent fraction (Fig. 5.13, Lane 2). In contrast, majority 
of hSec3p was washed off in the flow-through fraction of isotype antibody-treated 
samples (Fig. 5.13, Lane 3) and there was no hSec3p in the eluent fraction (Fig. 
5.13, Lane 4). The flow-through fractions from anti-hSec3p antibody-treated 
samples (Fig. 5.13, Lane 1) and isotype antibody-treated samples (Fig. 5.13, Lane 
3) were used in the subsequent assays to examine the mechanism behind hSec3p-























































Fig. 5.13: Immunodepletion assay. Presynthesized V5-hSec3pf1 was mixed 
with either anti-hSec3p antibody or mouse isotype antibody control and subjected 
to MACS column purification. The resultant flow-through (Lane 1) and eluent 
(Lane 2) from anti-hSec3p antibody-treated sample were subjected to 
immunoblotting using anti-hSec3p antibody. The flow-through (Lane 3) and 
eluent (Lane 4) from isotype control antibody-treated samples were also subjected 
to immunoblotting. As shown in Lane 1, significant immunodepletion is achieved 















5.3.2.1. Human Sec3 protein-mediated translational repression is virus-
specific 
After confirming the significant immunodepletion of hSec3p in the flow-through 
fraction, it was mixed with a new reticulocyte mixture containing either 
WNV/DENV or IRF2 or CAML or importin- RNA (Section 2.11.2). The 
resulting samples were probed using anti-WNV E, anti-DENV E, anti-IRF2, anti-
CAML or anti-importin- antibodies. The experiments were similarly performed 
using antibody isotype control.  
 
As shown in Fig. 5.14, the translation of viral E protein (Lanes 1 & 3) was 
lowered in isotype antibody-treated samples while the translation of viral proteins 
(Lanes 2 & 4) was unaffected in hSec3p-immunodepleted samples. In contrast, 
the translation of IRF2, CAML and importin- were not affected in both hSec3p-
immunodepleted and antibody isotype control samples (Fig. 5.14, Lanes 5-10). 
These in vitro experiments in rabbit reticulocyte lysates indicated that the hSec3p-
mediated translational repression was virus-specific and it did not affect the 

















































































































































































































































































































Fig. 5.14: In vitro translation assay. The flow-throughs from anti-hSec3p 
antibody-treated sample and isotype antibody-treated sample were separately 
mixed with WNV/DENV/IRF2/CAML/importin- RNA in the in vitro translation 
reaction. WNV/DENV E, IRF2, CAML and importin- protein levels were 
detected by Western blotting using anti-E, anti-IRF2, anti-CAML or anti-
importin- antibodies. As shown in Lanes 1 and 3, the translation of 
WNV/DENV E proteins are reduced in the presence of isotype control antibody-
treated reaction mixtures compared to those in the presence of anti-hSec3p 
antibody-treated flow-through (Lanes 2 and 4). In contrast, the translation of 
IRF2, CAML and importin- are not affected in both anti-hSec3p antibody-
treated and isotype control antibody-treated flow-throughs (Lanes 5-10). This 
confirms that hSec3p-mediated translational repression is virus-specific and does 













5.3.2.2. Human Sec3 protein suppressed viral translation by binding to 
elongation factor 1 
The results so far indicated that hSec3p impaired viral protein translation. Since 
the capability of hSec3p to bind a key translational enhancer EF1 was 
demonstrated (Fig. 5.1), it was tempting to investigate if EF1 is the candidate 
biomolecule targeted by hSec3p for translational suppression. To test this 
hypothesis, EF1 competition assay was performed (Section 2.11.2).  
 
The flow-through fractions from hSec3p-immunodepleted samples and isotype 
antibody-treated samples were mixed with an in vitro translation reaction 
containing either WNV/DENV or IRF2 or CAML or importin- RNA in the 
presence of 2 and 5 mole excess of EF1. The resulting samples were probed 
using anti-WNV E, anti-DENV E, anti-IRF2, anti-CAML or anti-importin- 
antibodies.  
 
The negative impact of hSec3p on protein translation was overcome when 2 and 5 
mole excess of EF1 was added to the reaction mixture [Fig. 5.15 (i & ii), Lanes 
1 & 3]. This further supported that the hSec3p-dependent inhibition of protein 
translation was mediated by sequestration of EF1.  
 
In this chapter, the molecular mechanism underlying the anti-viral activity of 
hSec3p was delineated by unveiling the interrelationship between hSec3p, EF1a 
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5 mole excess EF1 (ii) 





































































































































Fig. 5.15: In vitro translation assay in the presence of EF1. The flow-
throughs from anti-hSec3p antibody-treated sample and isotype antibody-treated 
sample were separately mixed with WNV/DENV/IRF2/CAML/importin- RNA 
in the rabbit reticulocyte reaction in the presence of (i) 2 or (ii) 5 mole excess of 
EF1. The protein levels of WNV/DENV E, IRF2, CAML and importin- were 
detected using anti-E, anti-IRF2, anti-CAML or anti-importin- antibodies. 
Addition of 2 or 5 mole excess of EF1circumvent the translational repression 


































6.0. MOLECULAR INSIGHTS INTO THE ANTAGONISTIC ACTIVITY 
OF FLAVIVIRUS CAPSID PROTEIN AGAINST HUMAN Sec3 PROTEIN 
6.1. INTRODUCTION 
The previous chapters highlighted the anti-flaviviral properties of hSec3p. 
However, it is unclear how WNV/DENV can still successfully infect the host in 
the presence of endogenous hSec3p. Can hSec3p-C protein interaction favour 
flaviviral infection? As described in Section 5.2.1, the amount of EF1-hSec3p 
complex formation was significantly lowered in the infected cells compared to 
uninfected cells. This indicated that WNV/DENV infection could interfere with 
EF1-hSec3p complex formation by altering the hSec3p level. This chapter thus 
sought to investigate the molecular mechanism underlying flavivirus-induced 
reduction in EF1-hSec3p complex formation. In this chapter, cell-based 
fluorescence assay was also developed in-house to quantitate the amount of 
hSec3p, hSec6p, viral E proteins or HA/Myc-tagged C proteins in high-
throughput formats.  
 
6.2. FLAVIVIRUS INFECTION REDUCED THE LEVELS OF HUMAN 
Sec3 PROTEIN  
6.2.1. Effect of flavivirus infection on human Sec3 protein levels 
To examine whether flavivirus infection regulated the levels of hSec3p, HEK293 
cells were infected with WNV/DENV. At the indicated timings, hSec3p 
expression was assessed at the protein level in WNV/DENV-infected HEK293 





in WNV/DENV-infected cells compared to that of un-infected cells [Figs. 6.1A(i) 
and 6.1B(i)]. The band intensities on the immunoblot were subsequently 
quantified using GeneTools program and the hSec3p levels were expressed as the 
percentage difference normalized against the hSec3p levels in the un-infected cell 
lysate. Densitometry analysis revealed that flavivirus reduced hSec3p level from 
as early as 4 h p.i. [Figs. 6.1A(iii) and 6.1B(iii)]. This showed that there was 
active down-regulation of hSec3p in flavivirus-infected cells. 
 
6.2.2. Development of cell-based fluorescence assay (CBF assay) 
To examine the levels of hSec3p following virus infection or plasmid transfection 
in the high-throughput format, CBF assay was developed. HEK293 cells were 
infected with WNV/DENV. At the indicated timings, cells were stained with anti-
hSec3p and anti-actin antibodies followed by incubation with anti-mouse or anti-
rabbit Alexa488 or Alexa594 secondary antibodies. The samples were analyzed in 
a microtitre plate
 
reader. The hSec3p levels in each experimental cohort were 
normalized against the actin control and the relative levels of hSec3p in virus-
infected cells were represented as the percentage difference with respect to that of 
un-infected HEK293 cells.  
 
Consistent with Fig. 6.1, reduced hSec3p levels were observed in WNV/DENV-
infected cells compared to that of un-infected cells (Figs. 6.2A and 6.2B). As 
shown in Fig. 6.3, the percentage difference of hSec3p levels obtained from 
Western blotting followed by densitometry (Fig. 6.1) coincided with the data 
obtained from CBF assay (Fig. 6.2). The data obtained from CBF assay showed 























Fig. 6.1: Effect of flavivirus infection on hSec3p expression - Western 
blotting. HEK293 cells were infected with (A) WNV or (B) DENV. (i) The 
hSec3p expression level was assessed at the indicated timings by immunoblotting 
with anti-hSec3p antibody. Reduced hSec3p level is detected in WNV/DENV-
infected cells from as early as 4 h p.i. and is sustained up to 24 h p.i. (ii) Actin 
loading controls are included to ensure equal loading. (iii) Densitometry analysis 
of the band intensities in the virus-infected cells obtained from the immunoblots 
[A(i) and B(ii)] after normalization against the band intensities in the un-infected 
cells. * represents P<0.05 compared to un-infected cells.   
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Fig. 6.2: Effect of flavivirus infection on hSec3p expression - CBF assay. 
HEK293 cells were infected with (A) WNV or (B) DENV. The hSec3p 
expression level was assessed at the indicated timings by CBF assay using anti-
hSec3p and anti-actin antibody. The hSec3p levels are normalized against the 
actin control and the relative levels of hSec3p in virus-infected cells are shown. 
Reduced hSec3p level is detected in WNV/DENV-infected cells from as early as 
4 h p.i. and is sustained up to 24 h p.i. * represents P<0.05 compared to un-






























Fig. 6.3: Comparison of hSec3p levels obtained from Western blotting and 
CBF assay. The hSec3p levels obtained from Western blotting followed by 
densitometry were compared with that assessed by CBF assay. There is no 
significant difference in the levels of hSec3p obtained from Western blotting 











from Western blotting followed by densitometry. However, this difference was 
not statistically significant (P>0.05) and similar trend was obtained from both 
assays. This demonstrated that CBF assay developed in this study was reliable 
and suitable to use in the high-throughput format. The CBF assay was thus 
utilized in the subsequent experiments to analyze the amount of 
hSec3p/hSec6p/actin/HA-tagged proteins/Myc-tagged proteins in the cells 
following various treatments.  
 
The accuracy of the assay could be compromised if the antibody non-specifically 
detects more than one protein or detects only the denatured protein. To overcome 
the non-specificity issue, the controls such as mock-infected samples (in case of 
virus infection) and vector alone-transfected samples (in case of transfection) 
were included in this study. This would facilitate the normalization to eliminate 
the non-specific signals contributed by the antibody. It was also confirmed in our 
laboratory that the antibodies used in this study were able to detect both denatured 
and non-denatured forms of the protein by performing Western blotting and 
immuno-fluorescence assay.  
 
6.2.3. Flavivirus infection did not alter the transcription of human Sec3 gene 
To examine if flavivirus-induced changes in hSec3p level were due to altered 
hSec3p mRNA level, HEK293 cells were infected with WNV/DENV. At the 
indicated time points, total RNA was extracted and subjected to real-time RT-
PCR to detect the differences in the level of hSec3p RNA in flavivirus-infected 
cells. Normalization was performed against mock-infected samples and GAPDH 
in all data sets. As shown in Figs. 6.4A and 6.4B, there were no significant 
changes in the mRNA levels of hSec3p in flavivirus-infected cells (P>0.05). This 
indicated that flavivirus infection did not alter the transcription of the hSec3 gene 

























Fig. 6.4: Effect of flavivirus infection on hSec3p mRNA level. HEK293 cells 
were infected with (A) WNV or (B) DENV. The levels of hSec3p mRNA was 
measured using real-time PCR. There is no significant difference in the levels of 











6.2.4. Flavivirus infection influenced human Sec3 protein level at the post-
transcription level 
To investigate if flavivirus infection manipulated the amount of hSec3p at the 
post-transcription level, cell-based fluorescence (CBF) assay was conducted in the 
presence of Actinomycin D. Host cell transcription was blocked by incubating 
HEK293 cells with Actinomycin D. This was followed by infection with 
WNV/DENV. As shown in Figs. 6.5A and 6.5B, hSec3p level was decreased in 
WNV/DENV-infected cells even in the presence of Actinomycin D.  
 
To further confirm that this reduction was specific to hSec3p, the expression 
levels of hSec6p were examined following flavivirus infection. The hSec6p levels 
were not affected in the presence of WNV/DENV infection (Figs. 6.6A and 6.6B). 
This indicated that the translation/stability of hSec3p was specifically affected by 
flavivirus infection.  
 
To investigate if flavivirus infection interfered with hSec3p translation or its 
stability, the above experiment was performed in the presence of MG132, a 
proteasomal inhibitor and the level of endogenous hSec3p was monitored. In the 
presence of MG132, hSec3p levels remained unchanged even after flavivirus 
infection (Figs. 6.7A and 6.7B). This indicated that intact proteasome activity was 
required to mediate the reduction of hSec3p levels and the stability of hSec3p was 























Fig. 6.5: Effect of flavivirus infection on hSec3p expression following 
Actinomycin treatment. HEK293 cells were treated with Actinomycin D and 
infected with (A) WNV or (B) DENV. The hSec3p expression level was assessed 
at the indicated timings by CBF assay using anti-hSec3p and anti-actin antibody. 
The hSec3p levels are normalized against the actin control and the relative levels 
of hSec3p in virus-infected cells are shown. Reduced hSec3p level is detected in 
WNV/DENV-infected cells from as early as 4 h p.i. even in the presence of 
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Fig. 6.6: Effect of flavivirus infection on hSec6p expression following 
Actinomycin treatment. HEK293 cells were treated with Actinomycin D and 
infected with (A) WNV or (B) DENV. The hSec6p expression level was assessed 
at the indicated timings by CBF assay using anti-hSec6p and anti-actin antibody. 
The hSec6p levels are normalized against the actin control and the relative levels 
of hSec6p in WNV/DENV-infected cells are shown. There are no significant 


























Fig. 6.7: Effect of flavivirus infection on hSec3p expression following MG132 
treatment. HEK293 cells were treated with MG132 and infected with (A) WNV 
or (B) DENV. The hSec3p expression level was assessed at the indicated timings 
by CBF assay using anti-hSec3p and anti-actin antibody. The hSec3p levels are 
normalized against the actin control and the relative levels of hSec3p in virus-
infected cells are shown. Reduced hSec3p level is detected in WNV/DENV-
infected cells from 4 h p.i. in the absence of MG132. In contrast, there are no 
significant differences in the levels of hSec3p in MG132-treated virus-infected 













6.3. FLAVIVIRUS CAPSID PROTEIN REDUCED THE LEVELS OF 
HUMAN Sec3 PROTEIN  
6.3.1. Flavivirus capsid protein down-regulated human Sec3 protein 
expression 
To evaluate the role of flavivirus C protein in reducing hSec3p level, HEK293 
cells were transfected with HA-tagged plasmids encoding full-length WNV C 
gene (WHAC) or Myc-tagged plasmids encoding full-length WNV/DENV C 
protein (WMycC and DMycC) in the absence or presence of MG132. At 24 h 
post-transfection, expression of hSec3p and full-length WNV/DENV C proteins 
were assessed using cell-based fluorescence (CBF) assay.  
 
In the absence of MG132, the hSec3p level was markedly reduced (P<0.05) 
following the transfection with full-length WNV/DENV C protein (Fig. 6.8A). 
Similar trends were obtained with HA-tagged or Myc-tagged C proteins. This 
confirmed that HA or Myc tag did not influence the outcome. In contrast, there 
were no significant differences (P>0.05) in the levels of hSec3p in MG132-treated 
full-length C plasmids-transfected cells (Fig. 6.8A). The expression of full-length 
WNV/DENV C protein was confirmed using anti-HA/anti-Myc and actin 
antibodies (Fig. 6.8B). There were no significant changes in the expression levels 
of hSec6p in the absence or presence of MG132 (Fig. 6.8C). Overall, this 
demonstrated that flavivirus C protein played an essential role in mediating the 























Fig. 6.8: Influence of flavivirus C protein on hSec3p expression. HEK293 cells 
were transfected with WHAC, WMycC and DMycC in the absence and presence 
of MG132. (A) The hSec3p expression level was assessed by CBF assay using 
anti-hSec3p and anti-actin antibody. The hSec3p levels are normalized against the 
actin control and the relative levels of hSec3p in transfected cells are shown. 
Reduced hSec3p level is detected in WNV/DENV C-transfected cells in the 
absence of MG132. In contrast, there are no significant differences in the levels of 
hSec3p in MG132-treated WNV/DENV C-transfected cells. (B) The expression 
of C protein is monitored by CBF assay using anti-HA/anti-Myc and anti-actin 
antibodies. (C) The expression of hSec6p is monitored by CBF assay using anti-
hSec6p and anti-actin antibodies. * represents P<0.05 compared to mock-
transfection.   
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6.3.2. Flavivirus capsid protein reduced human Sec3 protein expression in a 
dose-dependent manner 
To further determine whether the C protein-mediated reduction in hSec3p levels 
was dependent on the amount of C protein expression, a dose response 
experiment was performed. The expression of full-length WNV/DENV C protein 
was analyzed using CBF assay with anti-Myc and actin antibodies (Fig. 6.9A). 
Expression of hSec3p was assessed using cell-based fluorescence (CBF) assay. 
As little as 100 ng of transfected WMycC (WNV) or DMycC (DENV) construct 
was able to reduce hSec3p level (P<0.05), with a maximum reduction reached at 
300 ng of WMycC or DMycC plasmids (Fig. 6.9B). When the amount of WMycC 
or DMycC plasmid was increased, the levels of hSec3p were significantly reduced 
(Fig. 6.9C). This demonstrated that flavivirus C protein caused the decrement in 
hSec3p levels in a dose-dependent manner.  
 
6.3.3. Physical binding between capsid protein and human Sec3 protein is 
critical to reduce human Sec3 protein level 
This study was extended to examine whether physical binding flavivirus C protein 
and hSec3p is essential to mediate the reduction in hSec3p level. HEK293 cells 
were transfected with WMycC (WNV), WMycC5‟∆15 (WNV), DMycC (DENV) 
and DMycC5‟∆15 (DENV) plasmids. At 24 h post-transfection, expression of 
hSec3p and full-length/truncated WNV or DENV C proteins were assessed using 



























Fig. 6.9: Flavivirus C protein reduced hSec3p level in a dose-dependent manner. 
HEK293 cells were transfected with various concentrations of WMycC or DMycC. 
(A) The expression of C protein is monitored by CBF assay using anti-Myc and 
anti-actin antibodies. (B) The hSec3p expression level is assessed by CBF assay 
using anti-hSec3p and anti-actin antibody. The levels of hSec3p in 
WMycC/DMycC-transfected cells are reduced with the increasing concentrations 
of WMycC/DMycC plasmids. (C) The expression of C proteins negatively 



























Fig. 6.10: Measurement of hSec3p level in the presence of hSec3p-binding 
defective C mutants.  HEK293 cells were transfected with WMycC, 
WMycC5‟∆15, DMycC and DMycC5‟∆15 plasmids. The hSec3p expression level 
was assessed by CBF assay using anti-hSec3p and anti-actin antibody. The 
hSec3p levels are normalized against the actin control and the relative levels of 
hSec3p in transfected cells are shown. Reduced hSec3p level is detected in 
WMycC and DMycC-transfected cells. In contrast, there are no significant 
differences in the levels of hSec3p in WMycC5‟∆15 and DMycC5‟∆15-




















were markedly reduced following the transfection with full-length WNV/DENV 
C protein (Fig. 6.10). In contrast, equivalent amounts of hSec3p were detected in 
pCMV-Myc vector and WMycC5‟∆15/DMycC5‟∆15-transfected samples (Fig. 
6.10). This indicated that C protein- mediated depletion of hSec3 protein was 
dependent on the direct binding between C protein and hSec3p.  
 
To further confirm that direct binding between C protein and hSec3p was 
essential to mediate the decrement in hSec3p level, in vitro translation assay was 
performed by adding WMyCC, DMycC, WMycC5‟∆15 or DMycC5‟∆15 
plasmids to the rabbit reticulocyte mix containing hSec3p RNA. As shown in Fig. 
6.11A, translation of hSec3p RNA was reduced in the presence of full-length 
WNV/DENV C protein (Fig. 6.11A, Lanes 2 & 3) and remained unaffected in the 
presence of hSec3p-binding defective C mutant proteins (Fig. 6.11A, Lanes 4 & 
5) as compared to the presence of Myc vector (Fig. 6.11A, Lane 1).  
 
Densitometry analysis revealed that hSec3p level was reduced up to 60% in the 
presence of full-length WNV/DENV C proteins. There were no significant 
changes (P>0.05) in hSec3p level when hSec3p-binding defective C mutant 
proteins were added to the in vitro translation mix (Fig. 6.11B). This confirmed 






















6.11: In vitro translation assay. (A) The plasmids WMycC, DMycC, 
WMycC5‟∆15 or DMycC5‟∆15 were added to the rabbit reticulocyte mix 
containing hSec3p RNA and in vitro translation assays were performed. The 
resulting proteins were then subjected to Western blotting using anti-hSec3p 
antibody. Reduced hSec3p levels are observed in the presence of 
WMycC/DMycC (Lanes 2 & 3). There are no differences in the hSec3p levels in 
the presence of WMycC5‟∆15 or DMycC5‟∆15 plasmids (Lanes 4 & 5). (B) The 
relative intensity of hSec3p bands on the immunoblot from (A) was quantified. 
Full-length WNV/DENV C protein produces up to 60% reduction in hSec3p 
levels. In contrast, there are no significant changes in hSec3p levels in the 
presence of hSec3p-binding defective mutants. * represents P<0.05 compared to 






















































6.3.4. Influence of flavivirus capsid protein on hSec3p-EF1 complex 
formation.  
The results so far indicated that flavivirus C protein reduced hSec3p level 
(Sections 6.3.1 to 6.3.3) and the amount of EF1-hSec3p complex formation was 
significantly lowered in WNV/DENV-infected cells compared to un-infected cells 
(Fig. 5.1D). The study was extended to assess if flavivirus C protein played a 
direct role in reducing hSec3p-EF1 complex formation. HEK293 cells were 
transfected with WHAC (WNV), WHAC5‟15 (WNV), DMycC (DENV) or 
DMycC5‟15 (DENV) plasmids. The formation of hSec3p-EF1 complex in 
WHAC/WHAC5‟15- or DMycC/DMycC5‟15-transfected HEK293 cells 
were analyzed by immunoprecipitating the cell lysates using anti-hSec3p antibody 
followed by immunoblotting using anti-EF1 antibody. As depicted in Fig. 6.12(i 
& vii), the interaction between EF1 and hSec3p was significantly reduced 
(>80%) in the presence of C protein (Lane 3) and remained unaffected in mock-
transfected (Lane 1), vector transfected (Lane 2) and WHAC5‟15-
/DMycC5‟15-transfected (Lane 4) cells. The amount of EF1-hSec3p complex 
formation (i & vii) correlated with the amount of hSec3p (iv & x) in the cell 
lysates of various experimental cohorts. Taken together, this indicated that C 
protein induced the degradation of hSec3p. As a result, the hSec3p level was 
reduced which subsequently resulted in the decreased formation of EF1-hSec3p 
complex.  
 
The formation of C-hSec3p or C-EF1 complex in WHAC/WHAC5‟15- or 























Fig. 6.12: Effect of C protein on hSec3p-EF1 complex formation. HEK293 cells 
were transfected with WHAC, WHAC5‟15, DMycC or DMycC5‟15 plasmids. 
Lysates from (i) WHAC/WHAC5‟15 or (vii) DMycC/DMycC5‟15-transfected 
HEK293 cells were precipitated using anti-hSec3p antibody and immunoblotted with 
anti-EF1 antibody. The level of hSec3p-EF1 complex is reduced in the presence of 
C protein (Lane 3) and is unaffected in the absence of C-hSec3p interacting domain 
(WHAC5‟15/DMycC5‟15, Lane 4). A portion of the same cell lysates was 
immunoprecipitated using anti-HA (ii)/anti-Myc (viii) antibody and probed with anti-
hSec3p antibody. The immunoreactive band is detected only in WHAC/DMycC-
transfected samples (Lane 3). [(iii-vi) and (ix-xii)] The loading controls are shown. 






immunoprecipitating the cell lysates using anti-HA or anti-Myc antibody 
followed by immunoblotting using either anti-hSec3p or anti-EF1 antibody. As 
shown in Fig. 6.12(ii & viii), hSec3p-C association was only detected in the 
presence of full-length C protein (Lane 3). The reciprocal Co-IP also showed the 
same results and antibody isotype controls did not pull down the protein of 
interest (Figs. 6.13A and 6.13B). This demonstrated that the binding between C 
protein and hSec3p was critical to reduce hSec3p-EF1complex formation since 
the complex formation was not affected in the presence of hSec3p-binding 
defective C proteins (C5‟15). 
 
To further confirm that flavivirus C protein played a direct role in reducing 
hSec3p-EF1 complex formation, the formation of hSec3p-EF1 complex was 
analyzed by adding increasing amounts of in vitro translated C/C5‟15 proteins. 
Presynthesized hSec3p [Fig. 6.14(i-iii & v-vii)] was fractionated by SDS-PAGE 
and blotted to PVDF membrane. Individual lanes were then excised from the blot 
and incubated with EF1 [Fig. 6.14(i & v)] in combination with 5- or 10-fold 
mole excess of either in vitro translated full length WHAC [Fig. 6.14(i), Lanes 2 
& 3] or WHAC5‟15 [Fig. 6.14(i), Lanes 4 & 5] or DMycC [Fig. 6.14(v), Lanes 
2 & 3] or DMycC5‟15 [Fig. 6.14(v), Lanes 4 & 5]. No exogenous competitor 
(C/C5‟15) was added to hSec3p [Fig. 6.14(i & v), Lane 1] to determine 100% 
control binding to hSec3p.  
  
The formation of hSec3p-EF1 complex was then detected by immunoblotting 






































Fig. 6.13: Reciprocal Co-IP to study the effect of flavivirus C protein on hSec3p-
EF1 complex formation. [A & B(i)] HEK293 cells were transfected with WHAC, 
WHAC5‟15, DMycC or DMycC5‟15 plasmids. Lysates from (A) WNV or (B) 
DENV C/C5‟15-transfected HEK293 cells were immunoprecipitated using anti-
EF1 antibody and immunoblotted with anti-hSec3p antibody. The level of hSec3p-
EF1 complex is reduced in the presence of C protein (Lane 3) and is unaffected in 
the absence of C-hSec3p interacting domain (WHAC5‟15/DMycC5‟15, Lane 4). 
(ii) A portion of the same cell lysates was immunoprecipitated using anti-hSec3p 
antibody and immunoblotted with anti-HA/anti-Myc antibody. The immunoreactive 
band is detected only in the WHAC/DMycC-transfected samples (Lane 3). (iii) 
Immunoprecipitation using rabbit antibody isotype control and immunoblotting with 
anti-hSec3p antibody. (iv) Reciprocal immunoprecipitation using mouse antibody 
isotype control and immunoblotting with anti-EF1 antibody. IP: 
Immunoprecipitated sample; WB: Western blot; WCL: Whole cell lysate. 
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Fig. 6.14: Competition assay. In vitro translated hSec3p (i-iii & v-vii) was 
subjected to Western blotting. Individual lanes were then excised from the blot 
and incubated with EF1 in combination with 5- or 10-fold mole excess of either 
in vitro translated full length WHAC/DMycC (Lanes 2 & 
3)/WHAC5‟15/DMycC5‟15  (Lanes 4 & 5) proteins. No exogenous 
competitor was added to hSec3p (Lane 1) to determine 100% control binding to 
hSec3p. (i & v) The formation of hSec3p-EF1 complex is then detected by 
immunoblotting with anti-EF1 antibody. (ii & vi) The formation of hSec3p-C 
complex is also examined by immunoblotting with anti-HA or anti-Myc antibody. 
(iii & vii) The membrane bound hSec3p (input control) is also detected by 
immunoblotting the membrane with anti-hSec3p antibody. (iv & viii) The 
EF1binding is quantitated using three independent assays and plotted relative to 










C protein interfered with hSec3p-EF1 complex formation in a dose-dependent 
manner [Fig. 6.14(i & v), Lanes 2 & 3]. In contrast, hSec3p-binding defective C 
protein, C5‟15 failed to negate hSec3p-EF1interaction [Fig. 6.14(i & v), 
Lanes 4 & 5]. The formation of hSec3p-C complex [Fig. 6.14(ii & vi)] was also 
examined by immunoblotting with anti-HA or anti-Myc antibody. The membrane-
bound hSec3p (input control) was also detected by immunoblotting the membrane 
with anti-hSec3p [Fig. 6.14(iii & vii)] antibody. The EF1binding to hSec3p was 
then quantitated by performing densitometry analysis of the band intensities on 
the immunoblot obtained from [Fig. 6.14(i & v)] and plotted relative to its binding 
in the absence of competitor [Fig. 6.14(iv & viii)]. Densitometry analysis 
confirmed that C protein interfered with hSec3p-EF1 complex formation in a 
dose-dependent manner. Overall, this reaffirmed that the binding between C 
protein and hSec3p was crucial for reducing hSec3p-EF1complex formation. 
Similar results were also obtained from the reciprocal experiment performed 














Fig. 6.15: Reciprocal Competition assay. In vitro translated EF1 (i-iii & v-vii) 
was subjected to Western blotting. Individual lanes were then excised from the 
blot and incubated with hSec3p in combination with 5- or 10-fold mole excess of 
either in vitro translated full length WHAC/DMycC (Lanes 2 & 
3)/WHAC5‟15/DMycC5‟15 (Lanes 4 & 5) proteins. No exogenous 
competitor was added to EF1 (Lane 1) to determine 100% control binding to 
EF1. (i & v) The formation of hSec3p-EF1 complex is then detected by 
immunoblotting with anti-hSec3p antibody. (ii & vi) The formation of EF1-C 
complex is also examined by immunoblotting with anti-HA or anti-Myc antibody. 
(iii & vii) The membrane bound EF1 (input control) is also detected by 
immunoblotting the membrane with anti-EF1 antibody, respectively. (iv & viii) 
The hSec3p binding is quantitated and plotted relative to its binding in the 












6.3.5. Proteasome-dependent degradation of hSec3p  
6.3.5.1. Flavivirus C protein mediated proteasome-dependent degradation of 
hSec3p  
The results obtained from Figs. 6.7 and 6.8 indicated that flavivirus-dependent 
decrease in hSec3p expression levels was mediated through the proteasome 
pathway. To further confirm this, HEK293 cells were treated with a more specific 
inhibitor, epoxomicin and transfected with Myc-tagged plasmids encoding full-
length WNV/DENV C gene (WMycC and DMycC). At 24 h post-transfection, 
expression of hSec3p and full-length WNV/DENV C proteins were assessed 
using cell-based fluorescence (CBF) assay.  
 
In the absence of epoxomicin, the hSec3p level was markedly reduced following 
the transfection with full-length WNV/DENV C protein (Fig. 6.16A). In the 
presence of full-length WNV/DENV C protein, hSec3p expression levels were 
decreased by 65% (P<0.05). In contrast, there were no significant differences 
(P>0.05) in the levels of hSec3p in epoxomicin-treated full-length C plasmids-
transfected cells (Fig. 6.16A). In the presence of proteasomal inhibitor, 
epoxomicin, hSec3p level remained unchanged compared to that of mock-
transfection. This suggested that C protein should utilize the proteasomes to 
decrease the levels of hSec3p. The expression of full-length WNV or DENV C 
protein was confirmed by CBF assay using anti-Myc and actin antibodies (Fig. 
6.16B). There were no significant changes in the expression levels of hSec6p 
(Fig. 6.16C). Overall, this demonstrated that flavivirus C protein induced the 






















Fig. 6.16: Influence of flavivirus C protein on hSec3p expression in the 
presence of epoxomicin. HEK293 cells were transfected with WMycC and 
DMycC in the absence and presence of epoxomicin. (A) The hSec3p expression 
level was assessed by CBF assay using anti-hSec3p and anti-actin antibody. The 
levels of hSec3p are normalized against the actin control and the relative levels of 
hSec3p in transfected cells are shown. Reduced hSec3p level is detected in 
WNV/DENV C-transfected cells in the absence of epoxomicin. In contrast, there 
are no significant differences in the levels of hSec3p in epoxomicin-treated 
WNV/DENV C-transfected cells. (B) The expression of C protein is monitored by 
CBF assay using anti-Myc and anti-actin antibodies. (C) The expression of 
hSec6p protein is monitored by CBF assay using anti-hSec6p and anti-actin 









6.3.5.2. Titration of various proteolytic activities of 26S proteasome in 
HEK293 cells  
The above Sections indicated that flavivirus C protein induced the degradation of 
hSec3p through proteasome-mediated pathway. Three major proteolytic activities 
namely chymotrypsin-like, trypsin-like and caspase-like are contained within 26S 
proteasome. This study was thus extended to investigate which proteolytic 
activity of 26S proteasome was activated by flavivirus C protein. Prior to 
measuring the proteolytic activities of 26S proteasome following transfection with 
WNV/DENV C protein, it is essential to check whether the luminescence signal 
(representing the proteolytic activity of 26S proteasome) is proportional to the cell 
number of HEK293. To achieve this, Proteasome-Glo cell-based assay kits for 
chymotrypsin-like, trypsin-like and caspase-like activities were used. HEK293 
cells were serially diluted in a volume of 100 l/well of a 96-well plate. Newly 
reconstituted luminescent proteasome reagent containing substrates for 
chymotrypsin-like, trypsin-like, or caspase-like activity was then added. After 10 
min, relative luminescence units (RLU) were determined using a luminometer.  
 
As shown in Fig. 6.17, the results were linear for each of the substrates used 
(chymotrypsin-like activity R2 = 0.9897; trypsin-like activity R2 = 0.9939; 
caspase-like activity R2 = 0.9875). For each of the proteasome activities, 
luminescence was proportional to the cell number, with a linear sample range up 
to 8000 cells per well in a 96-well plate (Fig. 6.17). In the subsequent assays, 























Fig. 6.17: Luminescence is proportional to cell number for each of the 
proteasome activities. HEK293 cells were serially diluted in a 96-well plate. 
Following equal volume additions of luminescent proteasome reagent containing 
substrates for chymotrypsin-like, trypsin-like and caspase-like activity, 
luminescence was determined using a luminometer. The results are linear for each 
of the substrates used. The data point at 10000 cells/well is omitted since the 
relative luminescence signal obtained from 10000 cells/well does not fall within 






cells remained as 5000 cells per well. Direct comparison showed that the 
luminescent signal obtained from chymotrypsin-like proteasome activity varied 
significantly from that of trypsin-like or caspase-like proteasome activity. 
 
6.3.5.3. Flavivirus C protein activated the chymotrypsin-like and caspase-like 
activities of 26S proteasome  
To demonstrate the specific proteolytic function of 26S proteasome following 
transfection with WNV/DENV C protein, HEK293 cells were transfected with 
full-length C protein or hSec3p-binding defective C mutant. At 12 h post-
transfection, proteolytic activities of 26S proteasome was examined using 
Proteasome-Glo cell-based assay kits for chymotrypsin-like, trypsin-like and 
caspase-like activities.  
 
As shown in Fig. 6.18, full-length C protein of WNV/DENV activated the 
chymotrypsin-like (A) and caspase-like (C) functions of 26S proteasome 
(P<0.05). In contrast, hSec3p-binding defective C mutant failed to activate the 
proteolytic activities of 26S proteasome (P>0.05). There was no significant 
difference in the trypsin-like activity (Fig. 6.18B) of 26S proteasome following 
transfection with full-length C protein or hSec3p-binding defective mutant C 
protein (P>0.05). This suggested that full-length C protein of WNV and DENV 
triggered the chymotrypsin-like and caspase-like activities of 26S proteasome to 
























Fig. 6.18: Proteolytic activities of 26S proteasome following transfection with 
WNV/DENV C protein. HEK293 cells were transfected with full-length C 
protein (WMycC/DMycC) or hSec3p-binding defective C mutant 
(WMycC5‟∆15/DMycC5‟∆15) and the proteolytic activities of 26S proteasome 
was examined. (A) Chymotrypsin-like and (C) caspase-like functions of 26S 
proteasome are significantly increased following transfection with full-length C 
protein of WNV/DENV. (B) No significant difference in the trypsin-like activity 
of 26S proteasome is observed following transfection with WNV/DENV C 










6.3.5.4. Flavivirus C protein activated the chymotrypsin-like activity of 26S 
proteasome to degrade human Sec3 protein 
The above results suggested that flavivirus C protein utilized the chymotrypsin-
like and caspase-like functions of 26S proteasome to degrade hSec3p. To confirm 
whether these two proteolytic activities are essential to execute the degradation of 
hSec3p, bioassays were performed using proteasome inhibitors. HEK293 cells 
were incubated with various concentrations of inhibitors such as lactacystin 
(chymotrypsin-like) and YU-102 (caspase-like) at 37 
o
C for 2 h and observed for 
cytotoxic effects. It was determined that lactacystin and YU-102 up to 5 M 
concentration did not induce any cytotoxic effects in HEK293 cells (Fig. 6.19). 
 
After confirming the cytotoxic levels of lactacystin and YU-102, the study was 
extended to determine the inhibition curves for these inhibitors. Serial dilutions of 
lactacystin or YU-102 (0-10 μM) were added to the growth media of HEK293 
cells. Cells were incubated at 37 
o
C for 2 h. The plate was then allowed to 
equilibrate to 25 
o
C before the addition of Proteasome-Glo chymotrypsin-like or 
caspase-like cell-based reagents to measure the chymotrypsin-like or caspase-like 
activities, respectively. After 15 min, luminescence was measured. At 5 M 
concentration, lactacystin inhibited chymotrypsin-like activity by 92% and YU-
102 inhibited caspase-like activity by 93% (Fig. 6.20). Since there was no 
significant cytotoxicity observed at these concentrations (Fig. 6.19), 5 M 































Fig. 6.19: Relative cytotoxicity and viability of lactacystin and YU-102-
treated HEK293 cells. The viability and cytotoxicity of lactacystin and YU-102-
treated HEK293 cells were tested by incubating HEK293 cells with various 
concentrations of (A) lactacystin and (B) YU-102. These inhibitors are not shown 
to induce significant cytotoxicity up to 5 M concentration (P>0.05). At 10 M 






























Fig. 6.20: Measurement of chymotrypsin-like and caspase-like activities 
following inhibitor treatments. (A) HEK293 cells were incubated with various 
concentrations of lactacystin and chymotrypsin-like activity was measured. (B) 
HEK293 cells were incubated with various concentrations of YU-102 and 
caspase-like activity was measured. Both lactacystin and YU-102 efficiently 
inhibit chymotrypsin-like and caspase-like activities, respectively at 5 M 


















To answer whether chymotrypsin-like activity of 26S proteasome was exploited 
by flavivirus C protein to degrade hSec3p, HEK293 cells were incubated with 5 
M lactacystin (inhibitor of chymotrypsin-like activity) and transfected with 
Myc-tagged plasmids encoding full-length WNV/DENV C gene (WMycC and 
DMycC). At 24 h post-transfection, expression of hSec3p and full-length 
WNV/DENV C proteins were assessed using cell-based fluorescence (CBF) 
assay.  
 
In the absence of lactacystin, the hSec3p level was markedly reduced following 
the transfection with full-length WNV/DENV C protein (Fig. 6.21A). In the 
presence of full-length WNV/DENV C protein, hSec3p expression levels were 
decreased by 60% (P<0.05). In contrast, there were no significant differences 
(P>0.05) in the levels of hSec3p in lactacystin-treated full-length C plasmids-
transfected cells (Fig. 6.21A). The expression of full-length WNV or DENV C 
protein was confirmed by CBF assay using anti-Myc and actin antibodies (Fig. 
6.21B). There were no significant changes in the expression levels of hSec6p 
(Fig. 6.21C). This confirmed that flavivirus C protein induced the chymotrypsin-
like proteolytic function of 26S proteasome to mediate the degradation of hSec3p.  
 
To answer whether caspase-like activity of 26S proteasome was also utilized by 
flavivirus C protein to degrade hSec3p, HEK293 cells were incubated with 5 M 






















Fig. 6.21: Influence of flavivirus C protein on hSec3p expression in the 
presence of lactacystin. HEK293 cells were transfected with WMycC and 
DMycC in the absence and presence of lactacystin. (A) The hSec3p expression 
level was assessed by CBF assay using anti-hSec3p and anti-actin antibody. The 
hSec3p levels are normalized against the actin control and the relative levels of 
hSec3p in transfected cells are shown. Reduced hSec3p level is detected in 
WNV/DENV C-transfected cells in the absence of lactacystin. In contrast, there 
are no significant differences in the levels of hSec3p in lactacystin-treated 
WNV/DENV C-transfected cells. (B) The expression of C protein is monitored by 
CBF assay using anti-Myc and anti-actin antibodies. (C) The expression of 
hSec6p protein is monitored by CBF assay using anti-hSec6p and anti-actin 









plasmids encoding full-length WNV/DENV C gene (WMycC and DMycC). At 24 
h post-transfection, the expression of hSec3p and full-length WNV/DENV C 
proteins were assessed using CBF assay. In the absence or presence of YU102, 
there was no significant differences in hSec3p level (P>0.05) following the 
transfection with full-length WNV/DENV C protein (Fig. 6.22A). The expression 
of full-length WNV or DENV C protein was confirmed by CBF assay using anti-
Myc and actin antibodies (Fig. 6.22B). There were also no significant changes in 
the expression levels of hSec6p (Fig. 6.22C). This confirmed that flavivirus C 
protein did not utilize the caspase-like proteolytic function of 26S proteasome to 
mediate the degradation of hSec3p. Activation of caspase-like function by 
flavivirus C protein might be exploited to degrade other host proteins apart from 
hSec3p to favour the virus.  
 
6.3.5.5. Mapping the domains of flavivirus capsid protein responsible for 
activating chymotrypsin-like proteolytic function of 26S proteasome  
The results obtained from Figs. 6.10 and 6.11 indicated that flavivirus C protein 
must physically bind to hSec3p to reduce its level as the first 15 amino acids 
truncated mutant of C protein failed to reduce hSec3p level. To further confirm 
this, alanine-scanning mutagenesis studies were performed on the first 15 amino 
acids of C protein. This resulted in the formation of WMycC2-WMycC15 and 
DMycC12-15 mutants. Oh and colleagues (2006) reported that the last 15 amino 
acids of WNV C protein contained the cytotoxic and degradation inducing motif. 






















Fig. 6.22: Influence of flavivirus C protein on hSec3p expression in the 
presence of YU-102. HEK293 cells were transfected with WMycC and DMycC 
in the absence and presence of YU-102. (A) The hSec3p expression level was 
assessed by CBF assay using anti-hSec3p and anti-actin antibody. The hSec3p 
levels are normalized against the actin control and the relative levels of hSec3p in 
transfected cells are shown. There are no changes in hSec3p level in WNV/DENV 
C-transfected cells in the absence/presence of YU-102. (B) The expression of C 
protein is monitored by CBF assay using anti-Myc and anti-actin antibodies. (C) 
The expression of hSec6p protein is monitored by CBF assay using anti-hSec6p 









proteolytic function of 26S proteasome, multiple sequence alignment of the amino 
acid sequences of WNV and DENV C protein was performed using 
CLUSTALW2 alignment software (Fig. 6.23). Mutations were then introduced on 
the conserved and semi-conserved regions in the last 15 amino acids (putative 
degradation motif) of WNV and DENV C protein to produce WMycC109110111, 
WMycC112113114, WMycC115116117, DMycC102103104, DMycC105106107 
and DMycC108109110 mutants.  
 
HEK293 cells were transfected with full-length C protein or various C mutants. 
At 12 h post-transfection, chymotrypsin-like activity of 26S proteasome was 
examined using Proteasome-Glo cell-based assay kit. As shown in Fig. 6.24A, 
similar levels of chymotrypsin-like function was activated following transfection 
with full-length WNV C protein and all the mutants except WMycC14, 
WMycC109110111 and WMycC112113114. Similarly, full-length DENV C 
protein and all the mutants except DMycC13, DMycC102103104 and 
DMycC105106107 triggered same levels of chymotrypsin-like function (Fig. 
6.24B). The mutants WMycC14 and DMycC13 failed to activate any 
chymotrypsin-like function while the other mutants WMycC109110111, 
WMycC112113114, DMycC102103104 and DMycC105106107 activated the 
chymotrypsin-like activity at a much lower level (P<0.05) compared to that of 
full-length C protein. This indicated that the amino acids 14, 109-114 of WNV C 
protein and 13, 102-107 of DENV C protein played an important role in activating 







Fig. 6.23: Multiple sequence alignment of WNV/DENV C proteins derived 
using CLUSTALW software (http://www.ebi.ac.uk/Tools/clustalw2 
/index.html). The accession numbers of WNV_S and DENV2 are AY688948 and 


















Fig. 6.24: Chymotrypsin-like activity of 26S proteasome following 
transfection with full-length or mutant C proteins. HEK293 cells were 
transfected with full-length C protein (WMycC/DMycC) or various C mutants 
(WMycC2-WMycC15, WMycC109110111, WMycC112113114, 
WMycC115116117, DMycC12-15, DMycC102103104, DMycC105106107 and 
DMycC108109110) and the proteolytic activities of 26S proteasome was 
examined. Chymotrypsin-like functions of 26S proteasome are significantly 
increased following transfection with full-length C protein and all the mutants of 
WNV/DENV C protein except WMycC14, WMycC109110111, 
WMycC112113114, DMycC13, DMycC102103104 and DMycC105106107 
mutants. * represents P<0.05 compared to mock-transfection. ** represents 
P<0.05 compared to full-length C protein. The results shown here are obtained 
from three independent experiments with each experiment performed in 
triplicates.    
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6.3.5.6. Mapping the domains of flavivirus capsid protein responsible for 
degrading human Sec3 protein 
To investigate if the domains on C protein mediating the activation of 
chymotrypsin-like functions of 26S proteasome also caused the degradation of 
hSec3p, HEK293 cells were transfected with full-length C (WMycC/DMycC) or 
various mutant (WMycC2-WMycC15, WMycC109110111, WMycC112113114, 
WMycC115116117, DMycC12-15, DMycC102103104, DMycC105106107 and 
DMycC108109110) plasmids. At 12 h post-transfection, expression of hSec3p 
and full-length/mutated WNV or DENV C proteins were assessed using cell-
based fluorescence (CBF) assay.  
 
The levels of hSec3p were markedly reduced following transfection with full-
length WNV/DENV C protein and all the mutants except WMycC14, 
WMycC109110111, WMycC112113114, DMycC13, DMycC102103104 and 
DMycC105106107 mutant C proteins (Fig. 6.25). In contrast, equivalent amounts 
of hSec3p were detected in pCMV-Myc vector, WMycC14 and DMycC13-
transfected samples (Fig. 6.25). Although there was a significant reduction in 
hSec3p levels (P<0.05) following transfection with WMycC109110111, 
WMycC112113114, DMycC102103104 and DMycC105106107 mutants, these 
reductions were much lower than that observed with full-length C proteins 
(P<0.05). There were no significant differences in the level of C protein 








Fig. 6.25: Influence of flavivirus C protein mutants on hSec3p expression. 
HEK293 cells were transfected with (A) WMycC, WMycC2-WMycC15, 
WMycC109110111, WMycC112113114, WMycC115116117 or (B) DMycC, 
DMycC12-15, DMycC102103104, DMycC105106107 and DMycC108109110) 
plasmids. The hSec3p expression level was assessed by CBF assay using anti-hSec3p 
and anti-actin antibody. The levels of hSec3p are normalized against the actin control 
and the relative levels of hSec3p in transfected cells are shown. Similar level of 
reduction in hSec3p amount is detected in all the C-transfected experimental groups 
except with WMycC14, WMycC109110111, WMycC112113114, DMycC13, 
DMycC102103104 and DMycC105106107 mutants. * represents P<0.05 compared 
to mock-transfection. ** represents P<0.05 compared to WMycC/DMycC 
transfection.   
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Fig. 6.26: Effect of mutations on flavivirus C protein expression. HEK293 
cells were transfected with (A) WMycC, WMycC2-WMycC15, 
WMycC109110111, WMycC112113114, WMycC115116117 or (B) DMycC, 
DMycC12-15, DMycC102103104, DMycC105106107 and DMycC108109110) 
plasmids. The expression of C protein is monitored by CBF assay using anti-Myc 
and anti-actin antibodies. There are no significant differences in the level of C 











Overall, this demonstrated that the amino acids 14, 109-114 of WNV C protein 
and 13, 102-107 of DENV C protein were essential to mediate the degradation of 
hSec3p. The degradation motifs important to mediate the degradation of hSec3p 
resided between the amino acid residues 109-114 of WNV C protein and 102-107 
of DENV C protein. The mutations at the amino acid residues 14 of WNV C 
protein and 13 of DENV C protein falls within the hSec3p-bindng motif on C 
protein. This suggested that the amino acid residues at 14 of WNV C protein and 
15 of DENV C protein could be essential for its binding with hSec3p. 
 
6.3.5.7. Effect of mutations on the interaction between flavivirus capsid 
protein and human Sec3 protein 
To check the interaction status and the strength of interaction between hSec3p and 
C proteins carrying mutations in the first 15 amino acids, mammalian two-hybrid 
(M2H) assay was performed. The full-length or the mutated (mutations in the 
hSec3p interaction domain) WNV/DENV C linear constructs (bait) and the 
hSec3p linear construct (prey) were co-transfected into HEK293 cells together 
with the reporter plasmid, pGAL, which encoded for LacZ gene. The controls 
used in M2H assay were listed in Appendix 6A. The interaction between hSec3p 
and flavivirus full-length/mutated C proteins was then measured by M2H assay.  
 
All negative and background controls did not produce significant -gal activity 
and the positive controls activated significant -gal activity (Fig. 6.27A). In 





except in CW14+hSec3p and CD13+hSec3p pairs (Fig. 6.27B). There was no 
significant changes (P>0.05) in the strength of interaction between hSec3p and 
flavivirus C mutants other than WC14 and DC13 mutants (Fig. 6.27B). This 
indicated that the mutations introduced at the amino acid residues 14 of WNV C 
protein and 13 of DENV C protein affected the interaction between flavivirus C 
protein and hSec3p. Reduced chymotrypsin-like activity observed from 
WMycC14 and DMycC13 mutants (Fig. 6.24) could have resulted as a 
consequence of no interaction between C protein and hSec3p. This further 
supported the notion that physical binding between C protein and hSec3p was 


















Fig. 6.27: Effect of mutations on the interaction between flavivirus capsid 
protein and human Sec3 protein. HEK293 cells were transfected with full-
length/mutated C (bait) and hSec3p (prey) and subjected to M2H assay. The 
strength of interaction between C protein and hSec3p was measured by -
galactosidase assay. (A) All the necessary controls are included. (i) Positive 
controls, negative controls and background controls for WNV full-length/mutated 
C proteins and hSec3p. (ii) Positive controls, negative controls and background 
controls for DENV full-length/mutated C proteins and hSec3p. (B) High levels of 
-gal activity are detected from all the co-transfections except in (i) 
CW14+hSec3p and (ii) CD13+hSec3p pairs. There is no significant difference 
































































6.4. REVERSE GENETICS SYSTEM TO ANALYZE THE INFLUENCE 
OF DEGRADATION MOTIF OF CAPSID PROTEIN ON THE 
DEGRADATION OF HUMAN SEC3 PROTEIN 
To examine the influence of degradation motif of C protein on the degradation of 
hSec3p, reverse genetics system was utilized. Mutations were introduced on to the 
degradation motif of C protein in the full-length infectious clones of WNV and 
DENV. This resulted in the formation of pWNS109110111, pWNS112113114, 
pWNS115116117, pDENV102103104, pDENV105106107 and 
pDENV108109110 mutants. To evaluate the role of degradation motif of 
flavivirus C protein in reducing hSec3p level, HEK293 cells were transfected with 
the RNAs in vitro transcribed from pWNS, pDENV, pWNS109110111, 
pWNS112113114, pWNS115116117, pDENV102103104, pDENV105106107 
and pDENV108109110 plasmids. The expression of hSec3p and hSec6p were 
then assessed using cell-based fluorescence (CBF) assay at 18 h post-transfection. 
The chymotrypsin-like activity of 26S proteasome was also measured using 
Proteasome Glo cell-based kit.  
 
The hSec3p level was markedly reduced following the transfection with RNAs in 
vitro transcribed from pWNS, pDENV, pWNS115116117 and pDENV108109110 
[Figs. 6.28A(i) & 6.28B(i)]. In contrast, the reduction in hSec3p level was 
significantly compromised (P<0.05) in pWNS109110111, pWNS112113114, 
pDENV102103104 and pDENV105106107-RNA-transfected cells compared to 





hSec3p in each experimental group inversely correlated well with the level of 
chymotrypsin-like activity in that particular experimental group ([Fig. 6.28A(ii) & 
6.28B(ii)]. In contrast, there were no significant differences (P>0.05) in the levels 
of hSec6p in all the experimental cohorts [Fig. 6.28A(iii) & 6.28B(iii)]. Overall, 
this demonstrated that the degradation motif present on flavivirus C protein 
played an essential role in specifically mediating the proteasome-mediated 
degradation of hSec3p.  
 
This chapter highlighted how flavivirus infection can be successful in the 
presence of endogenous hSec3p by dissecting the role of WNV/DENV C protein 
in inducing chymotrypsin-like proteolytic function of 26S proteasome to degrade 
hSec3p. The experiments conducted in this chapter yielded novel information 















Fig. 6.28: Effect of mutations on degradation motif of C protein on hSec3p 
expression using reverse genetics system. HEK293 cells were transfected with 
RNAs in vitro transcribed from full-length/mutant infectious clones of (A) WNV 
and (B) DENV. (i) The hSec3p expression level was assessed by CBF assay using 
anti-hSec3p and anti-actin antibody. The hSec3p levels are normalized against the 
actin control and the relative levels of hSec3p in viral RNA-transfected cells are 
shown. Reduced hSec3p level is detected in [A(i)] pWNS, [A(i)] 
pWNS115116117, [B(i)] pDENV and [B(i)] pDENV108109110 compared to 
mock-transfection (* represents p<0.05). The hSec3p levels are significantly 
higher in other mutants compared to that of pWNS or pDENV (** represents 
p<0.05). (ii) Chymotrypsin-like activity of 26S proteasome following viral RNA 
transfections. Chymotrypsin-like functions of 26S proteasome are significantly 
increased following transfection with RNA in vitro transcribed from in [A(ii)] 
pWNS, [A(ii)] pWNS115116117, [B(ii)] pDENV and [B(ii)]pDENV108109110 
compared to mock-transfection (* represents p<0.05). The chymotrypsin-like 
activity is significantly lower in other mutants compared to that of pWNS or 
pDENV (** represents p<0.05). (iii) The expression of hSec6p protein is 
monitored by CBF assay using anti-hSec6p and anti-actin antibodies. There is no 

































































































































Viruses containing their nucleic acid enclosed in a protein shell are parasites of 
their host organisms. Although viruses possess simple structures, they employ 
sophisticated mechanisms to replicate within their hosts. RNA viruses, in general, 
rely on host cellular components for replication and transcription of their genomic 
RNAs. They utilize their structural and non-structural proteins to hijack and 
manipulate the host cell environment to support their life-cycle. These virus-host 
interactions are complex and dynamic. Understanding this multifaceted bio-
molecular process has the potential to yield new and exciting strategies for 
therapeutic intervention.  
 
The capsid (C) protein of flavivirus is the first viral protein synthesized in an 
infected cell. The capsid protein is the key structural component of virus particles. 
They are nucleic acid-binding proteins whose known function is packaging viral 
genomes into nucleocapsids. However it is not required as a structural component 
until the later phases of assembly pathway. Growing evidences showed that 
capsid protein of RNA viruses have non-structural functions in addition to their 
structural roles (Hunt et al., 2007; Ko et al., 2010; Oh et al., 2006; Yang et al., 
2002; Yang et al., 2008). These non-structural functions were achieved by 
modulating host cell signalling pathways. This is possible since the C protein is 






Although flavivirus replication is confined to the cytoplasm of host cells and virus 
assembly occurs on the endoplasmic reticulum (Mukhopadhyay et al., 2005), the 
C proteins are observed to have a nuclear phase (Bhuvanakantham et al., 2010; 
Bhuvanakantham et al., 2009; Bulich & Aaskov, 1992; Chang et al., 2001; 
Cheong & Ng, 2010; Makino et al., 1989; Mori et al., 2005; Oh & Song, 2006; 
Tadano et al., 1989; Westaway et al., 1997). As there is no obvious role for 
nuclear localization of C protein in virus assembly, this nuclear phase may 
presumably modify the host cell environment in such a way that virus replication 
and dissemination is enhanced (Bhuvanakantham et al., 2009; Mori et al., 2005). 
This suggested that the dual cellular distributions (nucleus and cytoplasm) of C 
proteins place them in a strategic position to act as a modulator of the host cell 
environment. 
 
Among the flaviviruses, the non-structural functions of capsid protein were well 
documented in Hepatitis C virus (HCV). They were shown to involve in multiple 
pathways such as lipid metabolism, T-cell response, cell cycle regulation, 
transcriptional control, signal transduction, apoptotic pathways, protein 
degradation and cell transformation (Hosui et al., 2003; Kittlesen et al., 2000; 
Machida et al., 2010; Ohkawa et al., 2004; Shi et al., 2002; Tu et al., 2010; 
Yoshida et al., 2002). The cellular functions of C protein in arthropod-borne 
flaviviruses other than its role as a major structural component are poorly defined. 
The reported principle non-structural function of C protein in arthropod-borne 





Lee et al., 2006; Liao et al., 2010; Limjindaporn et al., 2007; Netsawang et al., 
2010; Oh et al., 2006; Oh & Song, 2006; Yang et al., 2008). This study aimed to 
investigate if C protein of WNV and DENV possess any other novel non-
structural functions apart from its role in initiating apoptosis. As a starting point, 
Y2H cDNA library screening was performed to identify the host proteins that 
could interact with flavivirus C proteins.  
 
The Y2H library screening picked up several proteins associated with apoptosis 
such as calcium-modulating cyclophilin binding ligand (CAML), protein L-
isoaspartyl methyltransferase (PIMT), activating transcription factor 6 (ATF6), 
heat shock protein 27 (HSP 27), heat shock protein 70 (HSP 70) and human death 
domain-associated protein (Daxx). This re-affirmed that C proteins of flaviviruses 
establish a wide network of interactions with the proteins associated with 
apoptosis. This is consistent with the previous studies that implicated C protein as 
the inducer of apoptosis (Limjindaporn et al., 2007; Netsawang et al., 2010; Oh et 
al., 2006; Yang et al., 2002; Yang et al., 2008). It is possible that C protein 
associates with pro-apoptotic proteins to nullify the anti-viral effects mounted by 
host cells‟ defense mechanism in virus-infected cells.  
 
Some of the host proteins that were identified in this study [HSP 70, Daxx and 
phosphatase Inhibitor (I2PP2A)] were similarly reported as the interacting 
partners of WNV/DENV C protein (Hunt et al., 2007; Limjindaporn et al., 2007; 





reliability of Y2H library screening performed in this study. The Y2H library 
screening also isolated several other proteins that were involved in calcium 
signaling, protein translation, pH maintenance, protein degradation, trafficking, 
cell signaling and exocytosis (Tables 3.2 and 3.3). This illustrated that C protein 
of arthropod-borne flaviviruses do interact with a wide variety of cellular proteins 
during their replication process to manipulate the host cell environment conducive 
for virus replication.  
 
This study decided to select a novel host protein, human Sec3 protein (hSec3p) 
which interacted with both WNV/DENV C proteins and whose function is not 
widely studied in mammalian system. The hSec3p is a component of the human 
Sec6/8 exocyst complex. Using a combination of Y2H, M2H, Co-IP and confocal 
analyses, this study demonstrated a unique interaction between flavivirus C 
protein and an exocyst component. A combination of computational prediction 
and biochemical mapping studies revealed that the first 15 amino acids of 
flavivirus C protein and the SH2 domain binding motif in the last 15 amino acids 
of hSec3p were crucial for the functional interaction between hSec3p and C 
proteins. The hSec3p-interacting domain on WNV/DENV C protein coincided 
with the Jab1-interaction domain on WNV C protein and C-RNA interaction 
domain (Oh et al., 2006, Khromykh & Westaway, 1996; Cheong & Ng, 2010). 
This highlighted the crucial role played by the first 15 amino acids of flavirus C 
proein. Structural studies showed that this domain is non-structured in flavivirus 





2004)  One possible explanation for the existence of this non-strutured domain 
could allow C protein to interact with a wide variety of host proteins and viral 
RNA genomes.  
 
In yeast, Sec3p played a crucial role in the secretory pathways and the facilitation 
of polarized growth (Finger et al., 1998a; Finger & Novick, 1997; Wiederkehr et 
al., 2003). Recent paper has also shown that N terminus of Sec3p interacted with 
phosphatidylinositol 4, 5-bisphosphate and Cdc42 to regulate exocytosis (Zhang 
et al., 2008b). Thus, the initial hypothesis was that flavivirus C protein might 
exploit hSec3p for virus trafficking and release. However, hSec3p knock-down 
potentiated virus replication/production in WNV-/DENV-infected hSec3p293KD 
cells while the reverse phenomenon was observed in hSec3p293OE cells (Fig. 
4.5). This contradicted the initial hypothesis and indicated hSec3p as a negative 
regulator of flavivirus infection. This is the only study to date on the discovery 
that hSec3p exocyst can act as an anti-flaviviral host protein.   
 
It was observed that changes in hSec3p expression had a more pronounced effect 
on DENV replication compared to WNV(Sarafend). Dengue virus had a relatively 
longer latent period [(12-24 h) (Helt & Harris, 2005) compared to 
WNV(Sarafend) which possessed a very short latent period [(6 h) (Ng et al., 
2001)]. The hSec3p might require longer period to effectively execute its anti-
viral function. With the longer latent period for DENV replication, hSec3p might 





(Sarafend) replication. This hypothesis was substantiated when WNV(Wengler) 
which had a growth cycle similar to that of DENV showed same pronounced 
effect when hSec3p was differentially expressed [Fig. 4.5(iii)]. This demonstrated 
that the duration of latent period could influence the efficacy of the anti-viral 
effects of hSec3p. 
 
Viruses utilize hundreds of host cell machineries in a concerted manner to favour 
each step of their life cycles and identifying these host functions will be of great 
interest in virology to further the understanding of precise mechanisms of 
flaviviral life cycle. This study thus aimed to pinpoint which step in flavivirus 
life-cycle was targeted by hSec3p, i.e., virus entry, viral RNA transcription, viral 
protein translation and virus secretion. A combination of reverse genetics system, 
real-time PCR, Western blotting, densitometry, in vitro translation assay, Co-IP, 
pull down assay, competition assay and confocal analyses were employed to 
elucidate the critical step(s) in flavivirus life-cycle targeted by hSec3p.  
 
Molecular dissection of the mechanism underlying hSec3p-C protein interaction 
revealed that hSec3p functioned as an anti-viral host factor through a bimodal 
inhibitory pathway. The expression levels of hSec3p affected both viral 
transcription and translation processes, in that it significantly reduced the 
biosynthesis of both viral RNA and proteins (Figs.4.8 - 4.11). Although host 
proteins such as Interferon regulatory factor 3 and CCR5 receptor (Fredericksen 





this is the only report that implicated human exocyst component (hSec3p) as an 
anti-flavivirus factor. This study further showed that enhanced virus production in 
hSec3p293KD cells was not attributed to altered virus entry or genome uncoating 
(Fig. 4.7).  
 
Efforts to verify if physical binding between hSec3p and C protein was needed to 
negatively manipulate flavivirus production indicated that the physical binding 
between hSec3p and C protein was not essential. This suggested that there could 
be other unknown factor(s) mediating the effect of hSec3p on flavivirus 
production. Delineating the molecular mechanism by which hSec3p exerted its 
anti-viral effects discovered the translational enhancer, EF1as the binding 
partner of hSec3p. Another interesting discovery of this study is the 
demonstration of the physical interaction between hSec3p and EF1 in 
mammalian system. The hSec3p sequestered EF1 and reduced the binding 
opportunity of EF1with flaviviral RNA genome or RNA-associated replicative 
complex. It has been reported that EF1 acted as a regulator of (-) RNA synthesis 
and was a component of the viral transcriptase complex in viruses such as WNV, 
tobacco mosaic virus, vesicular stomatitis virus and tombusvirus (Davis et al., 
2007b; Li et al., 2009; Matsuda et al., 2004; Qanungo et al., 2004). It was also 
shown that EF1 interacted with 3‟UTR of WNV and DENV genome (Blackwell 
& Brinton, 1995; 1997; Davis et al., 2007b; De Nova-Ocampo et al., 2002; Shi et 
al., 1996) and this association was a critical determinant of viral (-) RNA 





inability of free EF1to bind flaviviral RNA genome efficiently due to the 
formation of hSec3p- EF1 complex could have led to the decrement in viral 
RNA synthesis (Figs. 4.8 and 4.9).  
 
A combination of in vitro translation assay, immunodepletion assay and 
competition assay demonstrated that hSec3p inhibited viral protein translation by 
similarly sequestrating the translational enhancer, EF1. The antagonistic activity 
of hSec3p on viral translation fitted snugly with the current awareness that the 
inhibition of viral protein translation is a common host response strategy against 
infection. Certain host proteins such as translation initiation factor DED1 and Y 
box-binding protein were also identified as cellular factors that block viral 
translation in Brome Mosaic virus and DENV (Noueiry et al., 2000; Paranjape & 
Harris, 2007). 
 
The concerted negative effect of hSec3p over-expression on viral transcription 
and translation resulted in the reduction of viral RNA and protein synthesis. This 
subsequently led to a decrease in the levels of secreted RNA and virus protein in 
the virus-infected cell culture supernatants (Figs. 4.12 and 4.13). This decrease 
correlated with the significant reduction in the virus yield observed in this study 
(Fig. 4.5). Overall, by highlighting the anti-viral properties of hSec3p, this study 






Interestingly, flavivirus capsid protein-binding defective mutant, hSec3pSH2 
inhibited flavivirus production at the same level as intact hSec3p (Fig. 4.6). 
Dissecting the underlying mechanism revealed that hSec3pSH2 mutant was also 
capable of sequestering EF1 (Fig. 5.2). Sequestration of EF1 would interfere 
with viral RNA transcription and translation as described above. This explained 
why hSec3pSH2 mutant is capable of impairing flavivirus production. This study 
also demonstrated that the anti-viral mechanism imposed by hSec3p was specific 
as it did not affect the binding of PTB to viral RNA (Figs. 5.4 and 5.6). When 
Sec6p was used in the place of Sec3p, it did not interfere with EF1-3‟UTR 
association (Fig. 5.7). 
 
Based on the known functions of the other cellular proteins identified in this 
study, Testis-specific protein Y (TSPY) was known to interact with EF1to 
enhance protein translation (Kido & Lau, 2008). It is not clear whether there is 
any cross-talk between flavivirus C protein, hSec3p and TSPY. It is possible that 
hSec3p could function together with TSPY to inhibit viral translation or C protein 
could make use of TSPY to alter cellular translation. This warrants further 
investigation.  
 
Although one may argue that the hSec3p-dependant sequestration of an abundant 
cellular protein like EF1should have minimal impact on cellular or viral 
processes, several studies had shown that differential levels of EF1 could 





reported that down-regulation of EF1could induce cell death in tetraploids. In 
addition, the importance of EF1 level was further exemplified by Leclercq and 
colleagues (2008), who demonstrated the dose-dependent effects of EF1on 
sphingosine kinase activity. Thus, it was not inconceivable that sequestration of 
EF1 by hSec3p could exert similar impact on biogenesis of flavivirus.  
 
Just as the host has evolved a mechanism to counter virus replication, virus 
proteins also developed the abilities to sequester host proteins to favour a 
productive infection. Zhou and colleagues (2008) reported that SARS 
nucleocapsid protein bound to EF1and inhibited cell cytokinesis to favour virus 
infection. Similarly, another study showed that the binding of EF1 by HCV 
NS4A inhibited host translation (Kou et al., 2006). Viruses could also utilize their 
structural and non-structural proteins to cleave and inactivate the key components 
of anti-viral signalling pathways (Elliott et al., 2007; Ulane & Horvath, 2002; 
Wright et al., 2006; Zhang et al., 2002; Zhang et al., 2005a) or to recruit host 
proteasome system to destabilise the anti-viral host proteins (Ashour et al., 2009; 
Barro & Patton, 2005; Graff et al., 2009; Kalantari et al., 2008). If hSec3p truly 
posed a hindrance to flavivirus replication, flaviviruses should have evolved some 
strategies to circumvent the anti-viral effects of hSec3p in a natural infection.  
 
This study has also unveiled how flavivirus C protein overcome the anti-viral 
effects of hSec3p. The amount of EF1-hSec3p complex formation was 





5.2.1). This indicated that WNV/DENV infection could interfere with EF1-
hSec3p complex formation by altering the hSec3p level. Investigation into the 
molecular mechanism underlying flavivirus-induced reduction in EF1-hSec3p 
complex formation revealed that there was active down-regulation of hSec3p in 
flavivirus-infected cells (Fig. 6.1). This study also unveiled that flavivirus 
infection did not alter the transcription or stability of hSec3 gene but influenced 
hSec3p concentration at the post-transcription level. Reduced hSec3p level 
resulted in decreased formation of hSec3p-EF1 complex as observed with 
hSec3p knock-down cells.  
 
The cell-based fluorescence assay developed during this study was used to 
quantitate hSec3p, hSec6p and epitope-tagged proteins. The results were highly 
reproducible after normalization against the internal control, actin. The percentage 
difference in hSec3p levels obtained from Western blotting followed by 
densitometry coincided with the data obtained from cell-based fluorescence assay 
(Fig. 6.3). This assay functioned as an alternative to Western blotting and saved 
time. This assay platform can easily be extended to measure a wide range of 
cellular and viral proteins, thus opening an avenue to quantitate the protein level 
at a faster rate in a high-throughput manner.   
 
The proteasome degradation pathway plays a crucial role in various biological 
processes in cells such as antigen processing, apoptosis, signal transduction, 





unwanted proteins (Coux et al., 1996; Glickman, 2000; Niedermann, 2002; 
Pickart, 1997). Several viruses exploited the proteasomal pathway to support 
efficient virus production such as to escape from the immune system, during 
release from cells or to suppress apoptosis (Hassink et al., 2006; Kikkert et al., 
2001; Lagunas-Martinez et al., 2010; Mack et al., 2008; Raaben et al.; Sakurai et 
al., 2004; Urata et al., 2007).  
 
Analysis of hSec3p stability in the presence of MG132, a proteasomal inhibitor 
indicated that intact proteasome activity was required to mediate the reduction of 
hSec3p levels. The stability of hSec3p was compromised following flavivirus 
infection (Fig. 6.7). This demonstrated that flaviviruses subverted the proteasome 
degradation pathway for their own advantage. Following the observation that 
hSec3p levels were reduced during flavivirus infection, this study analysed the 
role of recombinant C protein in altering hSec3p levels. Results indicated that 
flavivirus C protein was capable of reducing hSec3p levels in the absence of other 
viral components in a dose-dependent manner (Figs. 6.8 and 6.9). Studies 
performed with truncated and point mutants of C protein revealed that this protein 
must physically bind to hSec3p to execute the degradation of hSec3p via 
proteasome-mediated pathway (Figs. 6.10 and 6.11). The degradation motifs 
important to mediate the degradation of hSec3p resided between the amino acid 
residues 109-114 of WNV C protein and 102-107 of DENV C protein (Figs. 6.25 
and 6.28). It will be interesting to examine the influence of these introduced 





After confirming the involvement of proteasomes in decreasing hSec3p levels 
using MG132 and epoxomicin, this study was extended to dissect which of the 
three proteolytic functions of 20S proteasome was activated by flavivirus C 
protein. Analysis of the specific proteolytic activities of 20S proteasome 
delineated that chymotrypsin-like and caspase-like activities of 20S proteasome 
were activated by flavivirus C protein (Fig. 6.18). Further detailed analyses using 
inhibitors discovered that the chymotrypsin-like proteolytic function of 20S 
proteasome was activated by C protein to execute the proteasome-mediated 
degradation of hSec3p and caspase-like function had no effect on modulating 
endogenous hSec3p levels (Figs. 6.21 and 6.22). This study opened a new avenue 
for the researchers to look into how flavivirus C protein activates the proteasome 
pathway.  In summary, this study demonstrated that flavivirus C protein induced 
the degradation of hSec3p by activating the chymotrypsin-like proteolytic 
function of 20S proteasome. As a result, the hSec3p level was reduced which 
subsequently resulted in the decreased formation of EF1-hSec3p complex. This 
rendered free EF1 readily available to interact with 3‟UTR of viral RNA to aid 
viral RNA transcription and translation.  
 
Consistent with this study, the involvement of proteasomes to favour flavivirus 
infection have been reported for efficient WNV, DENV, HCV and JEV 
replication (Dutta et al., 2009; Fink et al., 2007; Gilfoy et al., 2009; Kanlaya et 
al., 2010; Krishnan et al., 2008; Lin et al., 2005b). Flaviviruses have also utilized 





STATs (Ashour et al., 2009). It is thus clear that proteasomes‟ involvement plays 
an essential role in favouring flavivirus infection. Similar scenario was observed 
during human immunodeficiency virus (HIV) infection. The deoxycytidine 
deaminase, APOBEC3G protein functioned as the anti-retroviral agent. One of the 
viral proteins encoded by HIV, Vif induced the proteasome-dependent pathway to 
degrade APOBEC3G and nullified the anti-viral function of APOBEC3G (Albin 
& Harris, 2010; Fourati et al., 2010; Mehle et al., 2004; Ooms et al., 2010; 
Wissing et al., 2010; Zangari et al., 2010). This showed that viruses are capable 
of utilizing proteasomal functions to degrade the anti-viral cellular proteins to 
favour the infection.  
 
Studies have also shown that host proteins such as Jab1, subunit of COP9 
signalosome and Makorin ring finger protein 1 induced the degradation of 
flavivirus C protein in a proteasome-dependent manner (Ko et al., 2010; Oh et al., 
2006). This suggested that proteasomal degradation pathway played a dual role 
during flavivirus infection. The host cell uses it as a tool to defend against the 
virus and the virus exploits it to support successful infection. This ambivalent 
behavior of proteasomal system suggested that this could have resulted from the 
co-evolution of the host and the flavivirus.  
 
By inhibiting proteasomal activity, it is possible to impair several processes such 
as cell proliferation, inflammatory responses and apoptosis. The proteasome 





organ transplantation (Everly et al., 2010; Flechner et al., 2010; Kennedy et al., 
2010; Zangari et al., 2010). It will therefore be of great interest to target the 
chymotrypsin-like proteolytic function of 20S proteasome in an effort to 
strengthen the host anti-viral state against flavivirus. This study indicated that the 
proteasomal pathway could serve as an attractive and novel therapeutic target for 
flavivirus infection.  
 
In addition, this study also revealed that although WNV and DENV C protein 
share only 25-35% sequence identity, they acted in the similar fashion to 
encounter hSec3p in the host cell. It is not surprising since it was known earlier 
that flavivirus C proteins are structurally and functionally similar although their 
amino acid sequences are poorly conserved. The C protein of flavivirus was 
shown to be an alpha-helical protein and it functions primarily to package the 
viral genome (Chambers et al., 1990a; Dokland et al., 2004; Jones et al., 2003; 
Kofler et al., 2002; Ma et al., 2004). 
 
In conclusion, this study identified a novel interaction between hSec3p and 
flavivirus C protein and also unraveled the biological significance of flavivirus C 
protein and hSec3p association as portrayed in Fig. 7.1. As shown in Fig. 7.1A, 
flavivirus enters the cell by receptor-mediated endocytosis and trafficked along an 
endosomal and lysosomal pathway. Subsequently, nucleocapsid is released into 
the cytoplasm followed by its dissociation into RNA and C particles (Chu & Ng, 
2004a). The RNA is translated into structural and non-structural proteins. The 
non-structural proteins together with some cellular proteins bind flaviviral RNA 





RNA or viral replicative complex and results in efficient negative strand RNA 
synthesis and subsequently leads to efficient positive strand RNA synthesis and 
viral protein synthesis. This results in enhanced virus assembly and virus 
secretion. The hSec3p battles against flavivirus infection by sequestering EF1 
and thereby decreasing the amount of free EF1 that can bind with flaviviral 
RNA/replicative complex (shown using red colour in Fig. 7.1B). In this way, 
hSec3p negates flaviviral RNA transcription and translation, in an attempt to 
protect the host.  
 
On the other front, flavivirus C protein forms a complex with hSec3p through a 
direct physical interaction and activates the chymotrypsin-like proteolytic activity 
of 20S proteasome (Fig. 7.1B, shown using blue colour). This results in the 
enhanced degradation of hSec3p. As a result, the endogenous hSec3p is 
exhausted. By increasing the turnover of endogenous hSec3p in the cytoplasm, C 
protein disrupts the formation of hSec3p-EF1 complex and renders the free 
EF1 easily available to interact with flaviviral RNA genome. This results in 
increased viral RNA and protein synthesis which subsequently enhances virus 
assembly and virus secretion. In this way, flavivirus C protein nullifies the anti-
viral checkpoints imposed by hSec3p and helps the virus to establish a 
microenvironment that facilitates successful replication and infection. 
Understanding the molecular mechanism of flavivirus C protein and hSec3p 
interaction, besides revealing the ground-breaking non-structural function of 
flavivirus C protein and cellular functions of hSec3p, could possibly provide a 







Fig. 7.1: A model depicting the biological consequences of flavivirus C 
protein-hSec3p interaction. Flavivirions enter the cell by receptor-mediated 
endocytosis and release the nucleocapsid in the cytoplasm followed by its 
dissociation into RNA and C proteins. The RNA is translated into a polyprotein 
which subsequently forms structural and non-structural proteins. The non-
structural proteins together with some cellular proteins bind flaviviral RNA and 
form the viral replicative complex. Free EF1 then interacts with viral replicative 
complex and results in efficient viral RNA and viral protein synthesis. This results 
in enhanced virus assembly and virus secretion. (A) The hSec3p battles against 
flavivirus infection by forming more hSec3p-EF1 complex and decreasing the 
amount of free EF1 available to bind with replicative complex. As a result, 
decreased viral RNA and proteins are synthesized, which then leads to decreased 
virus production. (B) Flavivirus C protein sequesters hSec3p and degrades it. This 
results in the decreased formation of hSec3p-EF1 complex. Free EF1 readily 
interacts with flaviviral RNA genome and potentiates flavivirus production. The 
effects mediated by hSec3p are shown in red (A) and the effects mediated by C 
protein are shown in blue (B). The broken arrow represents the interference 
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APPENDIX 1:  REAGENTS FOR CELL CULTURE  
The following are formulations for the preparation of media used to grow various 
cell lines used throughout the project. All contents except foetal bovine serum 
were warmed to 25
o
C and added to a glass beaker already containing 90% of the 
final required volume of water. A magnetic stirrer was used to agitate the contents 
until all solids were fully dissolved.  
 
A. Growth medium, L15 for C6/36 cells (~pH 7.3) 
Items Amount Source 
L15 1 bottle Sigma, USA 
Foetal bovine serum 100 ml PAA Laboratories, Austria 
Deionised water 900 ml Millipore, USA 
 
 
B. Growth medium, Dulbecco’s Modified Eagle’s Medium (DMEM) for 
HEK293 cells (~pH 7.3) 
Items Amount Source 
DMEM 1 bottle Sigma, USA 
Foetal bovine serum 100 ml PAA Laboratories, Austria 
NaHCO3 3.7 g Merck Germany 









C. Growth medium, Dulbecco’s Modified Eagle’s Medium (DMEM) for 
293FT cells (~pH 7.3) 
 
 
D. Growth medium, Roswell Park Memorial Institute-1640 (RPMI-1640) 
for BHK cells (~pH 7.3) 
Items Amount Source 
RPMI-1640 1 bottle  Sigma, USA 
NaHCO3 2.0 g Merck, Germany 
Foetal bovine serum 100 ml PAA Laboratories, Austria 
Deionised water 900 ml Millipore, USA 
 
The pH of the media was then adjusted to approximately 7.3 with a handheld pH 
meter (Beckman Coulter Inc., USA). The solution was then sterilised by filtration 
in a sterile environment through a 0.2 µm PES membrane bottle top filter unit 
(Nalge Nunc International, Denmark). A 20 ml aliquot of filtered media was used 
for screening of microbial contamination by incubation at 37°C for 3 days before 
the addition of FBS and antibiotic, geneticin. The serum supplemented media 
were kept at 4°C until further use. The cell culture media were warmed up in 
water bath to 37°C before use.  
Items Amount Source 
DMEM 1 bottle Sigma, USA 
Foetal bovine serum 100 ml PAA Laboratories, Austria 
NaHCO3 3.7 g Merck, Germany 
Geneticin 50 mg/ml Invitrogen, USA 





E. Heat-inactivated foetal bovine serum (FBS) 
Foetal bovine serum for the L15 and DMEM was heat inactivated at 56°C for 30 
min in a pre-warmed water bath before being added into the sterile media. 
 
F. 1 M Hydrochloric acid (1 M HCl) 
Hydrochloric acid (37% - Merck, Germany) was diluted by 1:10 in deionised 
water (Millipore, USA) to create a 1 M solution of hydrochloric acid. This was 
stored at 25°C and used to adjust the pH of media.  
 
G. 1 M Sodium hydroxide (1 M NaOH) 
Sodium hydroxide pellets (BDH Ltd., England) was weighed out to 50 g and 
mixed into 1 L of deionised water (Millipore, USA) to create a 1 M solution of 
sodium hydroxide. This was stored at 25°C and used to adjust the pH of media.  
 
H. Phosphate-buffered saline (PBS)  
Items Amount Source 
NaCl 8.0 g Lab Scan Limited, Ireland 
KCl 0.2 g Merck, Germany 
Na2HPO4 1.15 g Merck, Germany 
KH2PO4 0.2 g Merck, Germany 
Deionised water 900 ml Millipore, USA 
The above materials were dissolved in 1 L of deionised water. The pH was 
adjusted to 7.4 using either 1 M HCl or 1 M NaOH. The solution was aliquoted 






I. Trypsin  
Trypsin solution for the dissociation of cells from culture flask or plate was made 
by diluting 10 ml of sterile porcine pancreas derived 10x trypsin solution (Sigma, 
USA) in 90 ml PBS. This 1x stock of trypsin was stored at 4°C and warmed to 
37°C before use. 
 
J. Poly-L- lysine for coating flasks 
Poly-L-lysine was prepared from powder (Sigma, USA) into a stock solution of 
10 mg in 5 ml of distilled water (Millipore, USA). The stock was then diluted in 
1:100 with distilled water to obtain a working concentration. The resulting 
solution was sterilized by 0.2 µm syringe filter (Sartorius, Germany). This 
solution was used to plate the tissue culture flasks, plates or coverslips overnight 
at RT. The next day, the solution was removed and the surface was washed twice 
with sterile distilled water. The flasks and coverslips were then left in a laminar 








APPENDIX 2:  REAGENTS FOR VIRUS INFECTION, GROWTH OF 
VIRUS AND PLAQUE ASSAY  
A. Virus Diluent, Hanks’ balanced salt (pH 7.2 - 7.4)  
Items Amount Source 
Hanks‟ balanced salt 1 bottle  Sigma, USA 
NaHCO3 2.2 g Merck, Germany 
10% Bovine serum albumin 1 ml CSL, Australia 
Deionised water 1000 ml Millipore, USA 
 
The above materials were dissolved in 900 ml of deionised water. A magnetic 
stirrer was used to agitate the contents until all solids were fully dissolved. The 
solution was made up to 1000 ml and the pH was adjusted to 7.3 using a pH meter 
(Beckman Coulter Inc., USA). The solution was then sterilised by filtration 
through 0.2 µm PES membrane bottle top filter unit (Nalge Nunc International, 
USA) and stored at 4°C. Virus diluent was warmed to 37°C before use. 
 
B. Maintenance media, L15 for C6/36 cells 
Items Amount Source 
L15 1 bottle Sigma, USA 
Foetal bovine serum 20 ml PAA Laboratories, Austria 









C. Maintenance media, DMEM for HEK293 cells 
Items  Amount  Source  
DMEM 1 bottle Sigma, USA 
Foetal bovine serum 20 ml PAA Laboratories, Austria 
NaHCO3 3.7 g Merck, Germany 
Deionised water 980 ml Millipore, USA 
 
Maintenance media for all the cell lines were prepared in the same way as the 
growth media for the same cell line in Appendix 1A to 1D, except for the volume 
difference of foetal bovine serum and sterile deionised water. 
 
D. Overlay medium (pH 7.2 - 7.4) 
a. Double strength growth media 
Items Amount Source 
RPMI-1640 1 bottle Sigma, USA 
NaHCO3 2.0 g Merck, Germany 
Foetal bovine serum 40 ml PAA Laboratories, Austria 
Deionised water 460 ml Millipore, USA 
 
Double strength growth media was prepared in the same way as the growth media 
for BHK cells in Appendix 1D, except for the volume difference of foetal bovine 









b. 2% Carboxy-methyl-cellulose (2% CMC) 
To make 200 ml of 2% CMC, 4.0 g of CMC powder (Merck, Germany) was 
mixed well into 200 ml of sterile deionized water. The solution was then 
autoclaved for 15 min at 121°C and stored at 4°C until further use.  
 
c. Overlay medium 
Two hundred ml of double strength media was added to 200 ml of 2% CMC 
solution and mixed well and stored at 4°C. Overlay medium was warmed to 37°C 
before use. 
 
E. 0.5% Crystal violet / 25% formaldehyde solution  
Items Amount Source 
Crystal violet powder 5.0 g Sigma, USA 
37% Formaldehyde solution 270 ml Merck, Germany 
PBS 230 ml See Appendix 1H 
 












APPENDIX 3:  REAGENTS FOR MOLECULAR WORK 
A. Primers used in cloning 
Primer name Nucleotide sequence (5’-3’) Plasmid Vector 
(i) Yeast expression system 




pGADT7 (Clontech, USA) 
pGBKT7 (Clontech, USA) 
pGADT7 (Clontech, USA) 
pGADT7 (Clontech, USA) 
Y2HC5‟∆15 (F) CGTTGAATTCATGCTAAAACGCGGTATGC C5‟∆15 pGADT7 (Clontech, USA) 
Y2HC5‟∆30 (F) CGTTGAATTCAAGAGGGCTATGCTGAGTCTG C5‟∆30 pGADT7 (Clontech, USA) 
Y2HC5‟∆45 (F) CGTTGAATTCTTCGTGTTGGCTCTTCTGG C5‟∆45 pGADT7 (Clontech, USA) 
Y2HC3‟∆18 (R) CGGGATCCTTATCTTTTCTTTTGTTTTGTGC C3‟∆18 pGADT7 (Clontech, USA) 
Y2HC3‟∆39 (R) CGGGATCCTTAGAAACTCAAGAGATGCTTC C3‟∆39 pGADT7 (Clontech, USA) 





pGADT7 (Clontech, USA) 
pGBKT7 (Clontech, USA) 
pGADT7 (Clontech, USA) 
pGADT7 (Clontech, USA) 







pGADT7 (Clontech, USA) 
pGBKT7 (Clontech, USA) 
pGBKT7 (Clontech, USA) 
pGBKT7 (Clontech, USA) 
Y2HSec3f3(F) CGTTCATATGCAGCAGCGATTCAGTGAT hSec3pf3 pGBKT7 (Clontech, USA) 
Y2HSec3f4(F) CGTTCATATGGAGAAAGATATGATCCGC hSec3pf4 pGBKT7 (Clontech, USA) 






pGBKT7 (Clontech, USA) 
pGBKT7 (Clontech, USA) 
pGBKT7 (Clontech, USA) 
Y2HSec3pf2(R) CGGGATCCTTATTGCTGTTTGACTGCCAG hSec3pf2 pGBKT7 (Clontech, USA) 
Y2HSec3pf3(R) CGGGATCCTTAAGATGAAACAGGCAGTGG hSec3pf3 pGBKT7 (Clontech, USA) 
Y2HSec3pf5(R) CGGGATCCTTAAGTGAATTCCATTGTAAC hSec3pf5 pGBKT7 (Clontech, USA) 
D-BDC(F) CGTTGAATTCATGAATAACCAACGAAAA D-BDC 
D-ADC 
pGBKT7 (Clontech, USA) 
pGADT7 (Clontech, USA) 
D-BDC(R) CGGGATCCTTA CGCCATCACTGTTGGAAT D-BDC 
D-ADC 
pGBKT7 (Clontech, USA) 





Primer name Nucleotide sequence (5’-3’) Plasmid Vector 
(ii) Mammalian expression system 









pCMV-HA (Clontech, USA) 
pCMV-Myc (Clontech, USA) 
pCMV-HA (Clontech, USA) 
pCMV-HA (Clontech, USA) 
HACC5‟∆15 (F) CCGGAATTCGGATGCTAAAACGCGGTATGC HAC5‟∆15 pCMV-HA (Clontech, USA) 
HACC5‟∆30 (F) CCGGAATTCGGAAGAGGGCTATGCTGAGT HAC5‟∆30 pCMV-HA (Clontech, USA) 
HACC5‟∆45 (F) CCGGAATTCGGTTCGTGTTGGCTCTTCTG HAC5‟∆45 pCMV-HA (Clontech, USA) 
HACC3‟∆18 (R) CCGCTCGAGTTATCTTTTCTTTTGTTTTGTGC HAC3‟∆18 pCMV-HA (Clontech, USA) 
HACC3‟∆39 (R) CCGCTCGAGTTAGAAACTCAAGAGATGCTTC HAC3‟∆39 pCMV-HA (Clontech, USA) 





pCMV-HA (Clontech, USA) 
pCMV-Myc (Clontech, USA) 
pCMV-HA (Clontech, USA) 
pCMV-HA (Clontech, USA) 
pCMV-HA (Clontech, USA) 
















DMycC(F) CCGGAATTCGGATGAATAACCAACGAAAA (D)MycC pCMV-Myc (Clontech, USA) 
DMycC∆15(F) CCGGAATTCGG CTGAAACGCGAGAGAAAC (D)MycC∆15 pCMV-Myc (Clontech, USA) 
DMycC(R) CCGCTCGAGTTA CGCCATCACTGTTGGAAT (D)MycC 
(D)MycC∆15 
pCMV-Myc (Clontech, USA) 
pCMV-Myc (Clontech, USA) 
 
(F) denotes forward primer and (R) denotes reverse primer. Restriction site in 
each primer used for cloning in (i) yeast and (ii) mammalian expression systems 
are shown in bold. The overhang sequences were underlined. The Kozak 










B. Reagents for agarose gel electrophoresis 
(i) 50 x Tris-acetate-EDTA (TAE) buffer, pH 8.0 
Items Amount Source 
Tris base 242.0 g Merck, Germany 
Glacial acetic acid 57.1 g Merck, Germany 
0.5 M EDTA pH8.0 100 ml Merck, Germany 
Deionised water 900 ml Millipore, USA 
 
To prepare 1 x TAE buffer, 50 x stock solution was diluted in the ratio of 1:50 
using deionized water 
 
(ii) Ethidium bromide (EtBr) 
About 0.2 g of EtBr (Sigma, USA) was dissolved in 20 ml of deionized 
water (Millipore, USA) by stirring with a magnetic stirrer at RT for 




(iii) 1% Agarose gel 
Items Amount Source 
Ultra-pure agarose 3.0 g Invitrogen, USA 
10 TAE 300 ml See Appendix 3B(i) 
Ethidium Bromide (10 
mg/ml) 
10 l See Appendix 3B(ii) 
 
To cast 1% DNA agarose gel, 3 g of agarose was mixed with 300 ml 1x TAE 
buffer in a 500 ml conical flask and heated to a boil in a microwave. The flask of 





mixed. The molten agarose was then poured into a gel casting tray and the gel 
combs were inserted. The solidified gel was then submerged in the gel 
electrophoresis tank (Bio-Rad, USA) filled with 1x TAE buffer. 
 
(iv) 10 x Gel loading buffer 
Items Amount Source 
Glycerol 10 ml Merck, Germany 
Bromophenol Blue 83 mg Sigma, USA 
EDTA 10 mM Merck, Germany 
Tris-EDTA, pH 8.0 10 ml Merck, Germany 
Deionised water top up to 20 ml Millipore, USA 
 
C. Media for bacterial culture 
(i) Luria Bertani (LB) broth, pH 7.0 
Items Amount Source 
Bacto-tryptone 10.0 g Clontech, USA 
Bacto-yeast extract 5.0 g Clontech, USA 
NaCl  10.0 g Merck, Germany 
Deionised water top up to 1 L Millipore, USA 
 
All the above components were dissolved in 1 L deionized water and autoclaved 









(ii) Luria- Bertani (LB) agar, pH 7.0 
Items Amount Source 
Bacto-tryptone 10.0 g Clontech, USA 
Bacto-yeast extract 5.0 g Clontech, USA 
NaCl  10.0 g Merck, Germany 
Bacto-agar 20.0 g Clontech, USA 
Deionised water top up to 1 L Millipore, USA 
 
All the above components were mixed with 1 L deionized water and autoclaved at 
121°C for 15 min. After cooling to 55°C, the appropriate antibody was added and 
poured into petri dishes. The plates were stored at 4°C until further use.  
 
(iii) Antibiotics 
Items Amount Source 
Ampicillin 100 mg Sigma, USA 
Kanamycin 50 mg Sigma, USA 
Deionised water 1 ml Millipore, USA 
 
All antibiotic solutions were filter-sterilised through a 0.2 m filter and stored at -
20C prior to use. The stock concentrations of ampicillin and kanamycin are 100 
mg/ml and 50 mg/ml, respectively. Working concentrations of ampicillin and 








D. Sequencing primers 

















E. Reagents used for sequencing  
(i) DEPC-treated water 
One litre of 0.1% DEPC-treated water was prepared by adding 1 ml of 
DEPC (Sigma, USA) to 100 ml of deionised water (Millipore, New 
Hampshire, USA) and mixed well. It was left to stir on a magnetic 
stirrer/hotplate (Bibby Sterilin, UK) overnight at 25°C. The solution was 
then autoclaved for 15 min at 121°C. 
 
(ii) 70% ethanol 






F. Primers used in mutagenesis study 






















































































































































































































G. DEPC-treated PBS 
One litre of 0.1% DEPC-treated PBS was prepared by adding 1 ml of DEPC 
(Sigma, USA) to 100 ml of PBS (Appendix 1H) and mixed well. It was left to 
stir on a magnetic stirrer/hotplate (Bibby Sterilin, UK) overnight at 25°C. The 





H. Primers used for real-time PCR assay 
Primers used in Plus (+) strand RNA synthesis 
5‟ GGTTCGCCACATCACTACACTT 3‟ 
5‟ GATCAGTTCCGTGAAATGGTTTGA 3‟ 
Primers used in Minus (-) strand RNA synthesis 
5‟ GCGTAATACGACTCACTATA 3‟ 
5‟ GATCAGTTCCGTGAAATGGT 3‟ 
 
Viral RNAs extracted from the culture supernatant as well as from the cell 
lysates were reverse transcribed with Supercriptase III (Invitrogen, USA) 
using the primers corresponding to nucleotides 11000 to 11020. The 
reverse transcripts were applied to a real-time PCR assay using iTaq
TM
 
Supermix (BIO-RAD) with specific primers mentioned above. The 
kinetics of cDNA amplification were monitored with an ABI PRISM 7000 
sequence detection system (Applied Biosystems) using a dual labeled 
probe (5‟ TGGAACCTGCTGCCAGTCATACCACC  3‟) conjugated with 
6-carboxyfluorescein at the 5‟ end and 6-carboxy-tetramethylrhodamine at 
the 3‟ end. The in vitro transcribed RNAs from the full-length infectious 
clones of WNV and DENV were used as the standards for quantification. 
Detection of minus stand viral RNA was performed as mentioned by 
Davis and colleagues (2007). For the detection of minus-strand RNA 
level, T7-tagged primer real time RT-PCR was carried out. The minus-
strand primer, 5‟ gcgtaatacgactcactataGGTTCGCCACATCACTACACTT 





strand RNA. The resulting reverse transcripts with the introduced T7 
sequence were then applied to a real-time PCR assay using iTaq
TM
 

























APPENDIX 4:  REAGENTS FOR PROTEOMIC STUDIES  
A. 12% Separation/resolving gel mixture 
Items Amount Source 
30% Acrylamide & 0.8% 
bis-acrylamide 
12.0 ml BioRad, USA 
1 M Tris buffer, pH 8.8 11.25 ml Merck, Germany 
10% SDS 0.3 ml Merck, Germany 




40.0 l BioRad, USA 
10% Ammonium 
persulphate  
80.0 l Merck, Germany 
 
B. 5% Stacking gel mixture 
Items Amount Source 
30% Acrylamide & 0.8% 
bis-acrylamide 
1.67 ml BioRad, USA 
0.5 M Tris buffer, pH 6.8 2.5 ml Merck, Germany 
10% SDS 0.1 ml Merck, Germany 




l BioRad, USA 
10% Ammonium 
persulphate  








C. SDS-PAGE Running Buffer (pH 8.9) 
Items Amount Source 
Tris-base 6.07 g Merck, Germany 
Glycine 28.73 g Merck, Germany 
SDS 2.0 g Merck, Germany 
Deionised water 1 L Millipore, USA 
 
(i) Upper tank buffer 
To prepare 500 ml of upper tank buffer, 250 ml of above SDS-PAGE 
running buffer was mixed with 250 ml of deionized water.  
 
(ii) Lower tank buffer 
To prepare 4 L of lower tank buffer, 750 ml of above SDS-PAGE running 
buffer was mixed with 3250 ml of deionized water.  
 
D. Sample loading buffer 
Items Amount Source 
1 M Tris, pH 6.8 2.4 ml Merck, Germany 
SDS 0.8 g Merck, Germany 
Glycerol (100%) 4 ml Analar, USA 
Bromophenol Blue 0.01% 
(Final concentration is 
0.02%) 
Sigma, USA 
-mercaptoethanol  1 ml Sigma, USA 






E. Transfer buffer 
Items Amount Source 
Glycine 14.4 g Merck, Germany 
Tris-base 3.03 g Merck, Germany 
Methanol 200 ml Merck, Germany 
Deionised water 800 ml Millipore, USA 
 
Glycine and Tris-base were added and mixed well with 800 ml of deionised water 
before the addition of methanol. The reagent should be freshly prepared. 
 
F. 1 x Tris-buffered saline with 0.5% Tween-20 (TBST) 
Items Amount Source 
Tris-base 3.0 g Merck, Germany 
KCl 0.2 g Merck, Germany 
NaCl 8.8 g Merck, Germany 
Tween-20 1.0 ml Merck, Germany 
Deionised water 1 L Millipore, USA 
 
G. 5% Skimmed milk 
Items Amount Source 
Skimed milk 5.0 g Anlene, Australia 








H. 1 x Phosphate-buffered saline with 0.05% Tween-20 (PBST) 
Items Amount Source 
PBS 100 ml See Appendix 1H 
Tween-20 0.05 ml Merck, Germany 
 
I. 1% BSA in PBS 
Items Amount Source 
BSA 1.0 g Invitrogen, USA 
PBS 100 ml See Appendix 1H 
 
J. 4% Paraformaldehyde 
 
Items Amount Source 
25% Paraformaldehyde 16 ml Invitrogen, USA 
PBS 84 ml See Appendix 1H 
 





K. 0.2% Triton-X 
Items Amount Source 
10% Triton-X 200 l ICN, USA 
PBS 100 ml See Appendix 1H 
This reagent was prepared in a glass bottle and then filter sterilized using 0.2 μm 










APPENDIX 5: REAGENTS FOR YEAST TWO-HYBRID (Y2H) ASSAY 
 
A. Yeast peptone dextrose adenine (YPDA) medium 
Items Amount Source 
Difco peptone 20 g Clontech, USA 
Yeast extract 10 g Clontech, USA 
Agar (for plates only) 20 g Clontech, USA 
0.2% adenine hemisulphate 15 ml Sigma, USA 
 
All reagents were dissolved in 950 ml of deionized water. The pH of the medium 
was adjusted to 6.5 and autoclaved at 121°C for 15 min. The YPDA medium was 
cooled to ~55°C and 50 ml of sterile 40% dextrose was added and the final 
volume was adjusted to 1 L.  
 
B. 1 x TE/LiAc solution 
Items Amount Source 
10 x TE buffer 1 ml Clontech, USA 
10 x LiAc 1 ml Clontech, USA 
Deionised water 8 ml Millipore, USA 
 
The above reagents were mixed together before use. 
 
C. Herring testes carrier DNA (10 mg/ml) 
The herring testes carrier DNA in solution was denatured by placing it in a boiling 







D. PEG/LiAc solution 
Items Amount Source 
PEG 4000 8 ml Clontech, USA 
10 x TE buffer 1 ml Clontech, USA 
10 x LiAc 1 ml Clontech, USA 
 
The above reagents were mixed together before use. 
 
E. Synthetic drop-out (SD) medium 
Items Amount Source 
Minimal SD base 26.7 g Clontech, USA 
-Trp supplement (-Trp) 0.74 g Clontech, USA 
-Leu supplement (-Leu) 0.69 g Clontech, USA 
-His supplement (-His) 0.77 g Clontech, USA 
-Trp-Leu supplement (DDO) 0.64 g Clontech, USA 
-Trp-Leu-His supplement (TDO) 0.62 g Clontech, USA 
-Trp-Leu-His-Ade supplement (QDO) 0.6 g Clontech, USA 
Bacto-agar (for plates only) 20 g Clontech, USA 
Deionised water 1 L Millipore, USA 
 
Minimal SD base and one of the supplements were mixed in 1 L of sterile 
deionized water and the pH of the medium was adjusted to 5.8 and autoclaved at 










F. 2 x YPDA medium containing kanamycin (2 x YPDA/Kan) 
Items Amount Source 
Difco peptone 20 g Clontech, USA 
Yeast extract 10 g Clontech, USA 
Agar (for plates only) 20 g Clontech, USA 
0.2% adenine hemisulphate 15 ml Sigma, USA 
 
To prepare 2 x YPDA/Kan medium, the above reagents were dissolved in 475 ml 
of deionized water and the pH of the medium was adjusted to 6.5 and autoclaved 
at 121°C for 15 min. The YPDA medium was cooled to ~55°C and 25 ml of 
sterile 40% dextrose and 1.5 ml of 50 mg/ml kanamycin (final concentration 10-
15 mg/L) were added.  
 
G. 0.5 x YPDA medium containing kanamycin (0.5 x YPDA/Kan) 
Items Amount Source 
Difco peptone 20 g Clontech, USA 
Yeast extract 10 g Clontech, USA 
Agar (for plates only) 20 g Clontech, USA 
0.2% adenine hemisulphate 15 ml Sigma, USA 
 
To prepare 0.5 x YPDA/Kan medium, the above reagents were dissolved in 1900 
ml of sterile water and the pH of the medium was adjusted to 6.5 and autoclaved 
at 121°C for 15 min. The YPDA medium was cooled to ~55°C and 100 ml of 
sterile 40% dextrose and 6 ml of 50 mg/ml kanamycin (final concentration 10-15 







H. QDO + X-α-Gal plates 
Twenty micrograms of 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
(Clontech, USA) was dissolved in 1 ml of N, N‟-dimethylformamide (Sigma, 
USA) and store in the dark at -20°C until use. One hundred microlitres of X-α-Gal 
























APPENDIX 6: REAGENTS FOR MAMMALIAN TWO-HYBRID (M2H) 
ASSAY 
 
A. Controls used in M2H assay 
Controls Transfection  Purpose 
Negative control  
(NC) 
pCR®2.1/VP16-CP 
negative control plasmid 
was co-transfected with the 
reporter plasmid 
pGAL/lacZ 
To detect the levels of false 
positive interactions 
Background LacZ control 
(BCLac) 
No transfection 
To determine the 
background -galactosidase 





positive control plasmid 
was co-transfected with the 
reporter plasmid 
pGAL/lacZ 
To verify induction of the 
reporter gene 
Positive interaction control 
(PIC) 
pCR®2.1/p53 bait control 
plasmid and pCR®2.1/LgT 
prey control plasmid were 
co-transfected with the 
reporter plasmid 
pGAL/lacZ 
To verify that the cell line 
and detection are working 
properly 




Prey construct was co-
transfected with the 
reporter plasmid 
pGAL/lacZ in the absence 
of bait construct 
To check if prey protein can 
function as a transcriptional 
activator in the absence of 
bait protein 
Background controls for full-












Bait construct was co-
transfected with the 
reporter plasmid 
pGAL/lacZ in the absence 
of prey construct 
To check if bait protein can 
function as a transcriptional 







APPENDIX 7: REAGENTS USED IN LENTIVIRUS-MEDIATED KNOCK-
DOWN AND OVER-EXPRESSION OF hSec3p 
 
A. Primers used in the knock-down of hSec3p  
Short hairpin oilgos used in hSec3p gene silencing 
Top strand oligo 5‟-CACCGGAGGTAGATCAGATTGAATTCGAAAATTCAATCTGATCTACCTCC-3‟ 
5'-CACCGCTAAAGAGTACAGATTATGGCGAACCATAATCTGTACTCTTTAGC-3‟ 
Bottom strand oligo 
5'-AAAAGGAGGTAGATCAGATTGAATTTTCGAATTCAATCTGATCTACCTCC-3‟ 
5'-AAAAGCTAAAGAGTACAGATTATGGTTCGCCATAATCTGTACTCTTTAGC-3‟ 
Short hairpin oilgos used for scrambled control 
Top strand oligo 5‟-CACCTTGTGATGGAATAGGAAGCATCGAAATGCTTCCTATTCCATCACAA-3‟ 
Bottom strand oligo 5‟-AAAATTGTGATGGAATAGGAAGCATTTCGATGCTTCCTATTCCATCACAA-3‟ 
 
B. Primers used in the over-expression of hSec3p  
hSec3p over-expression 
Forward primer 5‟-CACCATGGCAGCAATCAAGCAT-3‟ 
Reverse primer 5‟-GTGGGACTGTGCAATGCT-3‟ 
Control vector 
Forward primer 5‟-CACCATGCTACCCAAAGACCTC-3‟ 














C. Growth medium, DMEM for hSec3p293OE and hSec3p293KD cells 
(~pH 7.3) 
 
The pH of the media was then adjusted to approximately 7.3 with a handheld pH 
meter (Beckman Coulter Inc., USA). The solution was then sterilised by filtration 
in a sterile environment through a 0.2 µm PES membrane bottle top filter unit 
(Nalge Nunc International, Denmark). A 20 ml aliquot of filtered media was used 
for screening of microbial contamination by incubation at 37°C for 3 days before 
the addition of FBS, geneticin, glutamine, non-essential amino acids and pyruvic 
acid. The serum supplemented media were kept at 4°C until further use. The cell 





Items Amount Source 
DMEM 1 bottle Sigma, USA 
Foetal bovine serum 100 ml PAA Laboratories, Austria 
NaHCO3 3.7 g Merck, Germany 
Geneticin 50 mg/ml Invitrogen, USA 
L-glutamine 2 mM Invitrogen, USA 
Non-essential amino acids 0.1 mM  Invitrogen, USA 
Pyruvic acid 1 mM Invitrogen, USA 





APPENDIX 8: REAGENTS USED IN PROTEIN-RNA INTERACTION 
ASSAYS 
 
A. Wash buffer used in streptavidin-conjugated magnetic pull down 
assay 
Items  Stock Final 50 ml Freshly add 
to 1 ml of 
wash buffer 
HEPES 0.5 M 10 mM 1 - 
MgCl2 1 M 2 mM 0.1 - 
KCl 1 M 10 mM 0.5 - 
NP-40 100% 0.1% 0.05 - 
EDTA 0.4 M 0.5 mM 0.0625 - 
NaCl 5 M 150 mM 1.5 - 
H2O - - 46.7875 - 
DTT 1 M 1 mM - 1 l 
PMSF 100% 0.1% - 1 l 
Protease 
cocktail 
25 units/ml 1 unit/ml - 40 l 
 
 
B. Binding buffer with BSA 
Items Final 
HEPES (pH 7.4) 20 mM 
MgCl2 2.5 mM 
KCl 75 mM 
NP-40 0.05% 
EDTA 0.1 mM 
BSA 1% 
DTT 1 mM 
Protease cocktail 1 unit/ml 
 
 
C. Binding buffer without BSA 
Items Final 
HEPES (pH 7.4) 20 mM 
MgCl2 2.5 mM 
KCl 75 mM 
NP-40 0.05% 
EDTA 0.1 mM 
DTT 1 mM 





APPENDIX 9: BIOINFORMATICS SOFTWARE USED IN THIS STUDY 
 
 
Function Name URL or Manufacturer 







































siRNA Wizard http://www.sirnawizard.com/scrambled.php 
 
 
 
 
